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Abstract 
 Herpes Simplex Virus-1 (HSV-1) is the primary cause of sporadic viral 
encephalitis in the United States. While prompt treatment results in high survival rates, 
greater than fifty percent of patients develop severe, life-altering neurological deficits 
subsequent to Herpes Simplex encephalitis (HSE). Inflammatory cues generated during 
non-HSE viral encephalitis have been shown to alter reparative neurogenesis in humans 
and mice. However, interactions between induced immune responses and the normal 
processes of adult neurogenesis remain unexplored during HSE. The present thesis 
hypothesized that inflammation induced by experimental HSV-1 infection of 
laboratory mice alters neural stem/progenitor cell (NSC) proliferation. The response 
of NSCs was dynamic throughout HSV-1 infection of adult BALB/c mice, with a 
significant increase in the NSC population during acute HSE at 6 d p.i. and a significant 
decrease by 15 d p.i.. The 6 d p.i. and 15 d p.i. time points coincided with macrophage 
infiltration and CD8(+) T cell infiltration respectively. 
At 6 d p.i., infiltrating macrophages were observed to be alternatively activated 
(M2) whereas macrophages at 15 d p.i. were classically activated (M1 macrophages). 
Treatment with M2 macrophages resulted in significant increases in the NSC population 
size both in vivo and in vitro. In vitro, the increase in NSC proliferation was found to be 
mediated via Wnt5a. In vivo, transplanted M2 macrophages increased the number of 
NSCs and Wnt5a(+)CD11b(+) macrophages were observed in the brains of 5 d p.i. mice. 
On the other hand, M1 macrophages activated with interferon-γ did not support NSC 
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proliferation, which suggested that macrophage effects may be modulated by other 
immune factors present in the infected brain. 
CD8(+) T cells are the largest population of infiltrating immune cells during 
chronic HSE and produce robust amounts of IFN-γ. The interactions of CD8(+) T cells 
and NSCs were addressed in vitro and in vivo experiments. Co-culture of activated 
CD8(+) T cells and NSCs abrogated NSC proliferation in vitro while in vivo depletion of 
CD8(+) T cells restored the NSC population in infected mice. Further evaluation of the 
effect of CD8(+) T cells on NSC proliferation was dependent on IFN-γ both in vivo and 
in vitro, as IFN-γ receptor 1 (IFN-γR1) knockout mice were unresponsive to CD8(+) T 
cells in culture and infected IFN-γR1 knockout mice had no reduction in the size of the 
NSC population.  
To continue evaluation of interactions of NSC proliferation and IFN-γ, alternative 
models of HSE were assessed in C57BL/6 mice. The kinetics of immune cell and NSC 
proliferation were similar between BALB/c and C57BL/6 mice, but macrophage and T 
cell phenotypes were different between the strains. Macrophages infiltrating the brain, at 
any time point examined, were persistently classically activated with an M1 phenotype, 
and T cell infiltration was dominated by CD4(+) T cells in C57BL/6 mice. On the other 
hand, NSC proliferation was significantly decreased when IFN-γ was expressed 
suggesting that the interactions of IFN-γ and NSCs were similar in both strains of mice 
tested.  
The studies presented in this dissertation are the first to suggest a connection 
between IFN-γ produced by infiltrating T cells and impaired NSC proliferation. The 
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mechanism by which T cells mediate this effect may be direct or through interaction with 
other cell types in the brain. However, there are implications that NSC proliferation and 
associated reparative neurogenesis may be impacted in any model of brain damage that 
exhibits prominent IFN-γ expression.  
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Introduction 
Herpes simplex virus type 1 infection (HSV-1) is the most common cause of 
sporadic viral encephalitis (HSE) of immunocompetent people in the United States. 
Acyclovir treatment is effective at preventing mortality, however approximately 70% of 
surviving patients develop life altering neurological deficits (Kapur N 1994; McGrath, 
Anderson et al. 1997; Whitley 2006; Baringer 2008). The predominant clinical conditions 
observed following HSE include anterograde memory loss, anosmia, and dysphasia 
(McGrath, Anderson et al. 1997). Classically, adult HSE manifests as bilateral lesions of 
the temporal lobes, with or without parietal and frontal lobe involvement (Margaret  
1982). Damage produced by HSV-1 is confined functionally and anatomically to the 
limbic system, particularly the amygdaloid nucleus, hippocampus, and insula.  
HSE is also associated with persistent immune activation in human patients. 
Studies evaluating the cerebrospinal fluid (CSF) have found circulating CD8(+) T cells 
two months after the presentation of disease (Lellouch-Tubiana, Fohlen et al. 2000; 
Kimberlin 2007; Studahl, Lindquist et al. 2013). Abnormally elevated levels of neopterin, 
a biomarker of immune cell activation, were detected in the CSF of HSE patients more 
than one year after the resolution of disease, whereas serum levels of neopterin in the 
same patients returned to normal limits within three weeks after viral activity ceased to be 
detectable   (Aurelius, Forsgren et al. 1993). As expected, robust increases in CSF 
concentration of interleukin-6, interferon-γ, and tumor necrosis factor-α (TNF-α) were 
observed in HSE patients during the symptomatic phase. However, CSF concentrations 
of these three cytokines remained abnormally elevated for several weeks after disease 
symptoms were resolved (Aurelius, Andersson et al. 1994; Studahl, Lindquist et al. 
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2013), suggesting that a robust and long-lasting immune response had been induced in 
the context of HSE in human patients.  
HSV-1 brain infection in the BALB/c mouse model used in this dissertation, 
induces a Th1-type immune response that persists long after virus ceases to be detectable 
which similar to the human condition. Robust secretion of TNF-α and IFN-γ coincides 
with peak macrophage and T cell infiltration during the acute phase of infection in the 
mouse model (Marques, Cheeran et al. 2008) and human patients (Lellouch-Tubiana, 
Fohlenet al. 2000) Moreover, the experimental infection model in BALB/c mice enables 
evaluation of both immune cells as well as the soluble components composing the 
inflammatory response to HSV-1 brain infection. Previous studies using this mouse 
model have shown that the cellular immune response is complex and highly dynamic. 
Peak macrophage infiltration occurs around 6 d p.i. and is followed by peak T cell 
infiltration at 15 d p.i. (Marques, Cheeran et al. 2008). In contrast to other models of 
encephalitis, HSE in BALB/c mice is marked by persistent infiltration (or possibly 
retention) of CD8(+) T cells, which is observed in the brain through 60 d p.i., long after 
apparent viral clearance. The prolonged retention of CD8(+) T cells in the HSV-1 
infected brain suggests that these cells may influence recovery from virus induced 
damage. Observations in the mouse models of West Nile encephalitis and HSV-1infected 
trigeminal ganglion have demonstrated that CD8(+) T cells are important for viral 
clearance from CNS tissue (Wang, Lobigs et al. 2003; Mackay, Wakim et al. 2012). 
However, CD8(+) T cells have also been shown to facilitate long-term immunopathology 
resulting from viral encephalitis or non-infectious brain damage (Fontana A 1987; 
Steinman 2001; Wang, Lobigs et al. 2003). 
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Neural stem/progenitor cells (NSCs) are remnants of the neuroectoderm layer 
from embryonic development that persist in the adult brain. There are two major germinal 
niches in the adult where neurogenesis occurs, the subventricular zone of the lateral 
ventricles (SVZ) and the subgranular zone (SGZ) of the dentate gyrus in the 
hippocampus (Doetsch and Alvarez-Buylla 1996; Kornblum 2007). The SVZ is 
composed of multiple cell types including, a population of  slowly dividing, radial 
astroglial stem cells called B cells, the transit amplifying intermediate C cells, and a 
population of immature, migratory neuroblasts called A cells (Doetsch, Garcı́a-Verdugo 
et al. 1997; Doetsch, Caillé et al. 1999; Danilov, Gomes-Leal et al. 2009). All three cell 
types are capable of proliferation while in close proximity to the neurogenic niche and are 
referred to collectively as neural stem/progenitor cells (NSCs) throughout this 
dissertation. In the healthy adult murine brain, the primary function of NSCs is to 
facilitate turnover of olfactory interneurons and provide new pyramidal neurons in the 
hippocampus during novel memory formation. Numerous murine model systems have 
suggested that this physiological process of adult neurogenesis may have the capacity to 
ameliorate brain damage by replacing damaged neuronal circuitry (Jordan, Ojeda et al. 
2009). 
Brain damage, regardless of the etiology, has been shown to stimulate reparative 
adult neurogenesis in humans and mice. Following a brain insult, the neurogenic process 
begins with proliferation of endogenous NSCs (Lichtenwalner and Parent 2005; Parent, 
Elliott et al. 2006). NSCs migrate towards areas of damage via a chemokine gradient 
(Imitola, Raddassi et al. 2004; Belmadani, Tran et al. 2006). At sites of damage NSCs are 
thought to have two primary functions: 1) differentiating into neurons to integrate into the 
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existing neuronal circuitry, and 2) trophic functions that promote an environment 
permissive of repair in the brain. Particularly, NSCs have been shown to increase 
production of anti-inflammatory cytokines and thereby suppress T cell activation 
(Fainstein, Einstein et al. 2013; Zhang, Liu et al. 2013). However, the pro-inflammatory 
milieu around lesion sites can decrease NSC survival and impair their ameliorative 
functions. This phenomenon was elegantly demonstrated in a rodent model of ischemic 
stroke where only 20% of NSCs generated survive this pro-inflammatory environment 
and become neurons (Arvidsson, Collin et al. 2002).  
To evaluate interactions between the immune system and NSCs during HSE, this 
research project makes use of a murine model, where the virus replication at the initial 
site of infection and subsequent spread into the brain via retrograde transport in discrete 
neural tracts is similar to that seen in humans. Intranasal inoculation of BALB/c mice 
with Herpes Simplex Virus (HSV)-1 results in initial infection of the olfactory nerve 
terminals and subsequent spread of the virus through olfactory nerves into the entorhinal 
cortex and fimbria of the hippocampus. In both humans and mice, the virus also traffics 
through the trigeminal nerve tract to associated brain stem regions (Webb SJ 1989; Esiri, 
Drummond et al. 1995; Armien, Hu et al. 2010). Importantly, and similar to the human 
condition, while the virus stays localized to the specific neural tracts used for trafficking 
within the infected mouse brain, the resultant inflammation is wide-spread throughout the 
brain. 
Interactions between inflammation and adult neurogenesis have been observed in 
other animal models of viral encephalitis, yet it remains unclear if such an association 
exists during in HSE. In addition, the immune components involved in bilateral 
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interactions with NSCs, during recovery from brain damage, are not well understood.  
The development of neurological sequelae in the presence of activated T cells suggests 
that such interactions may indeed occur during HSE. However, the mechanisms altering 
adult neurogenesis during HSE, if any, are unknown. Given the chronic presence of 
activated immune cells in the brain during HSE, the hypothesis tested in this dissertation 
is that inflammation induced by HSV-1 brain infection alters NSC proliferation. The 
first objective was to evaluate the response of the neurogenic niche during HSE (see 
Chapter 3). As immune responses have  been shown to promote anti-proliferative effects 
on NSCs in mouse models of Japanese encephalitis (JEV) and West Nile (WNV) 
encephalitis (Wang, Lobigs et al. 2003; Dutta, Mishra et al. 2010), the first hypothesis 
tested was that NSC proliferation is impaired during HSE with potential 
contributions to the development of neurological deficits. These experiments 
established strong associations between inflammatory cell infiltrates and NSC 
proliferation. During peak macrophage infiltration, at 6 d p.i., proliferation of 
nestin/Sox2(+) NSCs was significantly increased, relative to uninfected age-matched 
BALB/c mice. Conversely, nestin/Sox2(+) NSC proliferation was significantly decreased 
relative to uninfected mice at 15 d p.i., at a time corresponding to peak T cell infiltration.  
Specific macrophage activation profiles have been implicated in promoting tissue 
regeneration in a variety of damage models. Increased levels of tissue restoration and 
anti-inflammatory products have been shown to be associated with M2 macrophage 
function, particularly in myocardial infarction (Aurora, Porrello et al. 2014; Weirather, 
Hofmann et al. 2014), DSS-induced colitis (Takada, Hisamatsu et al. 2010), and ischemic 
stroke in rodent models (Hu, Li et al. 2012). To investigate the impact of macrophages on 
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NSCs during HSE, the hypothesis that alternatively activated 
monocytes/macrophages stimulate NSC proliferation between 3 and 6 d p.i. was 
tested. Data from these studies, as described in Chapter 4, demonstrated that 
macrophages infiltrating the brain at 5 d p.i. were alternatively activated (M2). While at 
15 d p.i., macrophages present in the brain exhibited a classically activated (M1) 
phenotype. Furthermore, treatment of NSCs with M2 conditioned macrophage 
supernatants significantly increased cell proliferation both in vitro and in vivo. Additional 
evaluation demonstrated that the M2 macrophage effect on NSC proliferation in vitro 
were dependent on the production of WNT5a. In contrast, M1 macrophage supernatants 
abrogated NSC proliferation, suggesting that M1 macrophage polarization may decrease 
NSC proliferation in vivo.  
IFN-γ is a known inducer of the M1 macrophage phenotype.. Significant amounts 
of IFN-γ are expressed during HSE (Marques, Cheeran et al. 2008), suggesting that IFN-γ 
may mediate the M1 macrophage polarization observed in the brain at 15 d p.i... The next 
objective of this research was to determine whether IFN-γ would alter NSC proliferation 
(see Chapter 5). The hypothesis underlying these studies was that CD8(+) T cells inhibit 
NSC proliferation in an IFN-γ dependent manner. Activated CD8(+) T cells, but not 
CD4(+) T cells, inhibited NSC proliferation in vitro and promoted NSC differentiation 
into GFAP(+) astrocyte-like cells. The inhibitory effects of activated CD8(+) T cells on 
NSC proliferation were mediated by IFN-γ, given that activated CD8(+) T cells did not 
alter NSC proliferation in IFN-γ receptor knockout NSCs in vitro.  
To further investigate the in vivo relevance of IFN-γ during HSE, the next series 
of experiments investigated the impact of CD8(+) T cells on adult neurogenesis in HSV-1 
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infected mouse brains at 15 d p.i. (see Chapter 6). Specifically the hypothesis tested was 
that CD8(+) T cells inhibit NSC proliferation in an IFN-γ dependent manner during 
chronic HSE. Removal of CD8(+) T cells using a depleting antibody resulted in a 
significant increase in the NSC population in infected BALB/c mice, without changing 
the numbers or phenotypes of the CD4(+) T cells present in CD8(+) T cell depleted mice. 
There was also a significant reduction in expression of IFN-γ compared to isotype 
antibody-treated controls. The specific role of IFN-γ was evaluated using HSV-1 infected 
IFN-γ receptor 1 knock out mice (IFN-γR1 KO). NSC proliferation in infected IFN-
γR1KO mice was assessed at 15 d p.i.. Total numbers of NSCs in the brains of infected 
mice were significantly increased compared to infected wild-type mice. Furthermore, the 
total numbers of NSCs in infected IFN-γR1 KO animals were consistent with numbers 
seen in uninfected IFN-γR1KO and wild-type BALB/c mice. 
The final objective of this dissertation was to develop a C57BL/6 mouse model of 
HSE as a possible alternative model of corroborating and extending the findings 
described above. The BALB/c mouse model of HSE is limited by the lack of genetically 
modified mice available on this background and thus the degree to which disease 
processes can be manipulated to test the role of IFN-γ and CD8(+) T cells on adult 
neurogenesis. The objective of this section of the dissertation was to validate the 
reproducibility of disease, assess HSV-1 induced neuroinflammation, and 
investigate its effect on NSC proliferation in a C57BL/6 mouse model. Mouse 
mortality and clinical disease scores were not significantly different in HSV-1 infected 
BALB/c vs C57BL/6 mice. While NSC proliferation followed roughly the same kinetics 
in C57BL/6 mice as in BALB/c mice, the profile of activated immune cells infiltrating 
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the brain was different. Infiltrating macrophages were consistently polarized to the M1 
phenotype and CD4(+) T cells comprised the majority of infiltrating T cell population 
from 10 d p.i. to 30 d p.i. in HSV-1 infected C57BL-6 mice.  
In summary, there are four major findings from these studies. First, NSCs respond 
dynamically to immune cues during HSE. Second, M2 macrophages promote NSC 
proliferation via a Wnt5a-dependent mechanism. Third, activated CD8(+) T cells inhibit 
NSC proliferation and promote an M1 phenotype in macrophages through the production 
of IFN-γ. Lastly, a C57BL/6 mouse model may prove valuable to examine the 
neuroimmune response in a more detailed fashion than is currently possible in the 
BALB/c mouse model as the C57BL/6 mouse macrophages are prone to classical 
activation during acute HSE. Importantly, these findings provide the first steps in 
understanding the reparative processes occurring in response to viral encephalitis. 
Comprehensive insight into these processes may facilitate development of novel 
therapeutic approaches for patients recovering from viral encephalitis. 
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Introduction: 
 Viral encephalitis results in severe neurological damage for surviving patients. 
Herpes Simplex virus type 1 (HSV-1) is the most common cause of sporadic viral 
encephalitis in the United States, leading to Herpes Simplex encephalitis (HSE) 
(Kimberlin 2007). Greater than 50% of HSE survivors develop life-altering neurological 
deficits following infection. HSE induces robust inflammatory responses during infection 
that contribute to the development of brain lesions in both humans (Esiri, Drummond et 
al. 1995) and in mouse models (Armien, Hu et al. 2010). Emerging evidence suggests 
that a small population of neural stem/progenitor cells in the brain respond to damage in 
an attempt to restore disrupted neuronal circuitry in murine ischemic stroke (Imitola, 
Raddassi et al. 2004). On the other hand, understanding of how the brain responds to 
intraorgan damage is poorly understood. This literature review examines the development 
and persistence of brain lesions during HSE and to address the potential of adult 
neurogenesis to improve associated tissue damage.  
Herpes Simplex encephalitis 
While survival rates with timely HSE treatment are approximately 97%, greater 
than 50% of HSE patients will develop life altering neurological deficits (Kimberlin 
2007). The nature of reported deficits  range from anosmia to significant reductions in 
verbal memory tasks and are consistent with damage lesions in the sensory motor cortex 
regions of the frontal cortex (Hokkanen, Poutiainen et al. 1996). Similar to the human 
condition, significant impairment during spatial memory tasks has been observed in the 
BALB/c mouse model of HSE, as animals are unable to find a platform during the Morris 
water maze task and have lesions in their sensory motor cortex (Armien, Hu et al. 2010). 
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While the physical damage resulting from HSE has been well characterized in both 
humans and mice, understanding of the pathophysiology of HSE is incomplete. 
Greater than 70% of the adult population in the United States is seropositive for 
Herpes Simplex Virus-1 (HSV-1) (Xu, Sternberg et al. 2006) and yet the incidence of 
HSE is very low (James, Kimberlin et al. 2009). It remains unknown if HSE results from 
primary infection of a previously unexposed individual with HSV-1 or if the encephalitis 
is the result of reactivation of HSV-1 latent in one or more nerve tracts (Aurelius, 
Forsgren et al. 1993; Kimberlin 2007; Baringer 2008). While the specific insult resulting 
in HSV-1 migration into the brain is unknown, the progression of the virus through the 
human brain has been suggested from damage patterns and sites of viral latency in HSE 
survivors. Progression of the virus through the human brain would seem to be begin with 
two possible origins of the virus in the brain, the olfactory bulb and the trigeminal ganglia 
(Margaret 1982; Kimberlin 2007; James, Kimberlin et al. 2009). From those two sites, 
the virus would seem to progress through the thalamus to the temporal lobe, creating 
characteristic lesions (Margaret 1982; McGrath, Anderson et al. 1997; James, Kimberlin 
et al. 2009).  
Based on this understanding of the progression of HSV-1 through the human 
brain, intranasal induction of HSV-1 infection in BALB/c mice can be regarded as a 
highly relevant experimental model of HSE. HSV-1 in BALB/c mice travels up neural 
tracts to infect the olfactory bulb and also travels up the trigeminal ganglia into the 
brainstem resulting in localization of the virus to specific neural tracts and virus lesion 
formation in regions that match the affected areas in human HSE patients (Margaret 
1982; Whitley 2006; Kimberlin 2007; Marques, Cheeran et al. 2008; Armien, Hu et al. 
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2010). Behaviorally, mice infected with HSV-1 via intranasal inoculation experience 
major deficits in their spatial memory (Armien, Hu et al. 2010), a type of memory that is 
also disrupted in human HSE patients (Whitley 2006), suggesting that the survivor 
phenotypes found in experimentally infected mice are consistent with humans surviving 
HSE. 
Macroscopic brain inflammation during Herpes Simplex Encephalitis 
Unlike Japanese encephalitis or West Nile encephalitis, HSE has two distinct 
phases to the inflammatory response corresponding to an acute phase of lytic viral 
infection where the immune response to the virus is markedly similar to JEV, and a 
chronic phase consisting of latent viral infection of brain neurons and persistent CD8(+) 
T cell infiltration in the brain despite a lack of detectable viral antigen (Marques, Cheeran 
et al. 2008; Armien, Hu et al. 2010). During the chronic phase, significant brain 
remodeling occurs as disease lesions are replaced with astrocytes (Armien, Hu et al. 
2010). HSE surviving animals had severe deficits in their spatial memory one month after 
the initial infection with the virus which were unresolved at the last time point tested, 60 
d p.i. (Armien, Hu et al. 2010). The formation of astrogliotic scars coincides with a robust 
CD8(+) T cell infiltration that has been shown to inhibit reparative brain mechanisms, 
such as adult neurogenesis in other mouse models of viral encephalitis such as Japanese 
encephalitis (Das, Dutta et al. 2011) and West Nile encephalitis (Wang, Lobigs et al. 
2003).  
Interactions of the immune system and the brain are dramatically different from 
interactions of the immune system and peripheral tissues due to physical and molecular 
constrains imposed by the blood-brain barrier (BBB) and the active promotion of an 
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immunosuppressive milieu in the brain parenchyma. The extreme regulation of 
permeability in the BBB minimizes immune surveillance in the brain parenchyma in the 
absence of infection, while many brain cell types, including astrocytes and microglia, 
constitutively produce low levels of anti-inflammatory cytokines (Aurelius, Andersson et 
al. 1994; Ekdahl, Kokaia et al. 2009; Obermeier, Daneman et al. 2013). Damage inducing 
stimuli, such as viruses, result in disruption of the BBB and an alteration in the immune 
activation state of the brain. However, the duration and scope of disruption to the BBB is 
highly variable and dependent both on the quantity and duration of damage processes 
(Schoknecht and Shalev 2012). Persistent disruptions, as observed with HSE, tend to be 
associated with more substantive brain pathology resulting in worse neurological deficits 
(Lellouch-Tubiana, Fohlen et al. 2000; Schoknecht and Shalev 2012). Importantly, with 
immune cell infiltration, the immunosuppressive microenvironment of the brain is shifted 
to allow development of robust and often pathological immune responses depending on 
the nature of the insult (Obermeier, Daneman et al. 2013). 
Cellular inflammation and brain damage: 
 During times of brain damage immune cell infiltration follows similar kinetics 
and mechanisms as the in the periphery. Cellular damage results in secretion of danger 
signaling molecules which are then detected by other local cells and the signal is 
perpetuated to induce opening of the BBB to allow infiltration of immune cells (Murphy, 
Lalor et al. 2010; Nishimura, Yasuda et al. 2013). In HSE, immune cell infiltration is 
temporally regulated with distinct peaks of immune cell infiltration. Initial inflammation 
is mediated by neutrophils, however by three days post-infection macrophage infiltration 
is noticeable. Macrophage infiltration peaks soon after that, between five and six days 
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post-infection before subsiding. By eight days post-infection, T cell infiltration comprises 
a prominent part of the inflammatory compartment (Marques, Cheeran et al. 2008). In 
contrast to the neutrophil and macrophage infiltration patterns, T cell infiltration remains 
persistent with T cells being detected in the brains of surviving humans for months 
(Aurelius, Forsgren et al. 1993) and mice past 60 days (Armien, Hu et al. 2010). 
Surprisingly, the phenotype of these T cells is altered over time going from a one to one 
ratio of CD4(+) to CD8(+) T cells to a two to one ratio of CD8(+) to CD4(+) T cells by 
15 d p.i.. Importantly, these CD8(+) T cells persist after viral antigen ceases to be 
detectable (Marques, Cheeran et al. 2008).  
Macrophage responses to brain damage: 
Macrophage response to brain damage has been shown to be largely pro-
inflammatory, and damaging to the brain parenchyma. However, recent evidence in 
mouse models of stroke suggest that early after ischemia macrophage functions are anti-
inflammatory (Hu, Li et al. 2012). These dichotomous functions can be grouped into two 
large activation states: the classical (M1) phenotype or the alternative (M2) phenotype 
(Fig. 2.1; Ka, Daumas et al. 2014) Classically activated macrophages predominantly 
produce pro-inflammatory cytokines and promote cell death in murine models of septic 
shock (Li, Ma et al. 2014; Lin, Yang et al. 2014). They also have been shown to worsen 
allergenic asthma (Hong, Chung et al. 2014). Predictably, macrophages responding to 
viral infections such as Japanese encephalitis (Dutta, Mishra et al. 2010), West Nile virus 
(Getts, Terry et al. 2012), Herpes Simplex virus (Aravalli, Hu et al. 2005; Marques, Hu et 
al. 2006), coronaviruses (Chen, Kuziel et al. 2001)  and rhinoviruses (Hong, Chung et al. 
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2014) also are classically M1 activated and express high levels of CD32 and iNOS as 
well as tumor necrosis factor-α (Kigerl, Gensel et al. 2009).  
In contrast, alternatively activated M2 macrophages have been associated with 
production of anti-inflammatory cytokines and increased production of growth factors. 
While this type of macrophage has been associated with some disease states, most 
prominently asthma (Müller, Jaunin et al. 1993), M2 macrophages are more frequently 
associated with brain and intestinal tissue growth during development and tissue 
remodeling post injury (Kigerl, Gensel et al. 2009). Specifically, M2 macrophages have 
been shown to have important roles in the development of mouse cortices in utero 
(Cunningham, Martínez-Cerdeño et al. 2013) as well as being essential for spinal cord 
repair in transection models (Kigerl, Gensel et al. 2009; Schwartz 2010; Nishimura, 
Yasuda et al. 2013). Furthermore, despite the dramatic differences in function, these 
macrophage polarization states are not terminal as crossover between  macrophage 
phenotypes has been shown, ex vivo in sheep macrophages (Crespo, Bertolotti et al. 
2013). 
In the context of brain damage, in vivo macrophage activation in murine models 
of stroke has demonstrated that macrophages undergo changes in function from a 
beneficial regenerative phenotype to a more pro-inflammatory damaging phenotype 
following induction of ischemia (Hu, Li et al. 2012). Importantly, pharmacological 
induction of an M2 like phenotype following stroke was associated with better behavioral 
outcomes in ischemic animals (Jin, Cheng et al. 2014). Furthermore, in murine models of 
experimental autoimmune encephalomyelitis, the M2 phenotype was associated with 
marked reduction in both inflammation and disease during remitting phases of disease  
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Figure 2.1: M1 and M2 macrophage polarization. The figure represents canonical M1 and 
M2 agonists that induce the production of M1 and M2 markers by human macrophages in vitro. 
These markers, isolated or combined, have been used to describe the polarization of monocytes 
and macrophages in clinical investigations. Figure reprinted from Ka et al. Frontiers in 
Immunology 2014. 
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(Khoury, Hancock et al. 1992). These findings suggest that the M2 phenotype is 
beneficial during both acute and chronic disease states. 
T cell responses to brain damage: 
Classically activated macrophages and Th1 T cells are often produced together in 
response to antigen while alternatively activated macrophages and Th2 T cells are 
produced together (Stout and Suttles 1993). West Nile virus (WNV) (Kitaura, Fujii et al. 
2011), Japanese Encephalitis virus (JEV) (Das, Dutta et al. 2011), murine (Mutnal, 
Cheeran et al. 2011) and human (Cheeran, Jiang et al. 2008) Cytomegalovirus (mCMV), 
and Herpes Simplex virus (HSV) (Marques, Cheeran et al. 2008) all induce a Th1 type 
immune response. Interestingly, while both CD4(+) and CD8(+) T cells contribute to 
peripheral Th1 type immune responses in these mouse models, CD8(+) T cells 
predominate in the immune response to JEV (Das, Dutta et al. 2011), WNV (Kitaura, 
Fujii et al. 2011), and HSV-1 (Marques, Cheeran et al. 2008). In addition, CD8(+) T cells 
in the brains of mice infected with either WNV or JEV have been shown to mediate 
development of immunopathology and a worsened neurological outcome (Wang, Lobigs 
et al. 2003; Das, Dutta et al. 2011). On the other hand, removal of CD8(+) T cells from 
the brains of encephalitic WNV infected mouse brains also decreased survival indicating 
that while CD8(+) T cells may mediate immunopathology, they are essential for control 
of the virus (Wang, Lobigs et al. 2003).  
Mechanistically, effects of CD8(+) T cells are thought to be dependent on two 
specific mechanisms. First, CD8(+) T cells are known to induce cell death in bystander 
cells during Th1 type immune responses (Lee, Chanamara et al. 2012; Too, Ball et al. 
2014 ). Modulation of CD8(+) T cell activation using the antibiotic minocycline has been 
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shown to greatly improve NSC proliferation following Japanese encephalitis (Dutta, 
Mishra et al. 2010). Secondly, CD8(+) T cells produce interferon-γ (a T cell cytokine), 
which while improving dendrite and synapse survival, has been shown to inhibit NSC 
proliferation following viral encephalitis (Kreutzfeldt, Bergthaler et al. 2013). 
Furthermore IFN-γ has been shown to stimulate an increase in major histocompatibility 
complex I expression on cultured NSCs (Cheeran, Jiang et al. 2008) thus increasing the 
visibility of NSCs to the immune system and increasing the possibility of NSC death via 
cytotoxic T cells. Induction of oligodendrocyte precursor proliferation during multiple 
sclerosis is also thought to be dependent on down regulating CD8(+) T cell activity as 
decreasing IFN-γ secretion during remitting phases of the disease is associated with 
increases in the proliferation of oligodendrocyte precursor cells (Khoury, Hancock et al. 
1992). 
Immunopathology and Neurological Deficits: 
The net effect of inflammatory responses to brain damage is dependent on the 
nature of the initial insult being either infectious or sterile, as these two types of brain 
damage trigger both different immune activation states and immune cell infiltration 
kinetics. Mouse models of ischemia (Hu, Li et al. 2012) and traumatic brain injury 
(Yoles, Hauben et al. 2001) have shown that there is greater infiltration of CD206, 
interleukin-10 expressing macrophages (M2-like) and earlier infiltration of regulatory T 
(Tregs) cells compared to infectious stimuli at acute time points suggesting that the 
immune response is less damaging to surrounding tissues. Specific induction of 
alternatively activated macrophages and immunosuppressive Tregs are important as they 
control multiple divergent phenotypes in T cells (Mosmann, Cherwinski et al. 1986; 
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Fiorentino, Bond et al. 1989) and macrophages (Stout and Suttles 1993; Kigerl, Gensel et 
al. 2009) thus having the capacity to directly affect the pro or anti-neurogenic nature of 
the brain milieu. Activation of these anti-inflammatory or immunosuppressive immune 
cell subsets is associated with decreased tissue damage in the brain (Kalluri and Dempsey 
2008; Hu, Li et al. 2012; Jin, Cheng et al. 2014) and the gut (Ito, Shin-Ya et al. 2006; Lin, 
Yang et al. 2014). 
 Development of neurological deficits following viral encephalitis is the result of 
damage to the neural tracts responsible for learning, memory, sensory perception, and 
other brain functions. Immune mediated brain damage during viral encephalitis has been 
shown to occur by two distinct mechanisms: destruction of infected cells and by-stander 
damage (Hokkanen, Poutiainen et al. 1996; Wang, Lobigs et al. 2003; Das and Basu 
2008). While destruction of infected cells is an essential feature of virus control, by-
stander damage is the destruction of uninfected cells in physical proximity to infected 
cells (Capone, Frigerio et al. 2007). Regeneration of neural tracts is dependent on 
replacement of neurons with neurons and not scar generating cells such as astroglia, 
furthermore these neurons must have the same functional connectivity as the neurons 
they replace (Kornblum 2007; Martino, Pluchino et al. 2011; L'Episcopo, Tirolo et al. 
2012). Currently, the best possible therapy for achieving these goals is the use of neural 
stem cells, a primordial cell population left over from embryogenesis.  
Neurogenesis and brain homeostasis in the healthy brain: 
Several regions experience high levels of neuron turnover in the healthy adult 
brain. In order to maintain the functions of these regions, new neurons are continually 
generated in the healthy brain. The process of neuron generation is termed adult 
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neurogenesis which is a multi-step process involving cellular changes mediated by a 
small population of cells identified as neural stem cells (NSCs). The process of adult 
neurogenesis is complex with five distinct phases: NSC proliferation, migration, 
differentiation, integration into the brain circuitry, and survival of newly integrated cells. 
Disruption of any or all of these stages can result in development or worsening of 
neurological sequelae. NSCs respond to brain injury by proliferating and migrating to 
distant sites of damage where they differentiate into neurons or glial cells and integrate 
into existing neural circuitry (Doetsch, Caillé et al. 1999). In the healthy adult brain, the 
purpose of adult neurogenesis in the subventricular zone of the lateral ventricles is to 
facilitate turnover of olfactory interneurons in the olfactory bulb and to supply the CA1 
region of the hippocampus with neurons from the neurogenic niche in the subgranular 
zone of the hippocampus (Doetsch and Alvarez-Buylla 1996; Brown, Couillard-Després 
et al. 2003).  
Neurogenesis is an elaborate process involving three distinct cell populations: true 
neural stem cells or B cells, transit amplifying cell or C cells, and migratory neuroblasts 
or A cells which are also known as neuroblasts (Doetsch, Garcı́a-Verdugo et al. 1997). A 
schematic representation of the structure of the subventricular zone (SVZ) of the lateral 
ventricles is present as figure 2.2 (reprinted from (Silva-Vargas, Crouch et al. 2013). 
Importantly, B cells are located immediately adjacent to the ependymal cells lining the 
lateral ventricles. Of these cell populations only B cells possess true stem cell like  
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Figure 2.2: Cell types in the V/SVZ niche. (A) Coronal schema showing V/SVZ 
adjacent to the lateral ventricles. Box is expanded to right and shows compartments and 
cell types in the V/SVZ niche. The CSF/ependymal compartment comprises the CSF, 
ependymal cells (multi-ciliated E1 cells and bi-ciliated E2 cells) and B1 stem cells that 
contact the ventricle, as well as axons. The intermediate SVZ niche contains all SVZ cells 
(B1 stem cells, transit amplifying Type C cells, and neuroblasts (Type A cells). Other 
components of the intermediate SVZ niche include other astrocytes (light gray), 
microglia and long distance axon terminals. The perivascular niche has unique features. 
Blood vessels are made of endothelial cells, surrounded by pericytes and astrocyte end 
feet. Stem cells and transit amplifying cells frequently contact the vasculature at 
specialized sites that lack pericytes and astrocyte endfoot coverage. Macrophages and 
fibroblasts (dark grey) are also present in the perivascular niche, as well as an enriched 
ECM and fractones that extend from blood vessels. (B) B1 stem cells have a polarized 
radial morphology and extend a long basal process (thin li) that contacts the vasculature 
(thick lines and puncta). Figure from Silva-Vargas et al. Current Opinion in 
Neurobiology 2013. 
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properties, as they maintain neurogenic niches in the brain via symmetrical cell division. 
Seminal work by Fiona Doetsch demonstrated that these cells are primordial cells with 
radial astrocyte phenotypes in the SVZ of the lateral ventricles(Doetsch, Caillé et al. 
1999). Progression down the neurogenic pathway continues when B cells differentiate 
into C cells. These cells fill an essential neural progenitor role as they are capable of 
symmetrical cell division to maintain the population in homeostasis or asymmetrical cell 
division into A cell/neuroblasts, which have the migratory phenotype (Doetsch and 
Alvarez-Buylla 1996; Doetsch, Garcı́a-Verdugo et al. 1997). Interestingly, the degree of 
differentiation of NSCs correlate to their location relative to the ependymal cells lining 
the SVZ, with B cells being the least differentiated and closest to the ependymal cells and 
the A cells being the most differentiated and farthest from the ependymal cells. In 
addition to the SVZ, proliferation of NSCs occurs in the subgranular zone of the 
hippocampus (Doetsch, Garcı́a-Verdugo et al. 1997; Brown, Couillard-Després et al. 
2003). In the undamaged brain, local sites of NSC proliferation provide continual cell 
renewal of discrete regions. In particular, the SVZ provides new olfactory interneurons in 
the olfactory bulb of humans and rodents (Altman and Das 1965; Eriksson, Perfilieva et 
al. 1998) as well as other species such as cats (Das and Altman 1971) and macaques 
(Rakic 1985). Numerous factors have been implicated in promotion of NSC proliferation 
including a variety of growth factors, such as FGF-2 (Bikfalvi, Klein et al. 1997; 
Matsuoka, Nozaki et al. 2003; Grote and Hannan 2007; Cheng, Wang et al. 2011), 
cytokines and hormones such as serotonin (Grote and Hannan 2007). 
Control of neurogenesis beyond cell proliferation in healthy adult mammalian 
brains is largely dependent on expression of gamma-aminobutyric acid (GABA) 
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receptors expressed on C cells. In contrast to the usual neurotransmitter function of 
GABA, these GABA receptors are located extra-synaptically and do not play a role in the 
transmission of action potentials (Yokoyama, Mochimaru et al. 2011). Persistent 
stimulation of these GABA receptors is required to induce differentiation into A cells 
(neuroblasts) to direct A cell migration in the healthy brain (Peretto, Schellino et al. 
2014). Successful completion of neurogenesis requires that neuroblasts mature into 
interneurons and develop both GABAergic and glutamatergic synapses on dendritic 
spines to complete neural circuitry (Lledo, Merkle et al. 2008; Khodosevich, Lazarini et 
al. 2013). In disease processes, GABA receptor mediated migration to the olfactory bulb 
or CA1 region of the hippocampus is effectively halted (Wang, Wang et al. 2014). 
However, in the diseased brain, NSCs have been shown to utilize chemokine signaling as 
a means of migrating to sites of damage (Belmadani, Tran et al. 2006; Hattermann, 
Ludwig et al. 2008).  
Adult neurogenesis has been demonstrated in numerous animal systems, most 
notably mice, rats, cats, non-human primates, and humans (Eriksson, Perfilieva et al. 
1998). Neurogenesis was first identified in the sub-granular zone of the hippocampus 
(SGZ) and the sub-ventricular zone of the lateral ventricles (SVZ) of rats by Robert 
Altman in mid-1960s. Proliferation of brain cells was observed by tritiated thymidine 
uptake after intracerebroventricular (icv) stereotactic injection into the lateral ventricles 
(Altman and Das 1965). Altman et al. identified these cells as astroglial in nature based 
on their morphology, an observation that was confirmed by Doetsch et al. in the late 
1990s, who observed glial fibrillary acidic protein(+) (GFAP(+); a structural protein in 
astrocytes) BrdU(+) (a thymidine analog and proliferation marker) double positive cells 
 30 
 
in the SVZ one cell layer below the ventricles (Doetsch, Caillé et al. 1999). Importantly, 
later studies identified comparable cell populations at numerous discreet brain regions of 
non-surgically manipulated mice (Brown, Couillard-Després et al. 2003); however the 
SVZ remains the largest neurogenic area identified. Importantly, this study demonstrated 
that the process of adult neurogenesis was able to produce functional neurons capable of 
conducting action potentials and thereby established the basis for the hypothesis that 
NSCs have the potential to replace damaged neurons (Brown, Couillard-Després et al. 
2003). 
Maintenance of the B and C cell populations in the neurogenic niche is dependent 
on physical proximity to the lateral ventricles or other blood/CSF sources. Blood 
products such as epidermal growth factor and fibroblast growth factor-2 are required for 
B cells to maintain their undifferentiated state (Frinchi, Bonomo et al. 2008; Danilov, 
Gomes-Leal et al. 2009). As B cells move away from the lateral ventricle wall they 
differentiate into transit amplifying cells (C cells) that are located within a few cell layers 
of the ventricle walls (reviewed in Doetsch et al. 1997). In fact, only the A cell 
population, or migratory neuroblasts, are observed distant from the lateral ventricles; 
however, expression of proliferation markers, such as proliferating cell nuclear antigen 
(PCNA) or Ki-67, in neuroblasts are only seen close to the ventricles (Brown, Couillard-
Després et al. 2003; Kiyota, Ingraham et al. 2011). Removal of B or C cell populations 
from the lateral ventricles leads to terminal differentiation of these cells (Espinosa-
Jeffrey, Becker-Catania et al. 2002) and a common problem in culturing embryonic NSCs 
is the spontaneous differentiation that occurs in prolonged passaging due to the absence 
of ventricle factors (Huh, Kataoka et al. 2009). 
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Neurogenesis in response to tissue damage:  
NSCs have long been suggested as a therapeutic option in response to damage of 
the central nervous system (CNS) as resident and transplanted NSCs have been shown to 
repair transected spinal cords in murine (Teng, Lavik et al. 2002; Boulland, Lambert et al. 
2013; Kumamaru, Saiwai et al. 2013; Nishimura, Yasuda et al. 2013; Sabelström, 
Stenudd et al. 2013) and canine (Gericota, Anderson et al. 2014) spinal cord injury 
models. Studies of NSC reparative effects in the brain are more ambiguous with 
infrequent reports of complete functional repair. However, in sterile models of brain 
damage such as ischemic stroke (Chu, Kim et al. 2004; Imitola, Raddassi et al. 2004; 
Capone, Frigerio et al. 2007; Luheshi, Kovacs et al. 2011; Hu, Li et al. 2012; Sekeljic, 
Bataveljic et al. 2012) and traumatic brain injury (Faiz, Acarin et al. 2005; Crawford, 
Wood et al. 2009; Kernie and Parent 2010; Savage, Lopez-Castejon et al. 2012), 
supplementation with exogenous NSCs has been shown to improve functional outcomes. 
On the other hand, administration of exogenous NSCs can be challenging and typically 
requires injection of NSCs into the already damaged brain. Few studies have documented 
the effect transplanted NSCs have on inflammation associated with encephalitis as many 
pathogens responsible for encephalitis can infect and lyse NSCs (Arvidsson, Kirik et al. 
2003; Das, Chakraborty et al. 2010; Kitaura, Fujii et al. 2011; Mutnal, Cheeran et al. 
2011) thus eliminating any beneficial effects of the NSCs. 
The alternative to using exogenous NSCs is to increase the activity of endogenous 
NSCs to improve behavioral outcomes. Complicating the use of endogenous NSCs is the 
intrinsic requirement that these cells survive the infection. Studies using a mouse model 
of Japanese encephalitis (JE) have suggested that NSC proliferation is abrogated early 
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during infection. Inhibition of NSC proliferation in JE is associated with increased 
neurological deficits in infected mice (Das, Dutta et al. 2011). Conversely, this group 
later demonstrated that expanding the NSC niche using the antibiotic minocycline to 
increase the proliferation of NSCs ameliorated the observed neurological deficits after the 
virus had been cleared (Dutta, Mishra et al. 2010). These findings suggest that increasing 
endogenous NSC proliferation following viral encephalitis may be a viable therapeutic 
option to improve behavioral outcomes.  
The mechanisms to increase NSC action in the infected brain are somewhat 
ambiguous. Studies in the mouse model of multiple sclerosis, experimental autoimmune 
encephalitis (EAE), suggest that increases in NSC numbers are due to these cells 
migrating to sites of demyelination and differentiating into oligodendrocytes 
(Aharonowiz, Einstein et al. 2008). During demyelination, NSC proliferation is increased 
and the resulting neuroblasts differentiate into a subset of progenitor cells called 
oligodendrocyte precursor cells (OPCs) in both mice (Aharonowiz, Einstein et al. 2008) 
and primates (Pluchino, Gritti et al. 2009). OPCs synthesize myelin and induce remission 
of disease symptoms. However, this explanation fails to address the immunomodulatory 
effects that NSCs may be having on the brain milieu during times of damage. In the same 
EAE model mentioned above, OPCs have immunomodulatory functions such as 
inhibiting antigen presentation (Pluchino, Gritti et al. 2009) and limiting T cell activation 
(Einstein, Fainstein et al. 2007; Fainstein, Einstein et al. 2013) through secretion of anti-
inflammatory cytokines (Aharonowiz, Einstein et al. 2008; Shahbazi, Kwang et al. 2013). 
OPC modulation of the inflammatory milieu reduces immune mediated damage and 
increases availability of trophic factors that promote NSC proliferation. Anti-
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inflammatory effects have been observed in other models of brain damage not associated 
with the production of OPCs such as traumatic brain injury (Zhang, Liu et al. 2013) and 
ischemic stroke (Jin, Mao et al. 2010). In contrast, anti-inflammatory effects of NSCs 
have not been observed during acute viral Japanese encephalitis (Das and Basu 2008; 
Dutta, Mishra et al. 2010; Das, Dutta et al. 2011), Alzheimer’s disease (Tatebayashi, Lee 
et al. 2003; Grote and Hannan 2007; Kiyota, Ingraham et al. 2011; Raj, Rothamel et al. 
2014), and Parkinson’s disease (Grote and Hannan 2007; L'Episcopo, Tirolo et al. 2012; 
Raj, Rothamel et al. 2014) although possible immunomodulatory effects of NSCs after 
resolution of virus in viral encephalitis remain unknown.  
Many of the mechanisms of NSC response to brain damage utilize the same 
migration pathways as the immune response. NSC migration is mediated by chemokines, 
particularly CXCR4 (Imitola, Raddassi et al. 2004; Rasmussen, Imitola et al. 2011), and 
NSCs are capable of producing a variety of cytokines (Shahbazi, Kwang et al. 2013). 
Commonalities in cell signaling with the immune system may explain how adult 
neurogenesis responds to different types of brain damage. Particularly, changes in neural 
stem cell (NSC) proliferation, migration, and differentiation have been observed 
following diverse types of brain damage including, experimental autoimmune 
encephalitis (Aharoni, Arnon et al. 2005; Guo, Li et al. 2010; Huehnchen, Prozorovski et 
al. 2011; Tepavčević, Lazarini et al. 2011),  
Depending on the etiologies of brain damage, neurogenesis is altered at multiple 
steps in the neurogenic pathway. Specifically, neurogenic changes resulting from sterile 
(non-infectious) brain damage are markedly different from neurogenesis resulting from 
infectious damage of the brain (Grote and Hannan 2007; Schoknecht and Shalev 2012). 
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Particularly, sterile models of brain damage tend to be associated with periods of active 
immune suppression immediately after damage (Teng, Lavik et al. 2002; Ekdahl, Kokaia 
et al. 2009; Kigerl, Gensel et al. 2009; Dietel, Cicha et al. 2012; Hu, Li et al. 2012) 
whereas with infectious causes of brain damage, the tissue microenvironment tends to 
remain in a pro-inflammatory state until the pathogen has been cleared (Das and Basu 
2008; Marques, Cheeran et al. 2008; Armien, Hu et al. 2010; Getts, Terry et al. 2012). 
Importantly, sterile brain injuries are often associated with better neurological prognosis 
compared to brain infections (Ganguly and Poo 2013; Ma, Chan et al. 2014). 
Conclusion:   
 Adult neurogenesis responds dynamically to damage in the brain. The success or 
failure of adult neurogenesis in repairing the brain seems to be dependent on the nature of 
the inflammatory milieu present in the brain during the repair process. Persistent 
activation of CD8(+) T cells and the activation phenotype of macrophages present in the 
brain have been shown to affect NSC proliferation during adult neurogenesis. However, 
the processes of adult neurogenesis and the influence of infiltrating immune cells during 
HSE have not been fully defined. The objective this thesis was to evaluate the effects of 
inflammation on NSC proliferation. 
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Abstract 
Neural stem cells (NSCs) respond to inflammatory cues induced during brain injury and 
are thought to be involved in recovery from brain damage. Little is known about NSC 
response during brain infections. The present study evaluated NSC proliferation during 
Herpes Simplex Virus-1 brain infection.  Total numbers of nestin(+) NSCs increased 
significantly in infected brains at 6 d post infection (p.i.). However, by 15 d p.i. the 
nestin(+) population decreased significantly below levels observed in uninfected brains 
and remained depressed through 30 d p.i.. This initial increase in NSC population 
occurred concurrently with increased brain cell proliferation, which peaked at 3 d p.i.. On 
closer examination, we found that while actively proliferating Sox2(+) NSCs increased in 
number at 6 d p.i., proliferating DCX(+) neuroblasts contributed to the increased 
response at 3 d p.i.. However, overall proliferation decreased steadily from 15 d p.i. to 
below control levels. To determine the mechanisms involved in altering NSC 
proliferation, neurotrophin and growth factor expression profiles were assessed. FGF-2 
gene expression increased at 5 d p.i. and was robustly down-regulated at 15 d p.i. (>1000 
fold), which was further confirmed by increased FGF-2 immunostaining around the 
lateral ventricles. Furthermore, supplementing infected animals with recombinant FGF-2, 
at 15 d p.i., significantly increased the number of proliferating brain cells. These findings 
demonstrate that the temporal changes in NSC proliferation are mediated through the 
regulation of FGF-2 and that the NSC niche may benefit from supplementation with 
FGF-2 during HSV-1 brain infection.  
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Introduction 
 Herpes Simplex encephalitis (HSE) is the most common cause of sporadic viral 
encephalitis in the United States. While acyclovir treatment is a highly effective means to 
control HSV-1 brain infection (Whitley 2006); greater than fifty percent of human 
patients with HSE develop life altering neurological deficits (McGrath, Anderson et al. 
1997; Kimberlin 2007). These neurological deficits are the result of severe brain damage 
manifesting as reactive astrogliosis and necrosis (Webb SJ 1989) which in human 
infections manifests with significant vascular changes with neuronal loss during early 
stages of disease and the development of astroglial scaring later in infection (Whitley 
2006).  The volume of glial scarring correlates to the level of neurological impairment, 
although the origins of HSV-1-mediated neurological damage and scar formation remain 
unclear. 
 In the murine model of experimental HSE, which closely resembles the human 
disease, immune responses to HSV-1 brain infection begins with infiltration of 
neutrophils and macrophages between 3 and 5 d p.i.. T cells infiltrate between 6 and 8 d 
p.i.. and peak between 14 and 16 d p.i. with significant persistence beyond 30 d p.i. 
(Marques, Cheeran et al. 2008; Armien, Hu et al. 2010). However, viral antigen is 
undetectable at 15 d p.i.. The role of persistent T cells at this stage of disease is unknown; 
however the presence of activated immune cells is indicative of on-going inflammation 
that facilitates development of damage and  resultant neurological deficits (Armien, Hu et 
al. 2010). Similar studies in the murine model of Japanese encephalitis and experimental 
autoimmune encephalitis (EAE) have found that CD8(+) T cell mediated inflammation 
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may be responsible for brain damage and development of long term sequelae (Steinman 
2001; Wang, Lobigs et al. 2003).  
 A small population of endogenous brain cells called neural stem/progenitor cells 
(NSCs) play a significant role in adult neurogenesis (Lichtenwalner and Parent 2005; 
Parent, Elliott et al. 2006). NSCs are maintained within distinct germinal niches, which 
support their multipotent phenotype and self-renewal properties. Adult neurogenesis is 
composed of highly complex and temporally non-linear progression of cell differentiation 
that begins with proliferation and ends with integration into existing brain circuitry. 
Three NSC sub-populations have been shown to proliferate during physiological adult 
neurogenesis: neural stem cells (B cells), transit-amplifying cells (C cells), and migratory 
neuroblasts (A cells) (Doetsch, Garcı́a-Verdugo et al. 1997; Brown, Couillard-Després et 
al. 2003) Previous studies have shown that B/C cells (neural stem/progenitor cells) are 
immunoreactive for nestin, Sox2, mushashi, and oct4 although levels of expression of 
these markers may depend on cell progression through differentiation (Kempermann 
2011). Doublecortin (DCX) is the primary cell marker expressed in A cells (Doetsch, 
Garcı́a-Verdugo et al. 1997; Brown, Couillard-Després et al. 2003; Kempermann 2011). 
Brain injury and its resultant inflammation initiate neurogenesis by altering the niche 
microenvironment to stimulate proliferation and NSC migration (Merkle, Tramontin et al. 
2004).  NSCs express numerous receptors that respond to immune signals which 
influence proliferation, direct migration to sites of damage and determine the fate of these 
pluripotent cells in the injured brain (Matsuoka, Nozaki et al. 2003; Chu, Kim et al. 
2004).  
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 Inflammation plays a complex role in the post-injury recovery of the CNS. It has 
been shown that T cells specific to CNS antigens promote recovery from brain injury, 
provided their activity is controlled (Hauben, Nevo et al. 2000; Yoles, Hauben et al. 
2001; Hofstetter, Sewell et al. 2003). However, during EAE, persistent 
neuroinflammation has been shown to abrogate proliferation of endogenous NSCs and 
neuroblast migration (Pluchino, Muzio et al. 2008). In fact, neurogenesis in several brain 
damage models, including acute ischemic injury (Arvidsson, Collin et al. 2002), 
neurotoxins (Tattersfield, Croon et al. 2004; Faiz, Acarin et al. 2005), and degenerative 
diseases like Alzheimer’s and Parkinson’s disease, have varying temporal neurogenic 
profiles (Capone, Frigerio et al. 2007), potentially directed by relatively unique 
inflammatory environments. The mechanisms instructing NSCs to maintain an 
undifferentiated state or differentiate within an inflamed tissue are poorly understood, 
particularly following viral encephalitis. 
 The objective of the present study was to evaluate NSC proliferation in the 
context of HSV-1 brain infection and its associated inflammation. Given the chronic 
inflammatory response observed during HSE, we hypothesized that NSC proliferation 
may be impaired during HSE which ultimately may contribute to the development of 
neurological deficits. 
Materials and Methods: 
Virus and Infection 
 HSV-1 brain infection that manifests as acute encephalitis in mice was performed 
as previously described (Marques, Cheeran et al. 2008). Briefly, HSV-1 strain Syn17+, a 
neurovirulent strain of HSV, was used in all experiments. The virus was propagated in 
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rabbit skin fibroblasts (CCL68; American Type Culture Collection) and titrated using 
standard plaque assay. Eight to ten week-old female BALB/c mice (Charles River 
Laboratories, Wilmington, MA) were infected with 2.5x105 plaque forming units (PFU) 
by intranasal instillation in anesthetized animals as previously described (Marques, Hu et 
al. 2006).   
Transplantation of luciferase(+) NSC 
 Embryonic NSCs were isolated from the cortices of E14.5 BALB/c mice 
expressing luciferase (kindly provided by Dr. James Lokensgard, University of 
Minnesota). The luciferase(+) BALB/c transgenic mice were generated by backcrossing 
FVB mice expressing luciferase under the control of a CAGGs-CMV promoter into the 
BALB/c background for ten generations. Luciferase positive (luc(+)) NSCs (≥90% 
nestin(+) by flow cytometry) were expanded in culture and transplanted by stereotaxic 
implantation into the subventricular zone (SVZ), within the striatum, of MHC-matched, 
non-transgenic BALB/c mice using previously described methods (Ni, Hu et al. 2004). 
Briefly, Luc(+) NSCs (106 cells in 3µL serum free medium) or 3µL serum-free medium 
control was transplanted into the right SVZ using specific stereotaxic coordinates: 
rostrocaudal vector [AP]=0mm, interaural vector [ML]=+1.2mm and the dorsoventral 
vector [DV]= -3.0mm; delivered over a period of 7-10 minutes. The number of luc(+) 
NSCs to be transplanted was determined by measuring the minimum number of luc(+) 
cells necessary to provide consistent measurable baseline bioluminescent signal 7 d post 
transplantation, when recipient mice were infected by intranasal instillation of 2.5x105 
PFU HSV-1 (Syn17+). By 7 d post-transplant, surgery-induced neuroinflammation had 
subsided and did not affect establishment of and mortality from HSV-1 brain infection. 
 56 
 
Bioimaging for luciferase expression in transplanted cells was performed using an in vivo 
imaging system, IVIS50 (Xenogen/Caliper Life Sciences, Alameda, CA) equipped with a 
charge-coupled camera device, as previously described (Marques, 2008). Briefly, 150µg 
of D-luciferin (Gold Biotechnology) was administered to anesthetized mice by i.p. 
injection. Animals were imaged 5-10 min after D-luciferin administration and data were 
acquired using a 5-min exposure window. Signal intensity of luciferase expression, as 
measured by the total amount of transmitted light, was quantified as a photons/sec/cm2 
using LivingImage (Caliper Life Sciences, Alameda CA) and Igor (Wavemetrics, 
Portland, OR) image analysis software. Change in bioluminescence was used as a 
measure of the numbers of luc(+) NSCs at indicated time points.  
Flow Cytometric Quantification of Endogenous Neural Stem Cells 
 Mouse brain regions from -1 to +3 mm Bregma, which includes the neurogenic 
regions in the brain, was isolated using a coronal brain matrix (Braintree, Braintree, MA), 
and a papain based neural tissue dissociation kit (Miltenyi Biotec, Auburn, CA) was used 
to generate a single cell suspension. Myelin was depleted using myelin depletion beads 
(Miltenyi, CA). Live cells were enumerated, and 5x105 cells were immunostained for 
CD45 and nestin (BD Biosciences, San Jose, CA) ,Ki-67 (Abcam, Cambridge, MA) or 
SRY-related HMG box-gene (Sox)-2  (eBioscience, San Diego, CA) expression. For 
absolute quantification of immunostained cells expressing these markers, 50μL blank 
AccuCount particles (Spherotech, Lake Forest, IL) were added to samples immediately 
before analysis on the flow cytometer (BD FACSCanto). Absolute numbers of each cell 
population was calculated per the manufacturer’s instruction, as a ratio of CD45(-
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)nestin(+),CD45(-)Ki-67(+), or CD45(-)Ki-67(+)Sox2(+) events to number of AccuCount 
particles counted.  
Immunohistochemistry 
 Mice were deeply anesthetized using a mixture of ketamine and xylazine and 
perfused intracardially with 4% paraformaldehyde. Brains were post fixed in 4% 
paraformaldehyde for 24 hours and equilibrated in 30% sucrose. Fixed equilibrated tissue 
was frozen in OCT under liquid nitrogen vapor and sectioned at 30μm thickness onto 
gelatin-coated slides. Coronal sections thus obtained were quenched in a 0.3% peroxide 
solution for ten minutes and blocked with goat serum (5%) in PBS with 0.5% Triton-X 
for one hour at 25°C. Primary antibodies (Abs) were incubated in the blocking solution 
overnight at 4°C. Primary antibodies used were rabbit anti-doublecortin Ab (1:1000; 
Pierce Biotechnologies, Rockford, IL, and PerkinElmer Tyramide Signal Amplification 
PLUS Flurorescein, Perkin Elmer, Waltham, MA), rabbit or mouse anti-PCNA Ab (1:50; 
Abcam, Cambridge, MA), mouse anti-Sox2 or rabbit anti-FGF-2 Abs (1:200, Abcam), rat 
anti-Ki-67 (1:50, eBioscience), and goat anti-HSV-1 (1:100, ViroStat, Portland, MA). 
This HSV-1 polyclonal antibody is reactive to both immediate early and late structural 
antigens. Immunostaining using the Tyramide Signal Amplification kit utilized anti-
rabbit IgG conjugated to horseradish peroxidase as secondary antibody. Fluorescein was 
used in the tyramide-horseradish peroxidase reaction step of the kit. Double 
immunostaining was performed following the Tyramide Signal Amplification kit using 
the Mouse-on-Mouse Immunohistochemistry kit (Vector Laboratories, Burlingame, CA) 
for mouse anti-PCNA Ab (1:50; eBioscience, San Diego, CA), or mouse anti-Sox2 Ab 
(1μg/mL; R&D Systems, Minneapolis, MN). The primary antibody incubation was 
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followed with a pan-mouse IgG biotinylated Ab, and an AlexaFluor 555 streptavidin Ab 
was used as the detecting antibody in this kit. Coronal brain sections were imaged using a 
Nikon ACT fluorescent microscope/camera system.  
 PCNA was used as a marker for IHC analysis of NSC proliferation, as an 
alternative to Ki-67, to identify cells in the S phase of the cell cycle. Sox2 expression was 
used as a surrogate marker of NSCs to confirm the findings observed within nestin(+) cell 
populations.  Expression of these markers around the lateral ventricles is considered to be 
specific to NSC (Kempermann 2011). Immunostaining for NSC phenotypes was 
quantified exclusively around the SVZ. PCNA or Sox2 immunostaining was not observed 
in other brain regions including around HSV-1 induced lesions. 
Quantification of IHC 
To quantify immunostained brain cells, ten sections from each brain were 
collected 320µm apart from (-1 to +3mm bregma) and double immunostained as 
described in the previous section. Images were collected using identical microscope and 
camera settings within a specific marker (i.e. PCNA or DCX) at 100X magnification. 
These images were analyzed using FIJI software (NIH, Bethesda, MD) to create merged 
images showing cell markers against the DAPI nuclear counterstain. The total numbers of 
single positive and double positive cells were counted on all ten sections from each brain, 
located around the sub-ventricular zone of the lateral ventricles and are presented as the 
average total number of cells per brain of all animals within a group. 
RNA isolation and RT-PCR 
 The neurogenic niche was isolated from infected and sham-infected mice as 
described above. Single cell suspensions from individual brains were generated using a 
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papain-based neural tissue dissociation kit (Miltenyi Biotec, Auburn, CA). Myelin was 
depleted as described before and the CD45(-) cell population was isolated by negative 
selection using CD45 selection beads (Miltenyi Biotec, Auburn, CA). Purity of the 
CD45(-) cell population was verified by flow cytometry (≥90% purity), and total RNA 
was isolated from them using the Qiagen RNeasy kit (Valencia, CA). For the initial 
screening, 2µg of total RNA (260/280 ratio between 1.95 and 2.05) from CD45(-) cells 
harvested from three uninfected and three 15 d p.i. animals. To assess average changes in 
gene expression from infected and uninfected controls brains, RNA was pooled within 
the groups and was analyzed by two PCR arrays to assess expression profiles of genes 
involved in Neurogenesis and Neural Stem Cell Pathway and Neurotrophin/Neurotrophin 
Receptor genes (SABiosciences; Valencia, CA). Individual gene expression profiles were 
confirmed by real time RT-PCR was performed on whole brains isolated from intact 
hemispheres of infected or sham-infected mouse brains at various times post infection 
(p.i.) by using the Aurum Fibrous and Fatty Tissue RNA isolation kit (Bio-Rad, Hercules, 
CA) in a SYBR green based PCR reaction. 2µg of total RNA was used to synthesize 
cDNA using the RT2 First Strand kit (Qiagen, Valencia, CA). Primers used in the single 
RT-PCR reactions were: Lif forward 5'-acggcaacctcatgaaccaga-3’, reverse 5'-
ctagaaggcctggaccaccac-3’; noggin forward 5'-cagatgtggctgtggtcac-3’, reverse 5'-
gcaggaacacttacactcgg-3’; Transforming Growth Factor-β forward 5'-
gactctccacctgcaagaccat-3’, reverse 5'-gggactggcgagccttagtt-3’; Fibroblast Growth Factor-
2 forward 5'-gcgacccacacgtcaaacta-3’, reverse 5'-tcccttgatagacacaactcctc-3’; and 
Neurotrophin-3 forward 5'-ggagtttgccggaagactctc-3’, reverse 5'-gggtgctctggtaattttcctta-3’. 
FGF-2 Administration 
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 Infected animals at 15 d p.i. or uninfected controls were given either 1µg 
recombinant carrier-free bovine FGF-2 (R&D Systems, Minneapolis, MN) in 1µL saline 
or 1µL vehicle only by intracerebroventricular (icv) injection into the lateral ventricles (-
0.9mm anterior/posterior, +0.5mm midline, and -2.5mm dorsal/ventral relative to 
bregma). Brains from experimental animals were collected 3 days later, and the 
neurogenic region was isolated (as in the previous section describing the quantification of 
endogenous NSCs) for analysis by flow cytometry for CD45 and nestin or CD45 and Ki-
67 to assess stem cell numbers and proliferation of brain cells. 
Statistics 
 Student’s T test was used to determine differences between groups. P values 
below 0.05 were considered to be significant. Analysis of Variance (ANOVA) was used 
for analysis of RT-PCR data. 
Results 
Transplanted NSCs in the adult brain respond to HSV-1 infection. 
 To evaluate if HSV-1 infection altered neural stem/progenitor cell (NSC) 
proliferation in the adult brain, embryonic NSCs cultured from E14.5 luc(+) transgenic 
mice were transplanted into the striatal SVZ of MHC-matched recipient animals and 
evaluated only as a measure of proliferation. Infected animals exhibited temporally 
distinct changes in levels of bioluminescence from transplanted luc(+) NSCs at various 
times post infection (Fig. 3.1). A robust increase in bioluminescence was observed at 3 d 
p.i., which was greater than that observed in uninfected control animals (Fig. 3.1A). This 
increase was sustained until 15 d p.i., when bioluminescent signal decreased precipitously 
until it reached steady state at 20 d p.i. to levels observed in uninfected animals (Fig.   
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Figure 3.1: NSCs proliferate during HSE. Bioluminescence images obtained from animals 
receiving MHC-matched, luciferase-expressing (luc+) NSCs (1 x 106 cells/animal), transplanted 
into the SVZ by stereotactic injection (coordinates at bregma: 1.2 mm lateral, 0.5 mm caudal and 
3.0 mm ventral from the skull surface). Animals were infected with HSV-1 17 syn+, 5 d post 
transplantation. (A) Levels of luciferase expression, indicative of the number of NSCs, were 
assessed by bioluminescence imaging longitudinally over the indicated time period. 
Bioluminescence images are presented on a pseudocolor scale showing photon flux values 
(photons/cm2/sec) at each time point in infected and uninfected animals. Representative images of 
the same animal (infected) at the indicated time points are shown. (B) Average percent change in 
total cranial luminescence normalized to the luminescence of each animal at time zero (0 d p.i.) is 
presented in HSV-1-infected (gray bars) and compared to uninfected animals (white bars). Mean 
values at each time point obtained from 4-6 animals followed longitudinally are presented as 
dashed lines in the plots and medians are solid lines. Luciferase expression levels were detected 
up to 40 d post-transplant, the latest time-point tested.   
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3.1A and B). In vitro analysis of luc(+) NSCs demonstrated that increased 
bioluminescence correlated with increased stem cell proliferation and total cell numbers 
(data not shown). These findings suggest that NSC exhibit an active proliferative 
response to HSV-1 brain infection during the acute phase of disease and that the 
increased cell numbers may not be sustained during the chronic phase. 
Temporal divergence in endogenous NSC numbers following HSV-1 brain infection.  
To determine if endogenous NSCs proliferated in response to HSV-1 brain 
infection, changes in the nestin(+) NSC population were evaluated at 3, 6, 10, 15, and 30 
d p.i. by flow cytometry. To exclude myeloid cells from the analysis, brain cells were 
concurrently immunostained with CD45 and the CD45(-)nestin(+) cell population was 
analyzed. Compared to uninfected controls, the proportion of nestin(+) NSCs among 
CD45(-) brain cells increased by 35% at 6 d p.i. from 17.77±2.00% to 24.00±5.76% 
(p≤0.05). However, this increase was transient and by 10 d p.i. the percentage decreased 
to 6.35±0.63% (p≤0.01) and remained at that level through 30 d p.i. (Fig. 3.2A). To 
further confirm the observed changes in the nestin(+) population during HSE, absolute 
numbers of CD45(-)nestin(+) cells were quantified against a fixed number of AccuCount 
particles added to each sample during flow cytometric analysis (Fig. 3.2B). The changes 
observed were preserved in the absolute quantification of total nestin(+) cell numbers. By 
15 d p.i., the size of the nestin(+) NSC population decreased by approximately 33% of 
control, which was sustained through 30 d p.i.. These findings demonstrate that 
endogenous nestin(+) NSCs exhibit temporally divergent changes in population size, with  
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Figure 3.2: Total number of nestin(+) NSCs increase in the HSV-1 infected brain. Flow 
cytometry on single cell suspensions from infected or sham-infected BALB/c mouse brains 
trimmed to include neurogenic regions (-1.98 mm to 3.80 mm relative to bregma) were analyzed 
for nestin expression in the non-myeloid cell population (CD45(-)) and is shown at the indicated 
time points during HSV-1 infection. (A) Representative dot plots showing nestin and CD45 
staining in brain cells demonstrate changes in a ratio of nestin(+) cells in the non-myeloid 
compartment (top left quadrant) over the course of HSV-1 infection. Quadrant gates were 
established based on isotype stained brain samples. Ratios of CD45(-)nestin(+) cells, presented as 
%±SEM, were obtained from 9-12 brains examined per time point. (B) The absolute number of 
nestin(+) cells was calculated from individual brain samples using a fixed number of AccuCount 
beads in each sample. Total number of live CD45(-)nestin(+) cells per brain was obtained from 3 
replicates using 9 animals per replicate at each time point. The pooled average numbers in each 
group is presented as ±SEM. * p≤0.05.  
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a robust increase in the nestin(+) cells during the acute phase of HSV-1 brain infection, 
and a persistent decrease in the size of this stem cell population late in the infection. 
Decrease in NSC numbers is not due to virus infection of stem cells during HSE. 
To ascertain if the decrease in NSCs could be explained by the HSV-1 infection 
of these cells, coronal brain sections from infected animals at 8 d p.i. were 
immunostained for both HSV-1 proteins and for representative brain cell phenotype 
markers. This specific time point was chosen based on previous studies in our laboratory 
demonstrating peak HSV-1 replication at 8 d p.i. in this murine model (Marques et al., 
2008). HSV-1-infected cells in the brain shown by immunostaining for viral antigens 
were negative for Sox2 staining (Fig. 3.3A), while Sox2(+) cells in the subventricular 
zone were negative for viral antigens (Fig. 3.3B). Viral antigens were predominantly 
found in MAP-2(+) mature neurons (Fig. 3.3C) and in TuJ-1 (+) immature neurons (Fig. 
3.3D). Tuj-1 is a neuronal specific class III β-tubulin expressed in immature neurons that 
precedes the expression of neurofilament protein and MAP-2 during differentiation 
(Memberg and Hall 1995; Ni, Hu et al. 2004; Mutnal, Cheeran et al. 2011). Tuj-1 and 
Map-2 (+) neurons were seen in cortical areas of the brain, distal from the SVZ and the 
NSC niche. Virus-infected GFAP positive astrocytes were not detected in brain sections 
obtained from the three animals tested (Fig. 3.3E) but occasional presence of O4+ 
infected oligodendrocytes were observed (Fig. 3.3F). HSV antigens were undetectable by 
IHC in infected brains at 30 d p.i (Armien, Hu et al. 2010). 
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Figure 3.3: NSCs are spared from HSV infection. Coronal brain sections from HSV-1 infected 
animals were immunostained for viral antigen and brain cell specific markers at the peak of viral 
infection in the brain (8 d p.i,) to determine the brain cell types susceptible to viral infection. 
Photomicrographs demonstrating the presence of viral antigens in the different cell types are 
presented. (A) Cells expressing viral antigens in the cortex did not express Sox2 while (B) 
Sox2(+) cells observed in the subventricular zone of the same section were negative for viral 
antigens. (C) On the other hand, viral antigens were predominantly found in MAP-2(+) neurons 
(D) and in immature neurons, immunostained with Tuj-1. Nuclei were counterstained with DAPI 
and arrowheads denote viral positive neurons. (E) Viral infected GFAP(+) astrocytes were not 
detected in brain sections tested (F) but occasional O4(+) infected oligodendrocytes (arrow) were 
observed.   
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Temporal changes in endogenous brain cell proliferation during HSE.  
To determine if changes in the nestin(+) NSC population were associated with 
concomitant alteration in brain cell proliferation, Ki-67 expression in CD45(-) brain cells 
was evaluated. An increase in the ratio of Ki-67(+) cells was observed at 3 d p.i. 
(54.37±3.54% vs. 43.03±4.89%, infected vs. uninfected respectively) which decreased 
steadily through 30 d p.i. to 1.57±0.14% (p≤0.01; Fig. 3.4A). Most notably, the 
percentage of proliferating cells decreased significantly at 10, 15, and 30 d p.i. 
(12.90±2.07%, p≥0.05; 8.46±2.87%, p≤0.05; 1.57±0.14%, p≤0.01 respectively) far below 
uninfected control levels (43.03±4.89%). The absolute numbers of CD45(-)Ki-67(+) per 
brain, quantified using AccuCount particles, decreased 20-fold from 3 to 30 d p.i. (from 
106,031±1628.1 Ki-67(+)cells to 5,745±1094 cells per brain respectively, p≤0.01; Fig. 
3.4B). These findings indicated a robust proliferative response in the brain early after 
infection at 3 d p.i. (approximately a two-fold increase), but severely reduced 
proliferation later during the infection. Since the nestin(+) NSC population increased only 
at 6 d p.i., these findings also suggest that the increase in proliferation occurring at 3 d 
p.i. may be mediated by a nestin(-) cell population, such as transient amplifying 
migratory neuroblast cells (A cells), which are also involved in neurogenesis associated 
with injury (Doetsch et al., 1997).   
To assess if NSC proliferation contributed to increased stem cell numbers, brain 
cells were co-immunostained with Sox2 and Ki-67 at 3, 6, and 15 d p.i., along with 
uninfected control brains, and analyzed by flow cytometry. These data revealed that 
trends observed by assessing nestin immunostaining were preserved, independent of  
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Figure 3.4: Endogenous brain cells initiate proliferation at 3 p.i.. Single cell brain 
suspensions, immunostained for Ki-67 and CD45, were analyzed by flow cytometry. (A) 
Representative dot plots showing Ki-67 and CD45 staining in the brain cells of uninfected or 
infected animals at 3, 6, 10, 15, and 30 d p.i. demonstrated changes in a percentage of 
proliferating cells in the non-myeloid compartment (top left quadrant) over the course of HSV-1 
infection. Quadrant gates were established based on isotype stained brain samples. Ratios of 
CD45(-)Ki-67(+) cells, presented in each quadrant as average values (%) ± SEM, were obtained 
from 9-12 brains at each time point. (B) Absolute numbers of non-myeloid brain cells 
proliferating in response to HSV-1 infection was determined using counting beads in each brain 
sample analyzed for Ki-67 expression by flow cytometry. Data presented are representative plots 
obtained from 3 independent experiments with 9-12 animals per time point. Average values 
(±SEM) from pooled data at each time point are presented. * p≤0.05.  
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Figure 3.5: Enhanced Sox2(+) NSC proliferation at 6 d p.i. is abrogated at 15 d p.i. Single 
cell suspensions from mouse brains encompassing regions between -1.0 and +3.0mm Bregma of 
(A) uninfected and (B-D) infected animals at (B) 3 d p.i. (C) 6 d p.i. or (D) 15 d p.i. was analyzed 
for Sox2 and Ki-67 expression by flow cytometry. Data presented was based on analysis of 
CD45(-) brain cell population. Absolute numbers of (E) Sox2(+) and (F) proliferating Ki-
67(+)Sox2(+) cells were quantified using counting beads in each brain sample analyzed, as 
described previously.  Data are presented as averages ± SEM of nine animals per time point. * 
p≤0.05 and ** p≤0.01. 
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analysis method (Fig. 3.5A-D). Notably, the total number of Sox2(+) cells was decreased 
at 3 d p.i. (Fig. 3.5E), but approximately 80% of the total Sox2(+) cells were proliferating 
(Ki-67(+)) at 6 d p.i. (Fig. 3.5F). However, both the total number of Sox2(+) and Ki-
67(+)Sox2(+) cells decreased significantly at 15 d p.i. This suggests that while the brain 
initially responds to HSV-1 infection with robust NSC proliferation, by the time viral 
infection is resolved and no detectable viral antigen is seen in the brain, NSC 
proliferation is suppressed below physiological levels. 
NSCs proliferative responses occur in the sub-ventricular zone of the lateral 
ventricles. 
We next proceeded to determine the neuroanatomical location of proliferative 
responses in HSV-1 infected brains by IHC and to determine the phenotype of NSCs 
located in the sub-ventricular zone, proliferating in response to viral infection. While the 
entire brain section was evaluated by IHC, PCNA(+)Sox2 populations were identified 
only within the SVZ. PCNA(+)Sox2(+) cell populations were quantified at 3, 6, and 15 d 
p.i. (Fig. 3.6B-E). Sox2 immunostaining confirmed that peak stem cell proliferation 
occurs at 6 d p.i., and that the initial increase in proliferation at 3 d p.i., measured by Ki-
67 flow cytometry may result from expansion of other progenitor cell populations. 
Sox2(+) cells were located predominantly in the SVZ. Interestingly the total number of 
Sox2(+) cells decreased at 3 d p.i. (124.0±10.1 total cells per infected brain vs 
194.5±27.3 total cells per control brain, p≤0.05; Fig. 3.6F), even though the number of 
PCNA(+) Sox2(+) stem/progenitor cells remained unchanged at this time point (37.0±2.0 
total cells per infected brain vs 21.5±0.7 total cells per control brain). However, both the 
total number of Sox2(+) and proliferating Sox2(+) cells were significantly increased at 6  
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Figure 3.6: Sox2(+) NSC proliferation is increased in the SVZ at 6 d p.i.. Infected and sham 
treated brains were perfused with fixative and cryosectioned for immunohistochemistry.  A total 
of 10 coronal sections were collected 320µm apart from the region between -1.0mm and +3.0mm 
relative to bregma. Photomicrographs of brain sections immunostained for Sox2, an NSC marker, 
and PCNA, proliferating cell nuclear antigen are presented. (A) The lateral ventricle (LV) from an 
uninfected mouse is shown to indicate the neuroanatomical location from which subsequent 
images (B-E) were obtained. Representative merged images showing Sox2 and PCNA 
immunostaining in the lateral ventricles from (B) uninfected animals, and infected animals at (C) 
3 d p.i., (D) 6 d p.i., (E) 15 d p.i. are presented. Arrow heads show double positive cells. (F) 
Single- and double-positive cells were counted from all 10 coronal sections obtained from 
infected and sham-infected brains at the various time points indicated. The total numbers of Sox2 
single-positive (black bars) and Sox2/PCNA double-positive (gray bars) cells are presented as the 
average (± SEM) number of cells observed in 10 sections obtained from 3 animals at each time 
point. * p≤0.05 and ** p≤0.01.   
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Figure 3.7: Doublecortin(+) neuroblasts proliferate at 3 d p.i.. Brain sections processed and 
prepared as described, in the previous figure were immunostained for PCNA and doublecortin 
(DCX), a marker for proliferating cells and neuroblasts, respectively. (A) IHC analysis of control 
brains showing PCNA (left panel) or DCX (middle panel) staining on a representative coronal 
section and the merged image (right panel) showing the nuclear localization of PCNA antigen in 
the cell (arrows indicating double positive cells). (B) The lateral ventricle from a 3 d p.i. infected 
brain is shown to indicate the neuroanatomical location from which subsequent images (C-F) 
were obtained. Representative merged images showing patterns of PCNA and DCX 
immunostaining around the ventricles from (C) uninfected, (D) 3 d p.i., (E) 6 d p.i., (F) 15 d p.i. 
brains are presented. Arrows showing the presences of double positive cells in the infected brain 
at 3 and 6 d p.i.. (G) Proliferating DCX(+)PCNA(+) neuroblasts were quantified from coronal 
sections obtained from infected and sham-infected brains at the various time points indicated (as 
described above). Increase in the total numbers of DCX(+)PCNA(+) cells in the brain was 
observed at 3 d p.i. but is significantly decreased at 15 d p.i. relative to uninfected controls. Data 
presented are averages (± SEM) cells counted from 3 animals at each time point. * p≤0.05 and ** 
p≤0.01.  
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d p.i. (269.5±19.11 total cells per infected brain, p≤0.01, and 69±4.02 total cells per 
control brain, p≤0.01).  As expected both total Sox2(+) and proliferating Sox2(+) cell 
numbers, at 15 d p.i., decreased significantly compared to uninfected brains levels (total 
Sox2(+), 175.00±9.02 total cells per infected brain, p≥0.05; double positive 20±4.04 total 
cells per infected brain, p≤0.01). These findings show that NSC proliferation increased at 
early points during HSV-1 brain infection, but decreased significantly at later points. 
The initial proliferative response is observed in doublecortin(+) migratory 
neuroblasts. 
Coronal brain sections were immunostained for doublecortin (DCX) and PCNA to 
determine if neuroblasts around the SVZ proliferated in response to HSV-1 infection 
(Fig. 3.7A-F). Proliferating DCX(+)PCNA(+) cells were significantly increased at 3 d p.i. 
(69.5±14.1 total cells per infected brain vs 23±2.1 total cells per control brain, p≤0.01). 
Although the number of proliferating DCX(+) neuroblasts around the SVZ contracted at 
6 d p.i. their numbers were larger than seen in uninfected animals (Fig. 3.7G). However, 
during the chronic phase of infection (15 d p.i.), the number of proliferating DCX(+) cells 
decreased significantly relative to uninfected controls (15.5±2.97 total cells per infected 
brain vs 23±2.1 total cells per control brain, p≤0.01). These findings suggest that both 
Sox2(+) stem cells and neuroblasts respond to HSV-1 infection in a temporally distinct 
manner (Table 1), and viral infection results in a significant decrease in proliferation of 
both neural stem and progenitor cells at 15 d p.i..  
Differential expression of genes associated with neurogenesis at 3 and 15 d p.i.. 
 To further investigate the mechanisms that decrease NSC proliferation, a 
preliminary screen of 153 genes associated with neurogenesis was performed on mRNA  
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Changes in NSC proliferation During HSE 
Cell Markers 3 d p.i. 6 d p.i. 10 d p.i. 15 d p.i. 30 d p.i. 
 Total Positive Cells     
Sox2(+) -- ++  -  
nestin(+) -- +++ -- -- -- 
Doublecortin(+)  + -  ++  
Ki-67(+) +++ ++ - -- ---- 
 Proliferating Cells     
Sox2(+) -- +++  ----  
Doublecortin(+) ++++ ++  --  
Fold change value ranges: ----≤0.3, ---=0.31 to 0.6, --=0.61 to 0.75,  
-=0.76 to 1, +=1.01 to 1.25, ++=1.26 to 1.5, +++=1.51 to 2, ++++≥2.01 
 
Table 3.1: Differential NSC proliferation during HSE. The table presents observed trends 
of proliferation by cell marker and total endogenous brain cell proliferation as fold-change 
compared to the uninfected samples. The fold change values are presented as follows: (----) 
≤0.3; (---), 0.31 to 0.6; (--), 0.61 to 0.75; (-), 0.76 to 1; (+), 1.01 to 1.25; (++), 1.26 to 1.5; 
(+++), 1.51 to 2, (++++), ≥2.01  
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Figure 3.8: NT-3 and FGF-2 are differentially regulated during acute and chronic HSE. To 
identify mediators involved during the changes observed in NSC proliferation at 3 and 15 d p.i., 
genes known to affect neurogenesis were amplified by reverse transcriptase-polymerase chain 
reaction (RT-PCR). Five selected genes (Leukemia inhibitory factor (Lif), Transforming Growth 
Factor-β (TGF-β), noggin, neurotrophic factor-3 (NT-3), and fibroblast growth factor-2 (FGF-2)) 
were assessed individually from total RNA obtained from whole brains of 3 infected animals at 3 
d p.i. (black bars) and 15 d p.i. (gray bars). Data are presented as average fold change (± SD), in 
normalized mRNA expression, from uninfected controls.  
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isolated from CD45(-) brain cells from infected or uninfected animals at 15 d p.i.. Gene 
expression was analyzed on two PCR arrays (Neurogenesis/Neural Stem Cell Pathway 
and Neurotrophin/Neurotrophin Receptors arrays, SABiosciences; data not shown) from 
which, five genes selected based on change in expression (≥2 fold) compared to 
uninfected controls. Expression of leukemia inhibitory factor (LIF), noggin, transforming 
growth factor-β (TGF-β), neurotrophin-3 (NT-3), and fibroblast growth factor-2 (FGF-2) 
was further analyzed to determine if these selected genes exhibited differential expression 
at 3 and 15 d p.i. (Fig. 3.8). LIF and noggin were down regulated while TGF-β was up 
regulated at both time points examined. However, NT-3 and FGF-2 were differentially 
regulated at 3 and 15 d p.i. NT-3 was down regulated by 2.00±0.77 fold at 3 d p.i. and 
up-regulated by 4.76±0.84 fold at 15 d p.i.. Conversely, FGF-2 expression increased by 
2.52±0.73 fold at 3 d p.i., but decreased 1342.84±33.33 fold at 15 d p.i.. Since FGF-2 has 
been shown to induce stem cell proliferation (Dayer et al., 2007), the role of FGF-2 in 
altering NSC proliferation during HSE was further investigated. 
Differential kinetics of FGF-2 gene and protein expression during acute and chronic 
HSE 
 To evaluate if FGF-2 played a role in altering NSC proliferation during HSE, the 
kinetics of FGF-2 gene expression at 3, 5, 11, and 15 d p.i. was first analyzed in whole 
brain samples (Fig. 3.9A). Consistent with the data demonstrating increased brain cell 
proliferation at 3 and 6 d p.i., FGF-2 gene expression was up-regulated during the acute 
phase of infection (2.52±0.73 and 3.44±0.34 fold respectively), and down-regulated  
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Figure 3.9: Kinetics of FGF-2 expression during HSE.  FGF-2 expression was evaluated over 
the course of HSE. (A) Total RNA isolated from uninfected and HSV-1-infected brains was 
assayed for FGF-2 mRNA expression at the time points indicated. Change in FGF-2 expression 
over time was calculated as an average fold change (± SEM) from normalized gene expression in 
uninfected controls (n=3-5 per time point). (B-D) To confirm FGF-2 mRNA changes were 
reflected in protein expression, coronal brain sections from uninfected and infected animals were 
evaluated by IHC. Representative photomicrographs of coronal brain sections showing the 
expression of FGF-2 protein around the lateral ventricles in (B) uninfected brains, compared to 
that observed in infected brains at (C) 3 d p.i., (D) 15 d p.i.. Images are representative of 3 brains 
assessed within each group. 
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during the chronic phase of infection at 11 and 15 d p.i. (288.35+13.33 and 
1342.84±33.33 fold respectively).  
 To verify that reductions in mRNA expression were reflected by altered FGF-2 
protein expression, brain sections from uninfected and infected animals at 3, 6 and 15 d 
p.i. were immunostained for FGF-2 and visualized by fluorescent microscopy (Fig. 3.9B). 
Consistent with the RT-PCR analysis, there was more FGF-2(+) immunofluorescence at 
3 and 6 d p.i. around the subventricular zone, compared to the 15 d p.i. animals (coronal 
sections examined from -1 to +2mm bregma). Interestingly, there was FGF-2 
immunostaining around the meninges, which also decreased at 15 d p.i. compared to 
uninfected controls (data not shown). These findings demonstrate that FGF-2 expression 
in infected brains correlates with observed changes in endogenous brain cell proliferation 
during HSE. These data also suggests that the decreased levels of FGF-2 may be 
responsible for decreased NSC proliferation at 15 d p.i..  
FGF-2 treatment of chronically infected mice increases endogenous brain cell 
proliferation. 
 To investigate if decreased FGF-2 levels in HSE animals influenced NSC 
proliferation, HSV-1 infected mice at 15 d p.i. were pulsed with 1µg FGF-2 or saline 
vehicle by intracerebroventricular (icv) injection. Brains were collected three days post-
treatment and single cell suspensions from the neurogenic region were assessed for 
changes in CD45(-)Ki-67(+) proliferating brain cells (Fig. 10A) and  nestin(+) neural 
stem/progenitor cells (Fig. 3.10B) by flow cytometry. In infected FGF-2 treated animals, 
CD45(-)Ki-67(+) proliferating endogenous brain cell population increased significantly  
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Figure 3.10: FGF-2 treatment rescues inhibition of cell proliferation at 15 d p.i.. To 
determine if FGF-2 replacement impacts brain cell proliferation, infected mice at 15 d p.i. were 
given 1µg FGF-2 or saline by icv injection. At 3 d post treatment, brains were analyzed by flow 
cytometry for total number of (A) CD45(-)Ki-67(+) proliferating cells and (B) CD45(-) nestin(+). 
(A) Total numbers of proliferating Ki-67(+) endogenous brain cells reverted to uninfected 
(control) levels post FGF-2 treatment (FGF-2) compared to HSV-1-infected saline treated (saline) 
animals. Data are presented as % or control compared to uninfected (control) animals. (B)  
Similar analysis of nestin(+) NSC showed no difference in the total numbers whether infected 
animals were given vehicle (saline) or FGF-2. Data demonstrating differences among treatment 
groups are presented as average values (± SEM) obtained from 5 animals per group. * p≤0.05. 
(C) FGF-2 treatment stimulates proliferation of DCX(+) cells in HSV-1 infected brains. 
Photomicrographs of coronal brains sections obtained at 15 d p.i from infected, untreated animals 
(left panel) or infected, FGF-2-treated animals (right panel) and immunostained for DCX and 
Ki67 are presented. Arrowheads indicate cells expressing DCX and Ki67Representative images 
taken from four animals per treatment group are shown.   
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relative to the saline-treated infected animals and was not significantly different from 
uninfected controls (Fig. 3.10A). Although brain cell proliferation increased with FGF-2 
treatment of infected animals, no increase was observed in the nestin(+) stem/progenitor 
cell population in these animals (Fig. 3.10B). We further characterized this increase in 
endogenous brain cell proliferation and observed that majority of proliferating cells with 
FGF-2 treatment in the SVZ were DCX(+) (Fig. 3.10C). These findings suggest that 
administration of exogenous FGF-2 in infected animals could stimulate brain cell 
proliferation and potentially be used to generate new stem/progenitor cells in virus-
infected brains.  
Discussion 
The present study demonstrates that adult murine neural stem/progenitor cells 
(NSCs) exhibit temporally distinct proliferative responses following Herpes Simplex 
Virus (HSV)-1 brain infection. In response to infection, luciferase(+) NSCs transplanted 
into the SVZ displayed robust expansion, indicated by an increase in total 
bioluminescence, which was sustained until 15 d p.i. This increase in bioluminescence 
was observed in infected animals, even as luminescence signals decreased in uninfected 
animals over time, indicative of NSC expansion or increased cell survival resulting from 
viral brain infection. Bioluminescence signals in infected animals subsequently dropped 
to levels observed in uninfected animals, during the chronic phase of infection (>15 d 
p.i). Bioluminescence imaging is a powerful non-invasive method to tract the behavior of 
stem cells longitudinally in vivo, which when optimized can detect the presence of ≤3000 
to 6000 transplanted cells in the brain (Aswendt, Adamczak et al. 2013). While this 
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method provides insight into acute responses of neural stem cells to HSV-1 brain 
infection, the fate of these implanted cells is not known.  
To expand our understanding of the impact of HSV-1 brain infection on adult 
neurogenesis, endogenous NSCs, identified by either nestin or Sox2 expression, were 
analyzed in infected mouse brains. NSC numbers increased at 6 d p.i., while total brain 
cells proliferating in response to infection increased as early as 3 d p.i. These early 
proliferating cells at 3 d p.i. were identified as DCX(+) neuroblasts. This initial increase 
in NSC and neuroblast proliferation was abrogated during the chronic phase of infection 
and resulted in significantly lower numbers of nestin and Sox2 (+) NSCs in the infected 
brain. Expression of several growth factors was evaluated to determine the mechanisms 
involved in mediating these temporally divergent NSC responses. Most notably, the 
change in FGF-2 gene expression in HSV-1 infected brains mirrored the changes in NSC 
proliferation, suggesting that decreased FGF-2 consequent to infection may lead to 
suppressed NSC proliferation. Interestingly, a single dose of exogenous FGF-2 in 
chronically infected animals was sufficient to increase endogenous brain cell proliferation 
within 3 days post treatment, albeit without net increases in nestin(+) NSCs.   
NSC proliferation in response to HSV-1 increased initially after infection.  This 
initial increase in neurogenesis was followed by chronic suppression of proliferation in 
endogenous NSCs.  This “window of neurogenesis” after the initiation of injury is not 
unique to HSE, but has been reported following non-infectious brain injury, like stroke 
and traumatic brain injury (Arvidsson, Collin et al. 2002; Kernie and Parent 2010; Zhou, 
Cheng et al. 2011). Interestingly, viral brain infections are reported to suppress 
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proliferative response (Das, Chakraborty et al. 2010), potentially due to virus infection 
and lysis of NSCs (Das and Basu 2008) or is mediated by inflammation resulting from 
viral infection (Das, Dutta et al. 2011). Our findings indicate that inhibition of NSC 
proliferation did not result directly from HSV-1 infection of NSCs, demonstrated by a 
distinct absence of viral antigen in the SVZ and in Sox2(+) NSCs. We and others have 
shown that experimental HSV-1 brain infection in mice typically occurs as a highly 
localized, focal neural tract infection without marked dissemination outside infected 
neurons in immunocompetent brains (Labetoulle, Maillet et al. 2003; Armien, Hu et al. 
2010; Himmelein, St Leger et al. 2011). Furthermore, suppression of NSC proliferation, 
in the present study, was observed at the time when viral replication was not detected in 
the brain (Marques, Cheeran et al. 2008; Armien, Hu et al. 2010). This implies that the 
effect of HSV-1 on NSC proliferation is spatially and temporally separated, potentially 
mediated by indirect mechanisms resulting from the host response to infection. 
Inflammatory mediators have been shown to influence NSC proliferation, 
migration and fate differentiation (Gonzalez-Perez 2010).The characteristics of 
inflammation in stroke and the early stages of HSV-1 brain infection, where NSC 
proliferation increases, are driven largely by macrophages and neutrophils (Arvidsson, 
Collin et al. 2002; Armien, Hu et al. 2010). These innate immune cells mediate both 
beneficial and harmful inhibitory effects on tissue regeneration (Dietel, Cicha et al. 2012; 
Hu, Li et al. 2012; Savage, Lopez-Castejon et al. 2012). On the other hand, acute 
inflammation following JEV infection, characterized by CD8(+) T cell infiltration, in 
addition to macrophages and neutrophils, results in inhibition of NSC proliferation (Das, 
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Dutta et al. 2011). Similarly, chronic T cell-mediated inflammation in EAE leads to 
decreased NSC proliferation and reduction of the NSC population (Ziv, Avidan et al. 
2006) over extended periods following disease induction (Khoury, Hancock et al. 1992; 
Imitola, Raddassi et al. 2004). We demonstrate in the present study that the initial 
increase in proliferative response is followed by a stepwise decrease in both total NSC 
numbers and proliferation (Table 1) at a time when activated CD8(+) T cells dominate 
the inflammatory milieu (Marques, Cheeran et al. 2008; Armien, Hu et al. 2010). 
Activated CD8(+) T cells are essential for the maintenance of latency in HSV-1 infected 
neurons, effected through interactions between virus-infected cells and lymphocyte-
derived lytic granule components viz. granzyme B (Knickelbein, Khanna et al. 2008; 
Jiang, Chentoufi et al. 2011). Release of granzyme B from activated CD8(+) T cells has 
been shown to impair NSC proliferation and differentiation via the voltage-dependent 
potassium channel, Kv1.3 (Wang, Lee et al. 2010). This suggests that persistent 
inflammation mediated by CD8(+) T cells following HSV-1 brain infection may similarly 
inhibit NSC proliferation thus impairing neurogenesis and brain recovery.   
Closer examination of proliferating brain cell phenotypes revealed that multiple 
cell types compose the initial proliferative response in the brain. This endogenous brain 
cell response at 3 d p.i. was enabled by an increase in DCX(+) neuroblasts, while 
Sox2(+) proliferation peaked a few days later at 6 d p.i.. Proliferative response to brain 
injury has been shown to involve both cell types, which have different functions in the 
neurogenic process. This initial proliferative response has been shown to occur as the 
result of macrophage activation independent of the etiology of injury (Doetsch, Garcı́a-
 83 
 
Verdugo et al. 1997; Kigerl, Gensel et al. 2009; Hu, Li et al. 2012). A number of studies 
have demonstrated unequivocally that proliferation of Sox2(+) cells occur early after 
injury, with few reporting the proliferation of DCX(+) neuroblasts. DCX(+) neuroblasts 
as the first identifiable proliferating cell type during neurogenesis in the adult brain 
(Brown, Couillard-Després et al. 2003), indicative of rapid expansion of these cells post 
injury. Involvement of DCX(+) neuroblasts have also been shown to be critical for the 
short-term outcomes associated with recovery from stroke (Jin, Mao et al. 2010). 
Similarly, progressive decrease in the proliferation and numbers of neuroblasts in EAE 
potentially influences clinical outcomes (Pluchino, Muzio et al. 2008; Huehnchen, 
Prozorovski et al. 2011; Tepavčević, Lazarini et al. 2011), indicative of the critical role 
neuroblasts play in recovery from brain injury. In the present study, the depressed 
proliferative response during the chronic phase of infection, where proliferation of both 
neural stem and progenitor cells was reduced, suggests clinical intervention at this point 
may be beneficial similar to that observed in ischemic injury following enhancement of 
NSC proliferation (Zhao, Singhal et al. 2007). Additional analysis of restorative 
neurogenesis in virus-infected brains is essential to demonstrate the contribution the 
different cell types make in the recovery from HSE-mediated damage. 
Chronic inflammation alters the molecular constituents of the tissue 
microenvironment leading to suppression of NSC proliferation. Studies in EAE 
(Clemente, Ortega et al. 2011), stroke (Arvidsson, Kirik et al. 2003), and neuropathy 
(DeLeo, Colburn et al. 1997) have demonstrated that neurotrophic factors, such as FGF-
2, glial-derived neurotrophic factor (GDNF), and anosmin-1, are down-regulated during 
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the chronic inflammation that develops subsequent to injury. This contrasts with findings 
during the acute injury where neurotrophic factors such as brain-derived neurotrophic 
factor (BDNF), stromal cell-derived  factor (SDF)-1α, and FGF-2 are up-regulated 
(Imitola, Raddassi et al. 2004; Kiprianova, Schindowski et al. 2004; Shruster, Ben-Zur et 
al. 2012). Our study found that during the course of HSV-1 infection and associated 
injury, NT-3 and FGF-2 gene expression is differentially regulated, increasing during the 
acute phase and decreasing in the chronic phase of infection.   
Decreased expression of FGF-2 in HSV-1 infected mice was associated with 
concomitant inhibition of NSC proliferation. Although virus infection is spatially 
separated from the NSC niche in the SVZ, it is known that immune mediated effects 
following viral infections induce global changes to the tissue microenvironment 
(Marques, Cheeran et al. 2008; Mutnal, Cheeran et al. 2011). In uninjured brains, FGF-2 
production is seen in GFAP(+) cells in the SVZ, which are unique from nestin(+) NSC 
(Frinchi, Bonomo et al. 2008), but the effects of virus induced inflammation on 
production of FGF-2 in the SVZ is poorly studied (Russo, Barlati et al. 2011). Changes in 
production of immune and brain produced growth factors, particularly FGF-2, have been 
documented consequent to inflammation resulting from ischemic injury (Dayer, Jenny et 
al. 2007; Cheng, Wang et al. 2011), multiple sclerosis (Clemente, Ortega et al. 2011), and 
Alzheimer’s Disease (Kiyota, Ingraham et al. 2011). The types of growth factors and 
cytokines present in the injured tissue alter the outcomes of neurogenic processes 
initiated by injury (Haughey, Nath et al. 2002; Kalluri and Dempsey 2008). IL-1β 
treatment of brain cell cultures induced FGF-2 production (Bourcier, Dockter et al. 1995; 
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DeLeo, Colburn et al. 1997). Production of IL-1β is seen early during HSV-1 infection 
(Aravalli, Hu et al. 2005) giving credence to the possibility that modulation of FGF-2 
expression early during HSV-1 brain infection may be mediated through IL-1β. Given the 
association between immune cytokines and growth factor production during 
neuroinflammation (Kalluri and Dempsey 2008; Bellavance and Rivest 2012; Zhu, Xu et 
al. 2012), it is plausible that the dynamic nature of the inflammatory cytokine milieu 
generated during HSE (Aravalli, Hu et al. 2005; Marques, Hu et al. 2006; Armien, Hu et 
al. 2010) modulates the functional response of NSCs ultimately defining outcomes 
associated with injury-induced neurogenesis. We demonstrate that treatment of infected 
animals with FGF-2 stimulates proliferation of brain cells. Similar results have been 
described after ischemic brain injury and in Alzheimer’s disease models, where 
exogenous FGF-2 administration stimulates proliferation of NSCs and improves 
behavioral outcomes. (Kiyota, Ingraham et al. 2011; Feng, Zhang et al. 2012). The 
present study demonstrates that a single FGF-2 pulse in the lateral ventricles during the 
chronic phase of infection is sufficient to promote proliferation of endogenous brain cells, 
indicating revitalization of neurogenesis suppressed by chronic inflammation.  
Conclusions: 
Our findings demonstrate that HSV-1 infected brains exhibits temporally distinct 
proliferative responses including evidence of increased neurogenesis early in disease that 
is progressively arrested during the chronic phase, and that FGF-2 expression rises and 
falls concomitant with this proliferative response. These divergent responses coincide 
directly with the constituents of the inflammatory milieu, dominated by macrophages and 
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neutrophils acutely and activated T cells in the chronic phase (Marques, Cheeran et al. 
2008; Armien, Hu et al. 2010). This implies that any intervention to enhance 
neurogenesis would need to consider the effect of the inflammatory milieu on NSCs. We 
demonstrate that supplementing FGF-2 in the chronic phase of HSE enhanced the 
proliferative response in the brain, a possible first step in the recovery process. Further 
studies are essential to determine if FGF-2 may be used to offset the neurological deficits 
seen in the wake of viral infections of the brain.  
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Chapter 4: Alternatively activated macrophages stimulate neural stem/progenitor 
cell proliferation through a Wnt5a dependent pathway: Implications for Herpes 
Simplex encephalitis. 
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Abstract: 
 
Activation of macrophages and microglia is a critical component of the host response to 
brain damage, regardless of the etiology. Previous studies in our laboratory demonstrated 
that HSV-1 brain infection in mice triggered an early increase in neural stem/progenitor 
cell (NSC) proliferation at 3 and 6 d p.i., concurrent with peak macrophage infiltration. In 
the present study, we examined the role of macrophages and their activation phenotypes 
on NSC proliferation. Examination of activation states showed that the number of 
macrophages (CD45(hi)CD11b(+)) expressing CD206, an M2 activation phenotype 
marker, was five-fold higher than those expressing CD86, an M1 phenotype marker. To 
further determine if M1 or M2 macrophage activation had a direct effect on NSC 
proliferation, cultured NSCs were treated with supernatants obtained from ex vivo 
polarized M1 or M2 bone-marrow derived macrophages (BMDM).  NSC cultures treated 
with M2 conditioned medium (M2CM) had 4-fold higher numbers of proliferating cells 
compared to those cultured in control growth media. To examine if M2 polarization 
would alter NSCs in vivo, M2 macrophages were transplanted into the lateral ventricles 
of uninfected mice.  At 5 d post-transplantation, M2 macrophages resulted in a 15% 
increase in Sox2(+) NSCs proliferation and doubled the total number of Sox2(+) NSCs in 
the brain, compared to animals treated with saline or heat-killed cells.  Interestingly, M2 
polarized macrophages also exhibited significant increase in Wnt5a expression, a factor 
known to promote stem cell proliferation.  Pretreatment of NSC cultures with either 
dickkopf-1, a Wnt5a inhibitor, or Wnt5a neutralizing antibody suppressed M2 
macrophage driven NSC proliferation, to levels observed in untreated cultures. Wnt5a 
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gene expression in HSV-1 infected brains increased at 3 d p.i., coinciding with the 
increase in neurogenesis and M2 macrophage infiltration into the brain. Results from 
these studies suggest that M2 macrophages promote NSC proliferation following HSE 
and may provide an avenue for therapeutic intervention utilizing the reparative properties 
of adult NSCs. 
Introduction: 
Monocytes and macrophages play a critical role in recovery from disease and are 
known for their important role in supporting tissue “clean-up” and regeneration post 
injury (Schwartz 2010). Consequent to tissue injury, inflammatory monocytes and 
macrophages migrate to injured sites and phagocytize pathogens and/or damaged cells. 
Depending on the etiology, innate sensor systems located on the macrophage detect 
molecular cues produced by damaged tissue that define the inflammatory milieu 
generated, either promoting regeneration or initiating immune cell activation and tissue 
destruction (Ekdahl, Kokaia et al. 2009; Kigerl, Gensel et al. 2009; Brancato and Albina 
2011). Macrophage phenotypes are intricately connected with this inflammatory tissue 
environment, where their effector functions are defined, often influencing the outcomes 
of injury. Macrophage effector subsets are broadly classified as M1 (or “classically 
activated”) pro-inflammatory or M2 (or “alternatively activated”) anti-inflammatory 
cells, albeit their activation and functional profiles are spread across a continuum of 
activation states where the M1 and M2 phenotypes serve as bookends of the spectrum 
(Mosser and Edwards 2008). 
 99 
 
M2 macrophages are often referred to as “healing or growth promoting” 
macrophages (Hu, Li et al. 2012). Although such functional phenotypes are associated 
with a specific subsets of cells, a blend of macrophage activation phenotypes are often 
found within injured tissue in vivo (Ka, Daumas et al. 2014). Studies in rodent models of 
spinal cord injury have shown that the predominance of macrophages in a specific 
activation state promotes different outcomes during recovery (Kigerl, Gensel et al. 2009; 
Schwartz 2010). M1 macrophage activation is associated with immunopathology (Colton 
2009; Getts, Terry et al. 2012; Crespo, Bertolotti et al. 2013), while M2 macrophage 
activation has been shown to facilitate regenerative processes (Kigerl, Gensel et al. 2009; 
Hu, Li et al. 2012). Similarly, a predominance of M2 macrophages have been shown to 
promote reparative myogenesis following toxin-induced damage (Arnold, Henry et al. 
2007; Brancato and Albina 2011). More recent studies show evidence that macrophages 
are essential for the complete and accurate regeneration of excised axolotl limbs, capable 
of influencing specific stages in the regenerative process occurring post-injury (Godwin, 
Pinto et al. 2013). In addition to their role in regeneration post injury, recent studies have 
implicated a role for microglia, the resident brain macrophage, in maintaining the size of 
the neural stem/progenitor pool during embryogenesis (Cunningham, Martínez-Cerdeño 
et al. 2013). Macrophages have also been found to be essential for the maintenance of gut 
homeostasis (Takada, Hisamatsu et al. 2010), indicating that macrophages, in addition to 
their unique roles in tissue clean-up, also directly promote regeneration.  
In the brain, regeneration is thought to be mediated by a specific subset of cells 
called neural stem/progenitor cells (NSCs). This self-renewing cell population is 
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responsible for the generation of olfactory interneurons (Doetsch, Garcı́a-Verdugo et al. 
1997) and promotes development of new neurons in the dentate gyrus of the 
hippocampus (Eriksson, Perfilieva et al. 1998) under homeostatic conditions. NSCs have 
been shown to migrate to sites of damage in response to specific cues in the brain 
associated with injury, such as chemokines (Brown, Couillard-Després et al. 2003; 
Imitola, Raddassi et al. 2004; Schuette-Nuetgen, Strecker et al. 2012). However, this 
system is seemingly less efficient in its ability to repair damaged brain tissue and long 
lasting neurological deficits are common outcomes following brain damage. 
Emerging evidence suggests that while NSC respond to cues originating at the 
injury site, the inflammatory milieu generated by resident and infiltrating immune cells 
play a prominent role in directing the reparative functions of NSCs. During ischemic 
stroke and other models of non-infectious brain injury, neurogenic mechanisms involved 
in generating new neurons are influenced by the recruitment of macrophages (Kernie and 
Parent 2010; Zhou, Cheng et al. 2011; Hu, Li et al. 2012).  Based on the cytokines 
involved, macrophage activation can be polarized to specific molecular and functional 
phenotypes (Martinez, Helming et al. 2013), which have distinct effects on neurogenesis. 
Infections of the brain, such as Japanese encephalitis (Das and Basu 2008) and West Nile 
encephalitis (Wang, Lobigs et al. 2003), typically induce a strong Th1 response which 
produces high levels of IFN-γ. IFN-γ is known to promote an M1 macrophage activation 
state that is associated with decreased levels of neurogenesis (Das and Basu 2008). 
Interestingly, sterile (non-infectious) models of brain damage, such as ischemic stroke 
(Hu, Li et al. 2012) and traumatic brain injury (Kernie and Parent 2010), appear to 
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promote an M2 macrophage activation state and are associated with less severe 
neurological outcomes (Colton 2009; Martino, Pluchino et al. 2011). While the role of 
cytokines in modulating NSC function have been studied, there is hitherto limited 
information on how macrophage activation alters NSCs. 
Previous studies in our laboratory (described in chapter 3) demonstrated that peak 
adult neural stem cell (NSC) proliferation occurs concurrent with peak macrophage 
infiltration, early during infection (Rotschafer, Hu et al. 2013). Using a mouse model of 
Herpes Simplex encephalitis (HSE) that closely resembles the human condition (Armien, 
Hu et al. 2010), we investigated the role of macrophages in enhancing adult neurogenesis 
during viral encephalitis.  Given the concurrent increases in NSC proliferation and 
macrophage infiltration, we hypothesized that an M2 like polarization of infiltrating 
macrophages stimulates NSC proliferation during the acute phase of infection. 
Methods: 
Animals and Infection 
All experimental procedures using animals were conducted per the guidelines set 
forth by the Guide for the Care and use of animals and is approved by the UMN IACUC. 
Briefly, 2.5x105 plaque forming units (PFU) HSV-1 strain Syn17+ was instilled 
intranasally into anesthetized eight to ten-week old female BALB/c mice (Charles River, 
Wilmington, MA) as described previously (Marques et al., 2006). 
Flow Cytometric Evaluation of Immune Cell Infiltration 
Infected and uninfected mouse brains were isolated and homogenized by 
mechanical dissociation. This homogenate was then centrifuged on a discontinuous 70-
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30% Percoll gradient (Sigma Aldrich, St. Louis, MO). Total brain leukocytes were 
isolated, washed, and enumerated for immunostaining. 5x105 cells were used for 
immunostaining for CD45 (PE-Cy7, PerCP-Cy5.5, APC, or FITC; eBioscience, San 
Diego, CA), CD11b (APC, APC-Cy7 or eFluor 405; eBioscience), Ly6C (PerCP-
eFluor710 or APC; eBioscience), CD206 (APC; BD Biosciences, San Jose, CA), CD86 
(PE or FITC; BD Biosciences), and MHC class II (PerCP-eFluor 710 or PE; BD 
Biosciences). Immunostaining samples were blocked for five minutes with anti-
CD16/CD32 antibody (BioXCell, West Lebanon, NH) prior to addition of fluorophore 
conjugated cell surface antibodies. Absolute quantification was achieved by adding 50uL 
AccuCount blank particles prior to sample acquisition on a BD FACSCanto cytometer 
within 24 hours of sample collection. 
Flow Cytometric Evaluation of Endogenous Neural Stem Cells 
The neurogenic regions of infected and uninfected mice were isolated (coronal -1 
to +3mm bregma). A papain-based Neural Tissue Dissociation Kit (Miltenyi Biotec, 
Auburn, CA) was used to generate a single cell suspension. Myelin was depleted using 
Myelin Removal Beads from Miltenyi and live cells were counted for immunostaining. 
5x105 cells were used for immunostaining for CD45 (PerCP-Cy5.5; eBioscience), Sox2 
(eFluor 660; eBioscience), and Ki-67 (Abcam, Cambridge, MA). Secondary antibody 
used for Ki-67 was donkey anti-rat F’ab PE (BD Biosciences). Quantification of 
endogenous stem cells was performed by adding 50µL blank AccuCount particles 
(Spherotech, Lake Forest, IL) immediately prior to reading on a BD FACSCanto. 
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Absolute numbers of NSCs and proliferating cells was calculated per the manufacturer’s 
instructions as a ratio of positive events to particle events read. 
In vitro culture and proliferation of NSCs 
Embryonic day 14.5 cortices were isolated from embryos of pregnant BALB/c 
mice. A single cell suspension was generated by mechanical dissociation and cultured in 
DMEM:F12 medium supplemented with N2 culture supplement. Epidermal growth factor 
(EGF) and fibroblast growth factor-2 (FGF-2) were added every other day to 20 ng/mL. 
Cultures were grown as spheres and cells between passages 1 and 4 were used in 
experiments. 
Proliferation of NSCs was measured by labeling the cells with a fixable 
proliferation dye. Briefly, NSCs were dissociated to a single cell suspension. The cells 
were then concentrated to 1x107 cells per mL by centrifugation and suspension in 900 µL 
complete NSC medium. 100µL 100nM diluted fixable Cell Proliferation Dye eFluor 670 
(1:500 dilution of recommended stock) was added and cells were cultured in the dark at 
37°C for five minutes. Labeling was quenched using 5 mL 1:1 7.5% bovine serum 
albumin (Sigma Aldrich) to complete NSC medium and incubated on ice for ten minutes. 
Cells were washed four times in the 1:1 BSA:NSC medium solution and once more in 
complete NSC medium. 1x105 labeled NSCs were then cultured with or without 
conditioned macrophage media in 24 well plates. A time course of proliferation was 
evaluated by cell cycle analysis using 7-aminoactinomycin (7-AAD) DNA binding. Cells 
in the G2/M phase were quantified with AccuCount particles, added prior to data 
acquisition to ensure accurate cell quantification of proliferating cells. 
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The role of Wnt/β-catenin signaling in M2C induced NSC proliferation was 
evaluated by adding an endogenous Wnt signaling blocker, dickkopf-1 (DKK-1; 100 
ng/mL, R&D Systems), to M2C treated NSCs and cultured for 72 hours (h). Wn5a 
specificity in was demonstrated by blocking Wnt5a specific signaling using a polyclonal 
neutralizing antibody to Wnt-5a (5 µg/mL; R&D Systems), and cultured with M2C 
treated NSCs for 72 h. 
In vitro Macrophage Polarization 
Bone-marrow derived monocytes (BMDMs) were isolated from tibias of 
uninfected BALB/c mice by flushing serum-free macrophage culture media (Life 
Technologies, Grand Island, NY) through the marrow cavity. Bone marrow cells were 
differentiated in to macrophages by supplementing serum free macrophage media (Life 
Technologies) with macrophage-colony stimulating factor (M-CSF, eBioscience; 10 
ng/mL) and allowed to grow for three days. Non-adherent cells were removed by 
washing and adherent macrophages were maintained as unstimulated, or were stimulated 
with either interleukin-4 (eBioscience; 20 ng/mL) or lipopolysaccharides (Sigma Aldrich; 
50 ng/mL) and interferon-γ (R&D Systems, Minneapolis, MN; 20 ng/mL) for 4 days to 
generate alternatively or classically activated macrophages respectively. Supernatants 
were collected at the end of the 4d period and stored at -80°C. Validation of classical or 
alternative activation was achieved by flow cytometry for CD45, CD11b, CD206 and 
CD86 as well as reverse transcription-PCR for gene products shown to be specific for 
each polarization including interleukin-15, interleukin-6, arginase1, and CD206. 
Immunocytochemistry of Polarized Macrophages 
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BMDMs were seeded onto glass coverslips in 24 well plates and polarized as 
described above. Unpolarized (M0) or IL-4 treated (M2) macrophages grown on 
coverslips were rinsed twice with PBS and fixed in 4% paraformaldehyde for 30 min at 
room temperature. Coverslips were washed three times with PBS and permeabilized 
using a 0.1% Triton-X 100 in PBS solution for 10 minutes at room temperature. 
Coverslips were washed three times in PBS and blocked for one hour at room 
temperature in 1% BSA. Primary antibody, goat anti-mouse Wnt5a (1:50 dilution, R&D 
Systems, Minneapolis, MN) was incubated overnight at 4°C. Coverslips were washed 
three times in PBS and anti-goat Ig conjugated to AlexaFluor 488 (1:500 dilution, Life 
Technologies, Carlsbad, CA) was applied for 30 min at room temp and protected from 
light. Coverslips were counterstained with DAPI and imaged using a Nikon fluorescent 
microscope. 
In vivo Macrophage Supplementation 
Uninfected 8 to 10-week old female BALB/c mice were anesthetized and heat-
killed or live M2 activated macrophages was administered by intracerebroventricular 
(icv) injection (-0.9mm anterior/posterior, +0.5mm midline, and -2.5mm dorsal/ventral 
relative to bregma) using a 27.5GA needle. Cells were heat-killed by incubation at 55°C 
for 15 minutes and cell death was verified by visual evaluation of the cells using a Trypan 
Blue (Sigma Aldrich) exclusion assay. 3x104 heat-killed or live macrophages were 
stereotactically injected in 3 µL saline at a rate of 1µL per minute into the right lateral 
ventricle. 
Immunohistochemistry in infected mouse brains 
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6 d p.i. mice infected with HSV-1 were perfused with 4% paraformaldehyde and 
their brains were isolated. These brains were post-fixed in 4% paraformaldehyde for 24 h 
and then cryopreserved by passaging through increasing amounts of 30% sucrose in 
phosphate buffered saline (PBS). Finally, brains were frozen in Optimal Cutting 
Temperature (OTC) medium (Sakura, Torrance, CA) and cryosectioned into 10 µm 
coronal or sagittal sections. 12 sections were collected 250 µm apart on each slide. 
Endogenous peroxidase was quenched in a 0.3% hydrogen peroxide solution for 10 min 
and washed 3 times in PBS. Sections were blocked in 10% bovine serum albumin (BSA) 
for 1 h at room temperature and CD11b primary antibody was applied (1:10, 
Pierce/ThermoScientific, Rockford, IL) overnight at 4°C. Slides were then washed three 
times in PBS and permeabilized in a 0.1% Triton-X 100 solution for 10 min. Slides were 
washed three times in PBS and anti-Wnt5a primary antibody was added (1:50, R&D 
Systems, Minneapolis, MN) overnight at 4°C. Following three PBS washes, chicken anti-
goat Ig AlexaFluor 488 and mouse anti-rat IgG2b Biotin secondary antibodies were 
applied for two h at room temperature. Slides were washed three times in PBS and 
incubated with streptavidin AlexaFluor 555 (1:100, Life Technologies, Carlsbad, CA) for 
10 min. Slides were washed and counterstained with DAPI. Sections were imaged using a 
Nikon fluorescent microscope. Images were collected at the same exposure times (within 
fluorophores) for all samples. 
RT-PCR 
Total RNA was isolated from mouse brains using the BioRad Aurum 
Fatty/Fibrous Tissue kit (Hercules, CA) per manufacturer’s recommendation. Total RNA 
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from polarized macrophages and cultured NSCs was isolated using the RNeasy Plus kit 
(Qiagen, Valencia, CA) and 2µg RNA was reverse transcribed to cDNA.  cDNA was 
amplified using a SyBR based PCR reaction on a Roche LightCycler 480 using primers 
designed for specific genes:  Wnt5a: Forward 5’-ATGAACTGGGGGCATCTTGG-3’, 
Reverse 5’-CGAGGAATTCAAGCGAAGCG-3’; Wnt7b: Forward 5’-
TCTCTGCTTTGGCGTCCTCTAC-3’, Reverse 5’-GCCAGGCCAGGAATCTGTTG-3’; 
Wnt10b:Forward 5’-TTCTCTCGGGATTTCTTGGATTC-3’, Reverse 5’-
TGCACTTCCGCTTCAGGTTTTC-3’; β-catenin: Forward 5’-
AAGGAAGCTTCCAGACATGC-3’, Reverse 5’-AGCTTGCTCTCTTGATTGCC-3’; 
IL-15 Forward 5’- CATCCATCTCGTGCTACTTGTGTT-3’, Reverse 5’- 
CATCTATCCAGTTGGCCTCTGTTT-3’; IL-6 Forward 5’- 
CAGAATTGCCATCGTACAACTCTTTTCTCA-3’, Reverse 5’- 
AAGTGCATCATCGTTGTTCATACA-3’; Arg1 Forward 5′-
ACAAGACAGGGCTCCTTTCAGG-3′,  Reverse 5′-
GGAGAAGGCGTTTGCTTAGTTCTG-3′; CD206 Forward 5’- 
TCTTTGCCTTTCCCAGTCTCC-3’, Reverse 5’- TGACACCCAGCGGAATTTC-3’. 
Results: 
Alternatively activated (M2) macrophages infiltrate the brain at 5 d p.i. 
To identify phenotypes of infiltrating macrophages in the brain during the course 
of Herpes Simplex encephalitis, brain leukocytes were stratified on a flow cytometer 
based on surface expression of CD45 and CD11b. Consistent with previous findings 
(Marques, Cheeran et al. 2008; Mutnal, Cheeran et al. 2011), the total infiltrating  
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Figure 4.1: Infiltrating monocyte/macrophages are Ly6C(hi)CCR2(+) at 5 d p.i. (A) 
Representative dot plots of CD45 versus CD11b immunostaining of brain immune cells showing 
several distinct populations of immune cells in infected brains. The infiltrating 
monocyte/macrophage population was defined as CD45(hi)CD11b(+) (gate R1).  Representative 
dot plots from 10-15 animals at each time point are presented. (B) Ly6C expression on infiltrating 
monocyte/macrophages (R1) from uninfected (dotted line) or infected (black line) brain samples 
at 5 d p.i. (top plot) or 15 d p.i. (bottom plot) was compared to isotype-stained controls (gray 
shaded). Representative histograms obtained from 10-15 animals per group at the indicated time 
points showing percentages of Ly6C(hi) and Ly6C(int) monocyte/macrophage populations. (C) 
To further characterize R1 cells, CCR2 expression was evaluated at 5 and 15 d p.i. Representative 
dot plots obtained from 10-15 animals are presented. (D) Absolute numbers of infiltrating 
monocyte/macrophages [CD45(hi)CD11b(+); black bars] and those that were also Ly6C(hi) (gray 
bars) were quantified using AccuCount particles from uninfected and HSV-1 infected brains at 5 
and 15 d p.i. Data presented as average number of cells (±SEM) per mouse brain. ** p≤0.01 vs 
uninfected animals. 
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macrophage population (CD45(hi) CD11b(+); R1, Fig. 4.1A) was larger at 5 d p.i. during 
acute HSE, compared to macrophage numbers observed at 15 d p.i. (282,000 ± 13,880 
cells vs 40,800 ± 1560 cells; p≤0.01) during the chronic phase of the disease (Fig. 4.1A). 
Presence of macrophages expressing high levels of the activation marker Ly6C 
significantly increased at 5 d p.i. However at 15 d p.i. a minor population of macrophages 
expressing intermediate levels of Ly6C was observed that was not seen at 5 d p.i. (Fig. 
4.1B). At 5 d p.i., more than 90% of Ly6C(hi) R1 macrophages also expressed CCR2(+) 
whereas at 15 d p.i. CCR2(+)Ly6C(hi) macrophages were undetectable in the brain. 
Interestingly, CCR2 was expressed on Ly6C(int) cells at 15 d p.i. (Fig. 4.1C). 
Quantification of these cell populations reveals that at 5 d p.i. approximately 83% of the 
total CD45(hi)CD11b(+) macrophage population also expressed Ly6C(hi); while at 15 d 
p.i. this population was greatly reduced (Fig. 4.1D). 
To examine if discreet macrophage activation states correlated with increases in 
NSC proliferation, expression of CD206 (the mannose binding receptor and an alternative 
activation marker) and CD86 (a beta-seven integrin and a classical activation marker), 
which represent two distinct activation states of the cell were evaluated. At 5 d p.i., an 
increase in macrophages expressing CD206 was observed, whereas a minimal change in 
CD86 expressing macrophages was seen at this time point (Fig. 4.2A). Furthermore total 
numbers of CD206(+)Ly6C(hi) macrophages outnumbered CD86(+)Ly6C(hi) 
macrophages by a ratio of approximately 5:1 (38,436 ± 2385 CD206(+) macrophages vs 
4983 ± 543 CD86(+) macrophages) compared to a 2:1 ratio in infected brains at 15 d p.i 
and uninfected  controls (Fig. 4.2B). In addition, more than half of the CD206(+) cells 
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expressed both CCR2 and CCR7 (Fig. 4.2C). This observation is congruent with 
observation that blocking macrophage infiltration using a CCL2 antibody alone does not 
abrogate macrophage infiltration into the brain at 5 d p.i (data not shown). Quantification 
of CCR2 and CCR7 expression on the CD206(+) infiltrating macrophage population 
revealed that in addition to a robust population of CCR2(+) CCR7(+) double positive 
Ly6C(hi) cells, there is significantly more CCR2(-)CCR7(+), single positive, CD206(+) 
cells than in uninfected control mice (Fig. 4.2D). Surprisingly, at 15 d p.i., CCR7 was 
absent in the CD206(+) macrophage population (Fig 4.2D). On the other hand, blocking 
CCR2 utilizing a CCL2 neutralizing antibody was unsuccessful (Fig 4.2E) in preventing 
infiltration of macrophages or total numbers of microglia (Fig 4.2F) present in the brain.  
In vitro polarization of BMDMs results in distinct M1 and M2 phenotypes. 
To determine if macrophage polarization altered NSC function, cultured BMDMs 
were differentiated with either IL-4 or LPS and IFN-γ as previously described (Hu, Li et 
al. 2012) to generate M2 and M1 macrophages, respectively. In vitro polarized 
macrophage activation profiles were validated using flow cytometry and RT-PCR (Fig. 
4.3). While CD206 and CD86 expression were observed in macrophages in all treatment 
groups (Fig. 4.3A), the ratio of CD206 expression was 4-fold greater than CD86 under 
M2 polarizing conditions than M1 (2471.63±226.26 CD206(+) cells vs. 214.66±59.98 
CD86(+) cells, p≤0.01). Fig. 4.3A). Similarly M1 macrophages expressed approximately 
4-fold more CD86 than CD206 (1063.03 ± 39.28 CD86(+) cells vs. 255.57 ± 32.58 
CD206(+) cells, p≤0.01). The M0 “unpolarized” treatment group had approximately a  
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Figure 4.2: Increased infiltration of alternatively activated (M2) monocyte/macrophages at 5 d 
p.i.  (A) Representative histograms of CD206 (left plot) and CD86 (right plot) expression on the 
infiltrating monocyte/macrophage population (R1 in Figure 1) from infected (solid black line) and 
uninfected (dotted black line) animals were compared to isotype stained controls (shaded line) at 5 d 
p.i. (B) Average numbers of cells per brain obtained from 10-15 animals per time point at 5 and 15 d 
p.i. are presented. (C) Further characterization of Ly6C(hi)CD206(+) M2 macrophages demonstrated 
that these cells expressed CCR7, in addition to CCR2. Representative dot plot showing CCR2 and 
CCR7 expression on Ly6C(hi) infiltrating monocyte/macrophages. (D) Total numbers of 
CCR7(+)CCR2(-) (black bar), CCR7(+)CCR2(+) (light gray bar), and CCR7(-)CCR2(+) (dark gray 
bar) cells from the CD206(+) infiltrating macrophage population were quantified using AccuCount 
particles from uninfected and infected brains at 5 and 15 d p.i. Total numbers of macrophages 
infiltrating the brain (E) or microglia (F) of infected mice given a CCL-2 (Anti-CCL2; CCR2 ligand) 
neutralizing antibody during acute HSE was not altered compared to infected mice given an isotype 
antibody (Isotype). Data are presented as average (±SEM) cells per brain. 
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Figure 4.3: In vitro polarization of bone marrow-derived macrophages (BMDMs). (A) Flow 
cytometry analysis of unpolarized (M0) and polarized M1 or M2 BMDMs for CD206 and CD86 
expression in the cultured CD11b(+) BMDMs is presented. Histograms obtained from CD11b(+) 
BMDM (top panel) immunostained for CD206 (top left panel) and CD86 (top right panel) show 
differential expression of CD206/CD86 on polarized BMDMs.  (B) The ratios of absolute 
numbers of CD11b(+)CD206(+) macrophages to CD11b(+)CD86(+) macrophages are presented 
(bottom panel) as average values obtained from 2 independent experiments using pooled bone 
marrow from 6 animals per experiment that were polarized in triplicate cultures.   (C-F) 
Quantitative RT-PCR analysis of in vitro polarized BMDMs from M0, M1, or M2 polarized 
macrophages, 24 hours post-polarization, is presented. Data are compiled from 3 independent 
experiments using pooled BMDMs from 6 animals per experiment and each polarization 
paradigm was tested in triplicate. PCR analysis of each sample was performed in triplicate and 
average relative gene expression, normalized to RPL27 housekeeping gene, is shown (average ± 
SEM). Gene expression profiles indicative of an M1 phenotype was demonstrated by (C) 
interleukin-6 (IL-6) and (D) interleukin-15 (IL-15) expression levels and those of an M2 
phenotype was demonstrated by (E) CD206 and (F) arginase-1 (Arg1) expression levels. 
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two to one ratio of CD86 to CD206 (2109.52 ± 339.00 CD86(+) cells to 1245.53 ± 
128.70 CD206(+) cells; (Fig. 4.3B).  
RT-PCR analysis of M1 and M2 macrophages revealed that expression of the M1 
markers IL-6 and IL-15 were up-regulated in the M1 treatment group after 24 hours of 
stimulation (Fig. 4.3C&D), and expression of the M2 markers CD206 and Arginase1 
were up-regulated in the M2 group (Fig. 3E&F). CD206 and Arginase1 were not 
detectable in the M1 polarized group. These data validated the polarized activation 
phenotypes of the macrophages used in the following experiments. 
M2 macrophage stimulation of proliferation is cell contact independent 
Unstimulated (M0C), M1 (M1C) and M2 (M2C) polarized macrophage culture 
supernatants or corresponding media controls (M0M, and M2M respectively) were added 
to embryonic (E14.5) neural stem cell cultures. Impressively, NSC grown in a 1:1 
supplemented M2 conditioned medium (M2C) exhibited a three-fold increase in 
proliferation over NSC only medium (35,281 ± 8,093 cells  vs 2,843 ± 808 cells in NSC 
control medium; p≤0.01; Fig. 4.4A). NSCs in all treatment groups expressed high levels 
of nestin (experiment average 92.3±3.46% nestin(+)) suggesting that none of the 
treatments induced differentiation of these cells. The proliferative effect of M2 
macrophage conditioned medium increased over time, with cultures having significantly 
higher total number of cells than control media at 72h (58,333.58 ± 834.65 cells vs 
33,397.03 ± 398.89 cells, p≤0.01), 96h (77,701 ± 2227.91 total cells vs 40,739.54 ± 
1823.12 cells) and 120h (87,701.03 ± 2274.45 cells vs 43, 548 ± 504.73, p≤0.01; Fig. 
4.4B). Increases in NSC proliferation by M2 conditioned media were robust and could be  
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Figure 4.4: Soluble mediators produced by M2 polarized macrophages stimulate NSC 
proliferation. (A) At 60 h post-treatment, dye dilution within dividing cells was measured by 
flow cytometry to determine changes in NSC proliferation following treatment with polarized 
macrophage supernatants. Increase in NSC division suggests that M2 macrophage supernatants 
secrete soluble factors that enhance NSC proliferation. (B) The kinetics of M2 macrophage driven 
NSC proliferation was measured by assessing the total numbers of NSCs treated with M2 control 
media (M2M), M2 polarized supernatant (M2C), or complete NSC control media (NSC) over the 
indicated time points. (Inset) Total DNA content per cell was also analyzed using 7-AAD and is 
presented as fold-change in the number of cells showing DNA doubling compared to untreated 
NSC control. Data are representative of three independent experiments done in triplicate and 
presented as average (± SEM) cells per well. **p≤0.01 vs. untreated NSC media.  (C) To evaluate 
the potency of M2 macrophage supernatants in enhancing NSC proliferation, M2 supernatants 
(M2C) and M0 media (M0M) were titrated against NSC media (NSC) to assess the dilution at 
which cells no longer respond to stimulation. 
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titrated with increasing dilutions of M2 macrophage supernatants, suggesting that soluble 
mediators with high potency media this effect (Fig. 4.4C).  
M2 polarized macrophages increase NSC proliferation in vivo. 
Previous reports have suggested that M2 polarized macrophages promote 
myogenesis (Arnold, Henry et al. 2007). To test the possibility that M2 macrophages 
might promote adult neurogenesis, M2 activated BDBMs were transplanted into the 
lateral ventricles of uninfected BALB/c mice by icv injection. Brains collected 5 d later 
were analyzed by flow cytometry for Sox2, a neural stem cell marker, and Ki-67, a 
proliferation marker. Quantification of the endogenous brain cell population (CD45(-)) 
revealed a significant increase in the total number of proliferating NSCs (Sox2(+)Ki-
67(+)) cells in recipients receiving live M2 macrophages (6,498 ± 265) when compared 
to recipients receiving heat-killed (1,702 ± 138) cells or saline-treated sham controls (vs   
(5,228 ± 465; Fig. 4.5A). Correspondingly, the total numbers of Sox2(+) NSCs in the 
animals receiving live M2 activated cells were also significantly increased (32,054±365 
cells; p≤0.01 to saline and heat-killed controls) compared to either the animals receiving 
saline or heat-killed M2 activated macrophages (15,586±3343 cells or 7,366±251 cells 
respectively; Fig 4.5B). 
Wnt5a mediates M2 macrophage induced NSC proliferation  
To identify the soluble factor(s) mediating M2 macrophage induced NSC 
proliferation, changes in gene expression of selected soluble factor were evaluated.  
Initially, common gene pathways associated with both macrophage activation profiles 
and NSC proliferation were evaluated for candidate gene selection with IPA (Ingenuity  
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Figure 4.5: NSC numbers increase following M2 macrophage transplant in vivo. Absolute 
numbers of (A) proliferating CD45(-)Sox2(+)Ki-67(+) NSCs and (B) total CD45(-) Sox2(+) 
NSCs was assessed using AccuCount particles by flow cytometry. A significant increase in the 
number of proliferating Sox2(+) NSCs was observed. A total of five animals were used per 
treatment group and data presented are average values (± SEM) per brain. ** p≤0.01. 
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Altered Gene Expression in Polarized Macrophages (RU) 
Gene M0 Macrophages M1 Macrophages M2 Macrophages 
Wnt5a 135.10±34.08 ND 1156.06±417.35 
Wnt7b 9.07±3.19 0.52±0.15 41.31±9.56 
Wnt10b 4.72±0.73 ND 1.74±0.24 
BDNF 123.65±39.3 132.88±32.05 93.41±5.17 
NT-3 117.04±0.35 652.19±60.50 404.98±10.82 
CSF1 77.70±3.77 31.91±0.51 70.69±0.98 
IL-1β 0.15±0.01 0.86±0.03 0.70±0.03 
IL-6 0.84±0.18 27.23±1.13 1.47±0.22 
IL-15 139.72±29.12 767.49±10.64 178.39±10.50 
IL-23 13.86±3.39 38.04±8.68 71.62±14.21 
Lif 0.09±0.01 6.37±0.40 0.87±0.054 
Bold numbers indicate genes with significantly (p≤0.05) different expression between M0 
and M2 polarized macrophages. 
 
Table 4.1: Wnt family growth factors are expressed in M2 macrophages. Total RNA from 
unpolarized (M0), classically activated (M1), and alternatively activated (M2) macrophages was 
isolated and amplified by RT-PCR for various growth factors known to affect NSC proliferation. 
While several factors had significantly increased gene expression in M2 macrophages, Wnt5a had 
the largest increase. 
 118 
 
Pathway Analysis, Ingenuity, Redwood City, CA) using data generated by (Martinez, 
Helming et al. 2013). Selected gene transcripts were then analyzed by quantitative RT-
PCR. Data obtained from the PCR analysis of M1 and M2 macrophages are summarized 
in Table 1. Notably, transcription of Wnt5a was significantly increased in M2 polarized 
macrophages compared to M0 (unpolarized) or M1 macrophages. This finding was 
confirmed by immunocytochemistry for Wnt5a expression in in vitro polarized M2 
macrophages, showing that M2 macrophages had greater Wnt5a specific staining (Fig 
4.6A) compared to unpolarized (M0) macrophages. The involvement of Wnt5a was 
confirmed by abrogating the effect of M2 macrophage on NSCs using either a Wnt5a 
neutralizing antibody or dickkopf-1 (DKK), an antagonist of low density lipoprotein 
receptor-related protein-5 (LRP-5) involved in Wnt signaling. Treatment with Wnt5a 
neutralizing antibody resulted in reduction in levels of NSC proliferation in M2 
conditioned media compared to cells grown in control medium or treatment with heat-
inactivated goat serum (isotype control; Fig. 4.6B).  Similarly, addition of 5 µg/mL DKK 
resulted in a significant reduction in proliferation in NSCs cultured in M2 macrophage 
conditioned media (Fig. 4.6C), whereas DKK in either the NSC medium or M2M 
controls had no significant effect on the numbers of proliferating NSC. 
Wnt5a is up-regulated during acute HSE 
To determine if Wnt5a was involved in mediating the increase in NSC 
proliferation during acute HSE in vivo, Wnt5a gene expression was measured using RT-
PCR from total RNA isolated from whole brain homogenates at various time points post 
infection. At 3 d p.i. Wnt5a gene expression increased by approximately three-fold (Fig.  
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Figure 4.6: M2 macrophage effects are dependent on Wnt5a. Polarized macrophages were 
assessed for expression of growth factors previously identified to alter NSC proliferation. (A) 
Only M2 macrophages expressed Wnt5a in culture. NSCs were cultured with M2 media control 
(M2M), M2 polarized macrophage supernatants (M2C), or NSC control media (NSC) as 
previously described (Figure 4) with or without (B) anti-Wnt5a neutralizing antibody (5µg/mL) 
or (C) the Wnt signaling antagonist, dickkopf-1 (DKK-1; 100ng/mL). Data are presented as 
average (±SEM) per well of 2 independent experiments with triplicate treatment groups. 
**p≤0.01. 
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Figure 4.7: Increased Wnt5a gene expression in HSV-1 infected brains at 3 d p.i. Average 
fold increases (± SEM) measured in triplicate from RNA obtained from 3-5 animals at each time 
point are presented. Wnt5a gene expression was found to increase acutely by 3-fold at 3 d p.i., 
which is concurrent with M2 macrophage infiltration and increased endogenous brain cell 
proliferation. 
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4.7). The increase in Wnt5a at 3 d p.i is consistent with previous work in our lab showing 
that endogenous NSC cell proliferation begins as early as 3 d p.i. (30), suggesting the 
involvement of Wnt5a in HSE induced neurogenesis. Limited Wnt5a protein expression 
was detected in CD11b(+) macrophages of the brain at 3 d p.i. (data not shown). 
However by 6 d p.i., Wnt5a production was observed in CD11b(+) macrophages at 
several brain regions (Fig. 4.8). Notably, Wnt5a(+) macrophages were found in the 
entorhinal cortex near the lateral ventricles (Fig. 4.8A) as well as in periventricular 
spaces (Fig. 4.8B) and in cortical regions where HSV-1 induced lesions are observed 
(Fig. 4.8C). The presence of Wnt5a positive macrophages in the brain suggests that brain 
macrophages produce Wnt5a in response to HSV-1 infection, which temporally 
corresponds to the increase in Sox2(+) NSC proliferation observed at 6 d p.i. in previous 
studies (Rotschafer, Hu et al. 2013). 
Discussion: 
The present study demonstrates that majority of infiltrating macrophages in HSV-
1 infected mouse brains, exhibited an alternatively activated phenotype at 6 d p.i., at a 
time when NSC proliferation is significantly increased (Rotschafer, Hu et al. 2013). In 
addition, M2 macrophages seen during the acute phase of HSE expressed high levels of 
Ly6C (Ly6Chi cells) and expressed both CCR2 and CCR7 on their cell membranes, 
indicating the potential redundancy in chemokine use by these cells for trafficking into 
the HSV-1 infected brain. Ex vivo analysis of revealed that M2 macrophages stimulated 
both potent and long-lasting proliferation of NSCs, without inducing stem cell  
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Figure 4.8: Wnt5a(+)CD11b(+) macrophages are present during acute HSE. Sections from 6 
d p.i. infected mice were stained for Wnt5a and CD11b. Arrowheads denote double positive 
macrophages were observed in three brain regions (A-C) identified in (E). Isotype antibody 
stained sections are observed in (D). All images are representative of 5 animals. 
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differentiation. Furthermore, transplantation of alternatively activated M2 macrophages 
into the lateral ventricles was sufficient to stimulate NSC proliferation and to double the 
population size in the adult mouse brain. Analysis of soluble factors expressed by 
macrophages, known to induce cell proliferation, suggested that select molecules of the 
Wnt family may be involved in mediating NSC proliferation. Gene expression analysis of 
M2 polarized macrophages showed a dramatic increase in Wnt5a, indicating this 
molecule was a likely soluble factor mediating proliferation of NSC. The involvement of 
activated macrophage induced Wnt5a both in vivo and in vitro was further confirmed by 
showing increased expression of Wnt5a at 6 d p.i. in HSV-1 infected brains and loss of 
proliferative activity in co-cultures of NSC and M2 macrophage supernatants treated with 
neutralizing antibodies to Wnt5a. 
Activated macrophages are known to exhibit distinct functional phenotypes that 
lie along a spectrum of activity ranging from toxic pro-inflammatory macrophages to 
healing macrophages essential for tissue regeneration (Brancato and Albina 2011). 
Simplistically, activated macrophages may be categorized into two distinct phenotypes 
usually observed at opposing ends of this functional spectrum: the classical, pro-
inflammatory M1 phenotype and the alternatively activated, healing M2 phenotype (Hu, 
Li et al. 2012; Crespo, Bertolotti et al. 2013; Hong, Chung et al. 2014). While the M1 
phenotype is a potent stimulator of inflammation, the M2 phenotype has been shown to 
promote tissue repair. Mechanisms by which M2 macrophage induced tissue repair 
include the production of growth factor, as seen during skeletal muscle (Arnold, Henry et 
al. 2007) and brain injury (Hu, Li et al. 2012). In the present study, majority of 
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infiltrating macrophages responding to experimental HSV-1 infection expressed one of 
the markers found on M2 polarized macrophages, CD206. The increase in CD206(+) 
infiltrating macrophages coincided with peak NSC proliferation. This study is the first to 
demonstrate a role for M2 macrophages in stimulating NSC proliferation during viral 
encephalitis. M2 polarized macrophages are essential in heart tissue regeneration after 
ischemia (Aurora, Porrello et al. 2014) and salamander limb regeneration after 
amputation (Godwin, Pinto et al. 2013). Our findings suggest that M2 macrophages may 
facilitate tissue repair after brain injury by stimulating adult NSC proliferation. Further 
experimentation is necessary to establish a role for infiltrating M2 macrophages in 
reparative processes and associated neurological outcomes during HSE.  
NSC proliferation is the first step in promoting resolution of neurological deficits 
associated with brain damage. Murine models of cerebral ischemia have demonstrated 
that in the presence of M2 polarized macrophages, proliferation of neuroblasts, a NSC 
derived cell type, is significantly elevated with improvement in balance and coordination 
following ischemia in mice (Jin, Cheng et al. 2014). The data presented in this chapter 
demonstrate that M2 macrophages increase NSC proliferation via a cell contact 
independent mechanism. Transplantation of M2 polarized macrophages into uninfected 
mice significantly increased the total number of NSCs 5 days after transplantation. 
Studies in Japanese encephalitis have shown that suppression of the M1 macrophage 
activation phenotype using minocycline results in robust increases in NSC proliferation 
(Das, Dutta et al. 2011). The M2 macrophage activation effects observed in the present 
study may be preserved in other models of viral encephalitis. 
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Previous studies using mouse models of HSE have demonstrated that CCR2(+) 
macrophages are essential to resolve HSV-1 brain infection (Boivin, Menasria et al. 
2012). However, in several models of viral encephalitis, infiltrating CCR2(+) 
macrophages largely possess a pro-inflammatory phenotype. In West Nile virus 
encephalitis, infiltration of Ly6C(hi)CCR2(+) macrophages results in worsened disease 
and increased mortality in infected mice (Getts, Terry et al. 2008). On the other hand, the 
present study demonstrated that at the early time points (5 d p.i.), majority of the 
CCR2(+) macrophages exhibited an alternatively activated phenotype, which later (at 15 
d p.i.) shifted to a predominance of classically activated phenotype in the brain. This 
finding suggests that while macrophage activation may change, chemotaxis signals that 
induce migration of different macrophage polarizations may be similar. The use of CCR2 
by M2 macrophages as a migratory mechanism was observed in mice infected with 
schistomiasis, where it was shown that M2 macrophages were absent in CCR2 knockout 
mice (Nascimento, Huang et al. 2014). In the present study, total number of infiltrating 
macrophages present in HSV-1 infected mice brains subsequent to treatment with a 
CCL2 neutralizing antibody did not change. However, the findings in the present study 
show that these M2 macrophages also express CCR7, suggesting an alternate mechanism 
for chemotaxis into the brain. 
The mechanism of M2 macrophage supernatant induced increase in NSC 
proliferation in vitro was dependent on Wnt5a, which is a prototypical activator of the 
non-classical Wnt signaling pathway (Pourreyron, Reilly et al. 2012). Wnt5a is most 
commonly associated with proliferation of tumor cells; however, Wnt5a also plays an 
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important role in cell turnover in healthy tissues, such as human periodontal ligament 
cells (Hasegawa, Wada et al. 2015), epithelial cell wound healing of colonic 
myofibroblasts (Raymond, Marchbank et al. 2012), and regeneration of colonic crypts 
after experimental crypt excision (Miyoshi, Ajima et al. 2012). Importantly, the fact that 
Wnt5a mediated its effects on villus epithelium replacement from progenitor cells in the 
crypt bed, well beneath the wound, suggests that Wnt5a can induce tissue regeneration 
from sites distal to the areas of tissue damage (Miyoshi, Ajima et al. 2012). Similarly, 
this present study identified Wnt5a(+)CD11b(+) cells present in brain lesions of mice at 6 
d p.i. that were distant from the sub-ventricular zone of the lateral ventricles. 
In conclusion, the present study shows that at peak NSC proliferation, the immune 
response to HSE is dominated by alternatively activated, M2 macrophages and that these 
macrophages have the capacity to induce NSC proliferation. In vitro these macrophages 
mediated their effect through Wnt5a and observation of Wnt5a(+)CD11b(+) cells in the 
brains of mice at 6 d p.i. suggests a possible mechanism by which M2 macrophages 
induce NSC proliferation in vivo. However, further studies are required to characterize 
M2 macrophages mediating increased NSC proliferation and to further evaluate the 
potential of Wnt5a to improve neurological deficits in humans. Together these findings 
suggest that alternatively activated M2 macrophages and the associated Wnt5a 
production may prove to be a useful point of intervention to stimulate NSC proliferation 
and subsequent neurogenesis in patients suffering life-altering deficits following viral 
encephalitis. 
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Abstract: 
The ability of neural stem/progenitor cells (NSCs) to self-renew, migrate to damaged 
sites, and differentiate into neurons has renewed interest in using them in therapies for 
neurodegenerative disorders. Neurological diseases, including viral infections of the 
brain, are often accompanied by chronic inflammation. The interactions of 
neuroinflammation and neuroregenerative processes are poorly understood. We have 
previously shown that chronic neuroinflammation during HSE is dominated by brain-
infiltrating activated CD8(+) T cells. In the present study, activated CD8(+) T cells were 
found to suppress NSC proliferation in vitro. Total numbers of proliferating Sox2(+) 
NSCs were decreased by half in wells cultured with either stimulated CD8(+) T cells or 
IFN-γ. Analysis of these cells for apoptosis revealed that CD8(+) T cell mediated 
decrease in NSC numbers are not due to apoptosis. Inhibition of NSC proliferation by 
CD8(+) T cells was found to be dependent on IFN-γ as NSCs from IFN-γ receptor 
knockout mice proliferated normally in the presence of either stimulated CD8(+) T cells 
or IFN-γ. Pre-treatment of NSCs with IFN-γ resulted in significant reduction of NSC 
proliferation even in the presence of growth stimuli, shown to produce four to five-fold 
increase in numbers of cultured NSCs. In addition, activated CD8(+) T cells increased 
GFAP expression in NSCs suggesting possible induction of an altered differentiation 
state. Taken together, the studies presented here demonstrate a role for activated CD8(+) 
T cells in regulating NSC function mediated through the production of IFN-γ. This 
cytokine may influence neuro-restorative processes and ultimately contribute to the long-
term sequelae commonly seen following herpes encephalitis. 
 135 
 
Introduction:  
Over the past decade it has become well established that adult mammalian brains 
possess an inherent ability to regenerate (Gage 2000). This property of neurogenesis is 
realized by a small population of undifferentiated, self-renewing cells called neural 
stem/progenitor cells (NSC). The neurogenic cell population is housed predominantly in 
two well-described, discrete germinal centers (niches) within the brain, the subventricular 
zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) of the hippocampus. 
These neurogenic niches are composed of multiple cell types (Merkle, Mirzadeh et al. 
2007), which when examined at the population level exhibit distinct morphological and 
functional properties. Importantly, all cell types present in the niche retain the ability to 
proliferate and differentiate into distinct cell types (Kempermann, Jessberger et al. 2004; 
Kempermann 2011). Astroglial-like B cells are the top-level stem/precursor population 
and are capable of symmetrical and asymmetrical division which generates C cells. These 
intermediate C, or transit-amplifying, cells retain expression of stem/progenitor markers 
(like Sox2) and begin to express lineage specific markers, like doublecortin (DCX) 
(Kempermann, Jessberger et al. 2004) before they become A cells or neuroblasts.  
Although several models have been proposed to define lineage relationships of 
different neural stem/progenitor cell types (Ming and Song 2011), it is very evident that 
the germinal niches provide complex and dynamic microenvironments necessary to 
sustain the NSC population in multiple stages of differentiation (Alvarez-Buylla and Lim 
2004). On the other hand, the niche is influenced by both intrinsic and extrinsic signals 
that modulate neurogenic processes in the brain (reviewed in Russo, Barlati et al. 2011). 
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The inflamed brain microenvironment consequent to infection (Das and Basu 2008), 
ischemic stroke (Arvidsson, Collin et al. 2002), or in neurodegenerative disease states, 
like Huntington’s and Parkinson’s disease (Winner, Jappelli et al. 2011), affects the 
composition and architecture of the SVZ resulting in changes in proliferation, migration 
and differentiation of NSCs (reviewed in Kaneko and Sawamoto 2009). Neurological 
injury, associated with concomitant acute and/or chronic inflammation, alters 
neurogenesis within these NSC niches. Hence, understanding the role and influence of 
inflammation on these germinal centers in the brain is essential to garner the potential for 
NSCs to regenerate/repair damaged brains (Gonzalez-Perez, Jauregui-Huerta et al. 2010; 
Gonzalez-Perez, Quinones-Hinojosa et al. 2010; Kernie and Parent 2010).  
T cells have been postulated to play a major role in neurogenesis. Activated T cells 
influence the recovery process regardless of the type of brain injury (Yirmiya and Goshen 
2011; Lynch and Mills 2012). In fact, it has been postulated that CD4(+) T cells may 
have a physiological role in maintenance of memory and learning. Impairment in CD4(+) 
T cells, either by genetic manipulation or immunological depletion, results in decreased 
hippocampal neurogenesis and significant impairment in performance on memory tests 
(Kipnis, Cohen et al. 2004; Ziv, Ron et al. 2006; Brynskikh, Warren et al. 2008; 
McGowan, Hope et al. 2011), suggesting that peripheral immune cells and mediators may 
play a role in maintaining cognitive function under physiological conditions (Yirmiya 
and Goshen 2011).  
Contrary to their physiological role in promoting neurogenesis, T cells in pathological 
conditions are known to inhibit neurogenesis and altering T cell function is often 
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associated with favorable outcomes (Wei, Yemisci et al. 2011).  Infiltration of myelin-
specific T cells during experimental autoimmune encephalitis (EAE) have been 
associated with dysfunctional alteration in both the composition and the architecture of 
the SVZ, the NSC niche (Pluchino, Muzio et al. 2008). Similarly, larger infarct volumes 
resulting from ischemic brain injury have been linked to presence of activated T cells in 
the brain (Hurn, Subramanian et al. 2007; Shichita, Sugiyama et al. 2009; Kleinschnitz, 
Schwab et al. 2010), presumably driven by the neurotoxic effects of immune mediators 
generated by Th1 and Th2 T cells (Gu, Xiong et al. 2012). Interestingly, T cell deficiency 
also increased neural stem/progenitor proliferation during the acute stages of stroke 
(Saino, Taguchi et al. 2010). This dichotomous function of activated T cells may be 
related to distinct cytokine profiles generated during the inflammatory process following 
brain injury (Whitney, Eidem et al. 2009) and suggests that immune cells play an critical 
role in both the initiation and progression of neurogenesis.  
Inflammation is an essential component of the host response that protects against 
brain infections. Our laboratory has demonstrated that the inflammatory response to 
HSV-1 infection clears virus from the brain, but leaves in its wake a chronic activated T 
(Marques, Cheeran et al. 2008; Mutnal, Hu et al.) and B lymphocyte (Mutnal, Hu et al. 
2012) response, potentially serving critical surveillance functions.  Persistent cytotoxic 
CD8(+) T cells produce IFN-γ, a cytokine that both our laboratory and others have shown 
to alter NSC functions (Cheeran, Jiang et al. 2008).  While a substantial number of 
studies have investigated the role of the inflammatory response in defense of and damage 
to the brain, little if anything is known about the impact of neuroimmune responses on 
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NSCs in the context of viral encephalitis. In the present study, we utilized a co-culture 
system to determine the impact of activated T cells on NSC proliferation and began to 
decipher the molecular cues associated with their effects on NSCs.  
Materials and Methods: 
Ethics Statement 
All experiments in this study using animals were conducted under protocols 
approved by the University of Minnesota Institutional Animal Care and Use Committee 
and in concordance with the Guide for the Care and Use of Laboratory Animals.  
Neural stem/progenitor cell culture:  
Murine NSCs were cultured from the brains of E14.5 BALB/c mice, or IFN-γR1 
KO mice (CByJ.129S7(B6)-Ifngr1tm1Agt/J; Jackson Laboratory, Bar Harbor Maine) as 
previously described (Ni, Hu et al. 2004; Cheeran, Hu et al. 2005) with few minor 
modifications. Briefly, timed-pregnant mouse embryos (E14.5) were dissected in Hank’s 
buffer (Sigma, St. Louis, MO). After decapitation and removal of skin, skull, and 
meninges, cerebral cortices were mechanically triturated in Hank’s buffer and dissociated 
cells were collected and resuspended in serum-free NSC medium (DMEM/F12, 8 mM 
glucose, glutamine, 20 mM sodium bicarbonate and N2 Plus supplement, R&D Systems, 
Minneapolis, MN). Cells (2 x 105) were then plated as neurospheres in 10-cm diameter 
dishes or as monolayers on 10-cm diameter dishes, pre-coated with 15 μg/ml poly-L-
ornithine and 1 μg/ml bovine fibronectin. Media for all culture conditions was NSC 
medium supplemented with bFGF (20 ng/ml; R&D Systems) and EGF (20 ng/ml; R&D 
Systems). NSC monolayer cultures, maintained at 37°C (5% CO2) in NSC growth 
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medium (with bFGF and EGF), were sub-cultured when 60-70% confluence was attained 
and re-plated at a density of 2x105 cells per 10 cm dish or 2x103 cells per well of 24-well 
plates. This culture was considered as passage 1. NSC cultures between passages 1-3 
were used throughout this study. Near homogeneity (>98% positive) in Sox2 and Nestin 
(stem cell markers) expression was observed in these cultures, with a proportion (41.2 ± 
5.1%) of the cells expressing doublecortin (neuroblast marker) in addition to Sox2. GFAP 
expression was not detected in cultured NSCs. 
T cell isolation and stimulation 
Spleens and lymph nodes were collected from naïve BALB/C mice, raised under 
SPF conditions, as previously described (Marques, Cheeran et al. 2008). Briefly, single 
cell suspensions of splenocytes were depleted of red blood cells by treatment with 0.87% 
ammonium chloride, washed twice, and cell viability was confirmed using Trypan blue. 
T cell subsets were isolated from RBC free, lymph node cells and splenocytes using a 
ferrofluid based system (R&D Systems Inc., Minneapolis, MN), according to the 
manufacturer’s instructions. Untouched CD4(+) and CD8(+) T cells were enriched from 
lymph node and spleen using a negative selection based antibody cocktail that enriches 
for each T cell population. Enrichment of T cell subtypes were >90% in all experiments.  
Enriched CD8(+) T cells were co-cultured with proliferation dye labelled NSCs 
(methods below) 24 h after seeding the stem cells. Cell ratios of NSC and T cells were 
calculated based on number of NSC seeded in each well.  All experiments were 
conducted using passage 1 (P1) -P3 NSC cultures, which were determined to have similar 
doubling rates. T cells were stimulated in co-cultures using a mixture of monoclonal 
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antibodies to CD3 (5 μg/ml; clone 17A2) and CD28 (5 μg/ml; clone 37.5; BioXCell, 
West Lebanon, NH). Appropriate controls with and without activating antibodies or T 
cells were used to compare NSC proliferation in the presence of T cells. T cell 
conditioned medium was prepared from cell free supernatants of stimulated or 
unstimulated T cells cultured in NSC growth medium for 72 h. Half of the NSC growth 
medium was replaced with T cell conditioned medium to investigated the role of soluble 
factors in T cell-mediated effects on NSCs.   
NSC Proliferation Assay 
E14.5 embryonic NSCs were labeled with 5nM fixable proliferation dye 
eFluor450 (eBioscience, San Diego, CA) for 5 minutes at 37°C and quenched with 5mL 
one to one ratio of complete NSC media (DMEM/F12 with N2 supplement) and 7.5% 
bovine serum albumin. 1x105 labeled cells were cultured in NSC media or in the presence 
of 20 pg/mL interferon-gamma (IFN-γ), 5x105 CD8(+) T cells either left unstimulated, or 
stimulated overnight (with 10 µg/mL each of anti-CD3 and anti-CD28) prior to co-
culture for 72 hours. Cells were immunostained for CD45 (PerCP-Cy5.5; eBioscience) 
and Sox2 (eFluor 670; eBioscience), and assayed on a BD FACSCanto for cell numbers 
with AccuCount blank particles for absolute quantification. Quantification of cell 
proliferation was performed by measuring dye dilution in the eFluor450 labeled cells, per 
the manufacturer’s instructions. Cell proliferation analysis was done using FlowJo 
software (Treestar Inc. Ashland OR) 
Analysis of NSC by Flow Cytometry 
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NSCs were stained for nestin expression by fixing cells in 4% paraformaldehyde 
(in PBS) for 20 min and incubating in SAP buffer (2% FCS, 0.5% saponin, and 0.1% 
sodium azide in PBS) containing anti-rat nestin-PE monoclonal antibody or IgG-PE 
isotype antibody (R&D Systems, MN). Following incubation for 30 min at room 
temperature the cells were washed once with SAP buffer, once with PBS, resuspended in 
400 l of PBS and analyzed on a FACS Canto flow cytometer (Becton-Dickinson, 
Mountain View, CA). At least ten thousand events were analyzed using FlowJo software 
(Tree Star Inc. Ashland OR). Doublets were eliminated from the analysis of live cell 
gated events using data obtained on their scatter height and width geometry.  
 NSCs were immunostained by fixing and permeabilizing cells (BD 
Cytofix/Cytoperm kit (Becton-Dickinson) prior to staining with anti-Human/Mouse 
Sox2-eFluor®660 (Clone-Btjce; eBioscience, San Diego, CA) and rabbit anti-mouse Ki-
67 (Abcam, Cambridge, MA). To visualize Ki67 staining, a PE labeled goat anti-rabbit 
IgG (Becton-Dickinson) secondary antibody was used.  Antibodies were incubated at 4°C 
and 50 µL blank AccuCount particles (Spherotech, Lake Forest, IL) were added 
immediately prior to data acquisition for cell quantification, per manufacturer’s 
directions. A minimum of 30,000 events was collected on a FACS Canto flow cytometer 
(BD, Mountain View, CA).  
Cytotoxicity analysis in NSC-T cell co-cultures.  
To identify NSC apoptosis in co-cultured cells, the monolayer was removed from 
the plate gently using Ca++/Mg++ free Hank’s balanced solution for dissociation. T cells 
were identified by staining with APC-conjugated anti-CD45 antibody (BD Biosciences) 
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in FACs blocking buffer (1 μg Fc block, 2% normal mouse and rat serum). The cell 
suspension was washed twice with cold PBS and re-suspended in 100 μL of Annexin V 
binding buffer with FITC-conjugated Annexin V (Invitrogen, Carlsbad, CA).  Cells were 
then stained with propidium iodide to identify dead cells and read on a FACS Canto 
within 1 hour of the assay. Data were analyzed using FlowJo software.  
Immunocytochemistry for stem cell differentiation.   
Murine NSCs were cultured in 24-well tissue culture plates alone, with 
unstimulated CD8(+) T cells, or with pan-stimulated CD8(+) T cells as described in the T 
cell Isolation and Stimulation methods section. Cells were cultured for 72 h. NSCs were 
fixed with 2% paraformaldehyde and permeabilized in PBS with 0.3% Triton-X 100 
(Sigma-Aldrich, St. Louis, MO). Cells were then blocked in PBS with 5% bovine serum 
albumin and 5% goat serum. Cells were incubated with primary GFAP (Dako 
Laboratories, Carpinteria, CA), β-III tubulin (R&D Systems, Minneapolis, MN), or O4 
(R&D Systems) antibodies. Secondary antibodies were as follows: goat anti-rabbit 
AlexaFluor 488 for GFAP, and biotinylated anti-mouse Ig for β-III tubulin and O4 (Life 
Technologies, Grand Island, NY). DAPI was used as a counterstain. Cells were imaged 
on an Olympus IX70 inverted fluorescence microscope. 
Results: 
Activated CD8(+) T cells inhibit neural stem cell proliferation 
To determine if activated T cells altered NSC functions, stem cells isolated from 
the cortices of BALB/c embryos (E14.5) were co-cultured with stimulated or 
unstimulated CD8 T cells. Previous experiments demonstrated that peak proliferation was 
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observed 48-72 h post seeding. CD8(+) T cells were activated by crosslinking CD3 and 
CD28 with monoclonal antibodies (Mab) and seeded at a 5 to 1 ratio CD8(+) T cells to 
NSC. At 72hrs post co-culture proliferation of NSC cultured with stimulated CD8(+) T 
cells was reduced two-fold compared to NSCs cultured without any CD8(+) T cells 
(41297.4±1918.6 cells per well vs 86712.5±2253.4 cells per well, p<0.01; Fig. 5.1). This 
reduction in NSC proliferation was consistent with the reduction observed in NSCs 
cultured in the presence of 10pg/mL IFN-γ (42324.5±9147.4 cells per well). 
Unstimulated CD8(+) T cells had no effect on NSC proliferation (86845.8±9391.1 cells 
per well).  
To exclude the possibility that CD8(+) T cell inhibition of NSC growth was 
mediated by cytotoxicity, NSCs co-cultured with activated and unstimulated CD8(+) T 
cells were assessed for Annexin V staining, along with changes in cell permeability to 
propidium iodide (PI), to evaluate cell death. CD45(+) staining was used to separate T 
cells and NSC for flow cytometry analysis. No differences in Annexin V binding or PI 
incorporation were observed in NSCs after 72 h co-culture (Fig 5.2A). On average, 
AnnexinV staining was seen in 3-5% of NSC cultured with or without T cells compared 
to 15% AnnexinV binding to NSC treated with hydrogen peroxide for 3 h prior to 
analysis (Fig 5.2B&C).  
Activated CD8(+) T cell effects are mediated through IFN-γ signaling.  
The IFN-γ receptor is composed of two chains, the alpha (R1 subunit) and beta 
chains (R2 subunit; Bach, Aguet et al. 1997). Previous studies have shown that murine  
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Figure 5.1: CD8(+) T cells inhibit NSC proliferation. BALB/c NSCs obtained from E14.5 d 
mice were co-cultured with stimulated or unstimulated CD8(+) T cells 24 h after labelling with 
proliferation dye. T cells in the co-cultures were either left unstimulated or were stimulated with 
a mixture of anti-CD3 and anti-CD28 antibodies (5μg/ml). NSCs treated with IFN-γ (10pg/mL) 
were used as positive controls. After 72 h of stimulation, cells were immunostained for Sox2 and 
read on a flow cytometer. Data presented are pooled from 3 separate experiments with each 
treatment performed in triplicate (mean ± SEM).  
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Figure 5.2: Stimulated CD8(+) T cells do not induce apoptosis. Using the same culture groups 
as in Figure 1, cells were analyzed for increased apoptosis and cell death by flow cytometry. 
Representative dot plots showing Annexin-V binding and propidium iodide uptake by (A) 
untreated NSCs (NSC), (B) NSCs cultured with antibody-stimulated CD8(+) T cells (stim CD8), 
and (C) NSCs treated with hydrogen peroxide for 1 hour (peroxide).   
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NSCs express functional IFN-γ receptors on the cell membrane (Walter, Honsek et al. 
2011). We verified using a quantitative RT-PCR that IFN-γR1 was expressed in NSC 
from all passages of culture used in this study (Fig 5.3). To further confirm that activated 
CD8(+) T cells mediated their effects on NSCs through the IFN-γ receptor, NSC cultures 
derived from IFN-γ R1 KO mice were assessed for both proliferation and expression of 
Sox2 in the presence or absence of stimulated CD8(+) T cells. In a dye dilution 
proliferation assay, eFluor670 labeled NSCs showed a graded decrease in the 
fluorescence intensity, with cells reaching up to >5 divisions in 72 h under proliferative 
culture conditions (Fig 5.4A; untreated). The majority of the wild-type NSCs co-cultured 
with stimulated CD8(+) T cells showed an arrest in proliferation at 2 to 4 cell divisions.  
However, this arrest in proliferation was not observed in IFN-γR1 KO NSCs, which 
proliferated to the same extent as untreated cells (Fig 5.4A). Wild-type and IFNγR1KO 
cells that were untreated or treated with unstimulated CD8(+) T cells showed similar 
patterns of proliferation in that majority of the cells (~80%) had undergone >5 cell 
divisions.  
When co-labeled for Sox2 expression, similar results were obtained 
demonstrating the loss of the inhibitory effect of activated CD8(+) T cells on IFN-γ R1 
KO NSC proliferation (Fig 5.4B). Total numbers of proliferating NSCs cultured with 
stimulated CD8(+) T cells were significantly increased in IFN-γ R1 KO NSC 
(94648.0±3970.3 cells per well) compared to wild-type BALB/c NSCs (41297.4±1918.6  
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Figure 5.3: IFN-γ receptor expression is consistent between passages 1 and 3. NSCs were 
cultured in the presence of IFN-γ for one hour prior to lysing and isolation of whole cell RNA. 
2µg of total RNA were used for cDNA synthesis and PCR was performed for expression of the 
IFN-γ receptor subunit 1. No significant differences were observed between the passages.  
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Figure 5.4: IFN-γR1 knockout NSCs are resistant to CD8(+) T cell mediated inhibition of 
proliferation. NSCs were labeled with eFluor670 proliferation dye and were cultured alone 
(untreated), with 20pg/mL IFN-γ (IFN) or in the presence of unstimulated (Unstim) or stimulated 
CD8(+) T cells (Stim). (A) Representative flow histograms of stimulated CD8(+) T cell treated 
and untreated NSCs demonstrating dilution of labeling dye fluorescence corresponding to cell 
divisions. Gates for generation of progeny was allocated based on progressive halving of the 
fluorescence measured in dividing NSCs (calculated using the cell proliferation algorithm in the 
FlowJo software).  Proliferation of IFN-γR1 KO NSCs when co-cultured with stimulated CD8(+) 
T cells (black line) compared to untreated NSCs (untreated, gray tinted line), or wild-type NSCs 
cultured with stimulated CD8(+) T cells (dotted line) is shown. (B) Quantification of total 
number of proliferating Sox2(+) NSCs in shown under each culture condition for wild type and 
IFN-γR1 KO NSCs. Data are presented as an average of three replicates ± SEM. ** p<0.01. (C) 
Representative dot plots showing Sox2 immunolabeling vs dilution of proliferation dye 
fluorescence observed in wild type (upper left) and IFN-GR1 KO NSCs (upper right) co-cultured 
with stimulated CD8(+) T cells. Untreated NSC cultures (lower left) and those co-cultured with 
unstimulated CD8(+) T cells (lower right) show no difference in proliferation or Sox2 
expression. Gates are drawn to indicate cells that have undergone five to seven rounds of division 
(or proliferation dye dilution) post culture and the percentages of proliferating cells are presented 
as average ± SEM.  
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cells per well, p<0.01) (Fig. 5.4B). Furthermore, there was no significant difference 
between any of the treatment groups in the IFN-γ R1 KO NSCs while the wild-type cells 
had significantly decreased NSC proliferation with both stimulated CD8(+) T cells and 
IFN-γ. Interestingly, arrested proliferation occurred in cells with decreased Sox2 
expression suggesting that Sox2 expression in NSCs may directly correlate with its 
proliferative ability.   
Previous studies in the laboratory demonstrated that co-culture of NSCs with 
alternatively activated macrophage supernatants result in four to five-fold increases in 
total numbers of NSCs per well. To evaluate the extent of IFN-γ mediated inhibition of 
NSC proliferation, we pretreated proliferation dye labelled NSCs with 20pg/mL IFN-γ 
for six hours prior to applying alternatively activated (M2) macrophage culture 
supernatants (M2C; Fig. 5.5). While NSCs not treated with IFN-γ increased proliferation 
in response to M2 polarized macrophage supernatants (50378.1±7175.3 cells per well vs 
15014.93±1917.2 cells per well untreated, p<0.01), proliferation of IFN-γ treated NSCs 
was not significantly different from controls (3080.9±434.1 cells per well M2C with IFN-
γ vs 2090.1±296.5 cells per well NSC with IFN-γ). Furthermore, there was no significant 
difference in the total number of proliferating cells per well in any of the IFN-γ treated 
groups, suggesting that pre-treatment with IFN-γ makes NSCs refractory to the growth 
promoting effects of M2 macrophages. 
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Figure 5.5: Pre-treatment with IFN-γ renders NSCs non-responsive to M2 induced 
proliferation. NSCs were labeled with a cell membrane bound proliferation dye and cultured 
with 20pg/mL IFN-γ for six hours prior to addition of conditioned or control (M2M or NSC 
alone) media at a 1:1 ratio with NSC culture media, for 60 hours. Absolute cell counts were 
quantified using AccuCount particles added to each sample. Notably, IFN-γ pre-treatment 
resulted in a significant reduction in proliferation, without change consequent to treatment with 
M2C. Data presented are averages ±SEM of 3 independent experiments performed in triplicate. 
** p≤0.01.  
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Stimulated CD8(+) T cells inhibit nestin and SOX2 expression in NSC 
Finally, to determine if activated CD8(+) T cells altered NSC phenotypes, 
expression of the stem cell and progenitor cell markers, nestin, Sox2 and doublecortin 
(DCX), were evaluated by flow cytometry. All NSC cultures used during these 
experiments had >98% of cells that expressed nestin and Sox2. Upon co-culture with 
activated CD8(+) T cells, nestin expression on NSCs decreased in magnitude. Nestin 
expression was high in all untreated NSCs (Fig 5.6A), and its expression was not altered 
following culture with unstimulated CD8(+) T cells (Fig. 5.6B). In contrast, CD8(+) T 
cell-treated cells expressed both high and intermediate levels of nestin (Fig. 5.6C). 
Although total number of NSCs expressing nestin did not alter significantly, 
approximately 38% of the cells showed lower fluorescence intensities of nestin 
immunoreactivity and ~55% continued to express the protein at high levels.  
Similarly, about 50% decrease in Sox2(+) expression was observed when NSCs 
were co-cultured with stimulated CD8(+) T cells (Fig. 5.6D). NSC cultures that were left 
untreated or co-cultured with unstimulated CD8(+) T cells showed two distinct CD45(-) 
cell populations when immunostained for both Sox2 and DCX; the Sox2(+)DCX(-) NSCs 
and Sox2(+)DCX(+) neuroblasts (Fig. 5.6E & F). CD45 immunostaining was used to 
exclude T cells from the analysis. When co-cultured with activated CD8(+) T cells, Sox2 
expression decreased in the Sox2(+)DCX(-) population but the proportion of 
Sox2(+)DCX(+) cells remained unaltered, further indicating that CD8(+) T cells may 
induce differentiation in a distinct subset of stem cells. To further validate that NSCs 
enter an altered differentiation state in response to activated CD8(+) T cells, co-cultures  
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Figure 5.6: Stimulated CD8(+) T cells initiate NSC differentiation. Co-cultures of NSC and T cells 
were assessed for nestin (a stem cell marker) expression by flow cytometry. NSCs were analyzed on a 
live cell gate after exclusion of CD45(+) lymphocytes. (A) Histogram showing nestin 
immunoreactivity in untreated NSCs (open), compared to isotype antibody staining (shaded). Nestin 
expression in NSCs was measured 72h after co-culture with (B) un-stimulated CD8(+) T cells and (C) 
with activated CD8(+) T cells. The amplitude of nestin expression and proportion of nestin-
expressing cells decreased when NSC were co-cultured with activated CD8(+) T cells. Representative 
data from 2 separate experiments are presented. (D) Representative dot plots showing expression of 
Sox2 and doublecortin (DCX) on untreated NSCs or (E) NSCs cultured with antibody-stimulated 
CD8(+) T cells. (F) Stacked bars demonstrating changes in ratios of NSCs phenotypes, defined by 
Sox2 and doublecortin (DCX) expression, in untreated (NSC) cultures, NSCs cultured with 
unstimulated CD8(+) T cells (US CD8), and NSCs cultured with antibody-stimulated CD8(+) T cells 
(S CD8). (G) Immunohistochemistry of cultured NSCs showing differentiation into GFAP(+) cells 
when treated with stimulated CD8(+) T cell (stim). Untreated (NSC) NSCs and those co-cultured with 
unstimulated CD8(+) T cells show no GFAP immunostaining (green fluorescence). Nuclei were 
counterstained with DAPI (blue).   
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were stained for Tuj1, O4, and GFAP to assess NSC differentiation towards neurons, 
oligodendrocytes, and astrocyte-like cells, respectively. Untreated NSC cultures did not 
express GFAP or O4 but showed very limited numbers of cells with Tuj-1 
immunostaining (<1% of cells). However, a large proportion of cells expressed GFAP 
when co-cultured with stimulated CD8(+) T cells compared to untreated (NSC) cultures 
or co-cultures with unstimulated CD8(+) T cells (Fig. 5.6G).  There were no observed 
differences in the limited Tuj-1 immunostaining in NSC cultures after 3 days in co-
culture with activated CD8(+) T cells.  O4 immunostaining was not detected in CD8(+) T 
cell treated NSC cultures.  
 In contrast NSCs co-cultured with stimulated CD4(+) T cells underwent minimal 
differentiation with approximately 10% of cells losing their Sox2 expression (Fig. 5.7). 
As with the unstimulated CD8(+) T cells, unstimulated CD4(+) T cells had no effect on 
NSC differentiation. Additional studies done in the lab using NSC constitutively 
expressing luciferase demonstrated that there was no significant difference in the total 
number of cells between control and stimulated CD4(+) T cell-treated groups. The 
differential effects of CD4(+) and CD8(+) T cell populations on NSC proliferation may 
perhaps be due to the robust expression of IFN-γ in CD8(+) T cells (data not shown). In 
contrast to CD8(+) T cells, CD4(+) T cells stimulated with antibodies to CD3 and CD28 
had no measureable production of IFN-γ. Addition of an IFN-γ neutralizing antibody to 
stimulated CD8(+) T cell-NSC co-cultures restored NSC proliferation to control levels. 
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Discussion:  
Data presented in this study demonstrate that activated CD8(+) T cells inhibit NSC 
proliferation. Proliferation of NSCs was reduced by approximately 50% in the presence 
of stimulated CD8(+) T cells. This decrease in cell number was not associated with an 
increase in cytotoxicity, a well-known CD8(+) T cell effector function. On the contrary, 
the inhibition of NSC proliferation was mediated via soluble factors produced by 
activated CD8(+) cells, effects of which could be abolished by eliminating IFN-γ 
signaling in the co-culture system. These effects of IFN-γ were robust with IFN-γ pre-
treatment rendering NSCs resistant to proliferation despite exposure to the potent 
stimulus of alternatively activated macrophage supernatants. Furthermore, co-culture 
with activated CD8(+) T cells drives NSCs into a differentiation pathway, an effect that 
has been previously attributed to IFN-γ (Kim, Son et al. 2007; Lum, Croze et al. 2009). 
Co-culture of NSCs with stimulated CD4(+) T cells did not have any effect on NSC 
proliferation and had minimal effects on NSC differentiation. 
Brain injury resulting from either infectious (Marques, Cheeran et al. 2008; Mutnal, 
Hu et al. 2011) or non-infectious insults (Chaitanya, Schwaninger et al. 2010; 
Kleinschnitz, Schwab et al. 2010), has been shown to result in CD8(+) T cell recruitment 
to sites of brain damage. Our laboratory has previously demonstrated that in response to 
herpesvirus infections, activated CD8(+) T cells accumulate and are retained in the brain 
long after the infection has been resolved (Marques, Cheeran et al. 2008; Mutnal, Hu et 
al. 2011). Retention and maintenance of activated CD8(+) T cells in damaged CNS tissue 
is not unique to infectious etiology, but is observed in models of ischemic stroke 
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(Sekeljic, Bataveljic et al. 2012) and aseptic cerebral injury (Ling, Sandor et al. 2003). 
Notably, this accumulation of CD8(+) T cells occurs without apparent replenishment 
from peripheral lymphoid tissues and is mediated through both antigen-dependent and -
independent mechanisms (Ling, Sandor et al. 2006). Several studies have demonstrated 
that CD8(+) T cells contribute to tissue damage, largely mediated by their cytotoxic 
effector functions (Chaitanya, Schwaninger et al. 2010; Kleinschnitz, Schwab et al. 
2010). We demonstrate that antigen-independent activation of CD8(+) T cells robustly 
inhibits NSC proliferation, without associated cytotoxicity. Recently, we reported that 
endogenous NSC proliferation is markedly reduced during chronic herpes encephalitis 
(Rotschafer, Hu et al. 2013). This decrease in NSC proliferation coincides with the 
accumulation of activated CD8(+) T cells are the present in the brain (Marques, Cheeran 
et al. 2008; Armien, Hu et al. 2010). Results from the present study suggest that activated 
CD8(+) T cells in the brain could foster an inflammatory milieu that inhibits 
neurogenesis, mediated in a large part by IFN-γ.  
Several studies have shown that IFN-γ alters NSC properties; including inhibition 
of cell proliferation (Cheeran, Jiang et al. 2008; Walter, Honsek et al. 2011), and driving 
differentiation into neurons or oligodendrocytes (Wong, Goldshmit et al. 2004; Ricci-
Vitiani, Casalbore et al. 2006; Kim, Son et al. 2007; Wang, Imitola et al. 2008; Lum, 
Croze et al. 2009). These effects are initiated by IFN-γ binding to its cognate receptor, 
which is widely expressed on NSCs and its derivative cells (Walter, Honsek et al. 2011). 
Data presented here demonstrate that by blocking IFN-γR1, using IFN-γ R1 KO NSCs, 
effectively abrogates the inhibitory effects produced by activated CD8(+) T cells, 
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indicating that these effects are likely mediated through the IFN-γ receptor. The 
downstream signaling pathways initiated by IFN-γ binding that drives these changes in 
NSCs are poorly understood. NSCs treated with IFN-γ show increased Stat 1 
phosphorylation (Lum, Croze et al. 2009), which in turn induces the expression of sonic 
hedgehog (Shh), a major brain morphogen (Wang, Imitola et al. 2008; Lum, Croze et al. 
2009; Li, Walker et al. 2010). These downstream signaling events are speculated to be 
involved in both dysregulation of NSC proliferation (Wang, Imitola et al. 2008; Li, 
Walker et al. 2010) and the generation of a unique neuronal phenotype with irregular 
electrophysiological properties (Lum, Croze et al. 2009). Data presented in our current 
study show that co-culture with activated CD8(+) T cells down regulates nestin and Sox2 
expression in NSCs, suggesting that activated CD8(+) T cells may initiate a 
differentiation program in cultured NSCs through the IFN-γ signaling pathway. However, 
decreased Sox2 expression in NSCs is directly correlated with decreased proliferation, a 
phenomenon that is abrogated in cells that lack IFN-γR1 expression. This direct 
relationship between Sox2 expression with cell proliferation and differentiation has been 
shown in several cell types, including NSCs (Tompkins 2011; Julian LM, 2013; 
Cimadamore, 2013; Thiel G, 2013). In addition, our results demonstrate that activated 
CD8(+) T cells may direct differentiation of NSC, driving them towards an astrocyte-like 
phenotype. Similar studies have shown that when induced to differentiate, IFN-γ drives 
NSC into a dysfunctional neuronal phenotype that express GFAP potentially skewing the 
reparative processes in response to brain injury (Walter, Honsek et al. 2011).  
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Activated CD8(+) T cells affect NSC function through different mechanisms. In 
the present study, we have demonstrated that antigen independent activation of CD8(+) T 
cells suppresses NSC proliferation through an IFN-γ mediated mechanism. Wang et al 
(2010) report that soluble mediators like Granzyme B (GrB), produced by human CD8(+) 
T cells activated by crosslinking CD3/CD28, inhibit NSC proliferation and drive 
differentiation of cells to an astrocyte phenotype (Wang, Lee et al. 2010). This inhibitory 
effect of GrB is mediated through the induction of a voltage-dependent potassium 
channel, Kv1.3, on NSC. GrB signaling in NSC is sensitive to Pertussis toxin, indicating 
that it may be mediated through a G protein-coupled receptor (Wang, Lee et al. 2010). It 
is noteworthy that the effects of T cells on NSC function are dependent on both the 
inflammatory context and developmental stage at which these cells interact (reviewed in 
Kokaia, Martino et al. 2012). In fact, IFN-γ treatment of human embryonic stem cell 
derived neural progenitors fosters different differentiation profiles compared to murine 
NSCs (Walter and Dihne 2012). Similarly, T cell derived IFN-γ production during acute 
HSV-1 brain infection is significantly higher than that expressed during the chronic phase 
(Armien, Hu et al. 2010). Studies on the effect of various concentrations of IFN-γ have 
indicated that higher concentrations of IFN-γ may activate caspases and potentially 
induce NSC apoptosis Walter and Honsek 2011). Previous studies in our lab have shown 
that at low concentration, IFN-γ can inhibit NSC proliferating without inducing apoptosis 
(Cheeran, Jiang et al. 2008). In the present study, we show that at the ratios of T cells 
tested, NSC proliferation is suppressed without the overt induction of apoptosis. In 
several brain diseases (like Multiple Sclerosis, and ischemic stroke) among humans, IFN-
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γ is present at relatively high concentrations (~1000 pg/ml) in the cerebrospinal fluid 
(Walter and Dihne) and understanding the interactions between soluble mediators 
produced by T cells and is critical to developing therapeutic approaches, particularly 
when using stem cells.  
In summary, the impact of CD8(+) T cells on reparative processes in the inflamed 
brain is both complex and poorly understood. Our study demonstrates the antigen-
independent effects of activated CD8(+) T cells on NSCs is mediated by IFN-γ, through 
its effect on the IFNγR1 on NSCs. Antigen-dependent effects of CD8(+) T cells could be 
facilitated by IFN-γ-induced increases in MHC-1 expression on NSCs (Cheeran, Jiang et 
al. 2008; Johansson, Price et al. 2008) and may be unique to the antigens involved in the 
insult. Numerous immune mediators have been shown to modulate the reparative 
processes initiated at the NSC niches (reviewed in Gonzalez-Perez, Gutierrez-Fernandez 
et al. 2012), suggesting that understanding the inflammatory context is critical for 
evaluating the impact of immune cells on neurogenesis. The data presented in this study 
elucidate one of many mechanisms that may be involved in immune modulation of adult 
neurogenesis.  
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Chapter 6: Persistent CD8(+) T cells impair adult neurogenesis during chronic 
Herpes Simplex encephalitis via an interferon-γ-mediated mechanism. 
 167 
 
Abstract: 
CD8(+) T cells are the dominant immune cell type present in the inflammatory milieu 
following experimental Herpes Simplex encephalitis (HSE). At 15 d p.i, 49.4±2.76% of 
CD8(+) T cells isolated from HSV-1-infected mouse brains produced interferon-gamma 
(IFN-γ) in response to viral antigen. The objective of the present study was to evaluate 
the role of CD8(+) T cells in inhibiting NSC proliferation during HSE at 15 d p.i.. 
Depletion of CD8(+) T cells from the HSV-1 infected brain resulted in a 5-fold increase 
in CD45(-)nestin(+) NSCs, compared to isotype antibody-treated controls. CD4(+) T cell 
numbers and activation phenotype did not change significantly following CD8(+) T cell 
depletion. Interestingly, in the absence of CD8(+) T cells, total numbers of 
CD45(hi)CD11b(+) macrophages increased concurrent with a shift in activation 
phenotypes from 1:2 CD206 to CD86 to 4:1. Macrophages have been shown to 
preferentially polarize to a classical CD86(+) phenotype in the presence of IFN-γ. As 
expected, gene transcription analysis demonstrated a six-fold reduction in IFN-γ 
expression in CD8(+) depleted animals, compared to isotype-treated mice. To assess the 
contribution of IFN-γ signaling on the observed changes in NSC proliferation and 
macrophage polarization, IFN-γ receptor knockout (IFN-γR1KO) mice were infected. At 
15 d p.i., total numbers of Sox2(+) NSCs were significantly increased in infected IFN-
γR1KO mice compared to infected wild-type mice. Furthermore the total number of 
NSCs in 15 d p.i. IFN-γR1KO mice was not significantly different from uninfected mice. 
Taken together, these data suggest that in the experimental HSE model, CD8(+) T cells 
impair endogenous NSC proliferation in an IFN-γ dependent manner. Future directions of 
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these studies may identify crucial steps for therapeutic intervention in patients with brain 
damage resulting from viral encephalitis. 
Introduction 
 Herpes Simplex virus type 1 (HSV-1) is the most common cause of sporadic viral 
encephalitis (HSE) in the United States, and more than fifty percent of human patients 
surviving HSE develop life altering neurological deficits (McGrath, Anderson et al. 1997; 
Kimberlin 2007). The murine model of experimental HSE, which closely resembles the 
human disease, is characterized by robust T cell infiltration that begins at 6 d p.i. and 
peaks between 14 and 16 d p.i.. These T cells persist in the brain beyond 30 d p.i. 
(Marques, Cheeran et al. 2008; Armien, Hu et al. 2010). Notably, the phenotypes of 
infiltrating T cells changes as the inflammation progresses, being largely CD4(+) at 8 d 
p.i. and shifting to a primarily CD8(+) phenotype at 15 and 30 d p.i. (Marques, Cheeran 
et al. 2008). Furthermore, T cells present in the brain at 15 d p.i. express high levels of 
IFN-γ, despite a lack of detectable viral antigen (Marques, Cheeran et al. 2008). 
CD8(+) T cells are essential for clearance of viral infections (Wang, Lobigs et al. 
2003; Lang and Nikolich-Zugich 2005; Kreutzfeldt, Bergthaler et al. 2013). However, 
these cells have been shown to promote neuronal degeneration and tissue damage 
subsequent to viral infections, like West Nile virus (WNV) (Wang, Lobigs et al. 2003).  
In addition, adoptive transfer of myelin-specific CD8(+) T cells, obtained from mice with 
experimental autoimmune encephalitis (EAE), into naïve animals resulted in 
development of clinical signs including ataxia, spastic reflexes, loss of coordination and 
spinning behaviors (Huseby, Liggitt et al. 2001). In mouse models of Japanese 
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encephalitis and EAE, the resultant T cell mediated neuroinflammation has also been 
shown to disrupt proliferation and migration of adult neural stem cells (NSCs) (Pluchino, 
Muzio et al. 2008; Das, Dutta et al. 2011; Sekeljic, Bataveljic et al. 2012). In mice with 
ischemic brain injury, increased numbers of T cells are associated with decreased 
numbers of NSCs and increased lesion volume several days post infection resulting in 
more severe neurological deficits (Takata, Nakagomi et al. 2012; Schuhmann, Kraft et al. 
2015). Similarly, depletion of T cells from ischemic mice was associated with increased 
numbers of NSCs and decreased lesion volumes, suggesting that activated T cells play an 
critical role in development of brain damage. 
IFN-γ has been implicated in promoting CD8(+) T cell associated central nervous 
system (CNS) immunopathology in numerous model systems. Pneumococcal meningitis 
in IFN-γ knockout mice results in decreased neuronal damage of the hippocampus and 
cerebral cortices, associated with significantly improved clinical disease scores (Too, Ball 
et al. 2014 ). Adoptive transfer of malaria-specific IFN-γ(+) CD4(+) T cells induced 
significant increases in clinical symptoms of cerebral malaria in IFN-γ knockout mice 
manifesting as disruption of the blood-brain barrier and increased cerebral edema 
(Villegas-Mendez, Greig et al. 2012). Similarly, in experimental lymphocytic 
choriomeningitis (LCMV) encephalitis, IFN-γ inhibited adult neurogenesis and worsened 
coordination deficits seen during the disease (Kreutzfeldt, Bergthaler et al. 2013). 
Furthermore, CD8(+) T cells have been shown to significantly impair NSC proliferation 
in vitro via an IFN-γ dependent mechanism (Hu, Rotschafer et al. 2014), which suggests 
that CD8(+) T cells may influence reparative functions in the brain.  
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Adult neurogenesis is mediated by a persistent, small population of endogenous 
brain cells called neural stem/progenitor cells (NSCs) which proliferate in response to 
brain damage including viral encephalitis (Lichtenwalner and Parent 2005; Parent, Elliott 
et al. 2006; Das, Dutta et al. 2011; Rotschafer, Hu et al. 2013). NSCs are maintained 
within distinct germinal niches in the brain that support their multipotent phenotype and 
self-renewal properties. Brain injury and the resultant inflammation initiate NSC 
proliferation by altering the niche to activate neurogenesis (Merkle, Tramontin et al. 
2004). Increased NSC proliferation is associated with reduced inflammation and has been 
shown to replace damaged neurons following brain injury in several models, including 
EAE (Aharoni, Arnon et al. 2005), stroke (Arvidsson, Collin et al. 2002) and Japanese 
encephalitis (Das, Dutta et al. 2011). The reduction in inflammation combined with 
increased neurogenesis results in improvement of brain function following damage.  
The objective of the present study was to evaluate the contribution of CD8(+) T 
cells and IFN-γ to NSC proliferation during chronic HSE. Given the persistent 
inflammatory response observed during HSE, we hypothesized that CD8(+) T cells 
impair NSC proliferation through IFN-γ dependent mechanisms. 
Materials and Methods: 
Ethics Statement: 
 All animal procedures were done in accordance with the policies and practices of 
the animal care and use committee of the University of Minnesota. 
HSV-1 Infection: 
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Cannulated and uncannulated female BALB/c and IFN-γR1 knock out mice (eight 
and ten weeks of age) were anesthetized using ketamine and xylazine. 1.25x105 plaque 
forming units of Herpes Simplex Virus-1 (HSV-1) strain Syn17+, a neurovirulent virus, 
was instilled into both nares in a volume not exceeding 2 µL per nostril. Disease 
progression and cannula stability was evaluated daily for the duration of the experiment. 
Peak mortality was observed between 5 and 12 d p.i. and only animals surviving the 
infection were used for CD8(+) depletion. 
Ex vivo Evaluation of IFN-γ Production 
BALB/c mice were infected as described above. At 15 d p.i. brains, cervical 
lymph nodes, and spleens were isolated from infected and uninfected mice. The tissues 
were processed aseptically to generate a single cell suspensions mechanical dissociation 
and passed through 100, 70, and 40µm cell strainers. Red blood cells were chemically 
lysed and the cell suspension was washed three times.  
Isolated cells were plated in six-well tissue culture plates and left unstimulated or 
stimulated with 2µg/mL heat inactivated, sucrose purified HSV-1 Syn17+, 2µg heat 
inactivated, sucrose purified Swine Influenza Virus (SIV H1N1; non-specific stimulation 
control), 10ng/mL phorbol myristate acetate with 200ng/mL ionomycin (Sigma Aldrich, 
St. Louis, MO; positive stimulation control). Viruses were heat inactivated by incubation 
at 55°C for 15 minutes. HSV-1 inactivation was confirmed by plaque assay on rabbit skin 
epithelial cells (ATCC, Manassas, VA). SIV inactivation was measured by TCID50 on 
MDCK cells (ATCC). No virus growth was observed at any virus dilution. Isolated brain 
leukocytes were incubated for 20 hours with or without antigen. 1µg Brefeldin A per mL 
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culture medium as GolgiPlug (BD Biosciences) was added to inhibit protein transport for 
the last four hours of incubation. Cells were collected for immunostained with CD45 (BD 
Biosciences, 1:50 dilution APC), CD3e (eBioscience, 1:50, PE-Cy7), CD4 (BD 
Biosciences; 1:50 dilution, conjugated to APC-Cy7), CD8b (eBioscience; 1:50, 
conjugated to APC), and IFN-γ (BD Biosciences; 1:25 dilution, conjugated to PE). Cells 
were analyzed by flow cytometry within 24 hours of immunostaining. 
Mouse Cannulations: 
 To facilitate depletion of CD8(+) T cells from the brain, an 
intracerebroventricular (icv) cannula were placed in the right lateral ventricle of BALB/c 
mice prior to infection with HSV-1. Briefly, six to seven week old BALB/c mice were 
anesthetized using ketamine/xylazine and placed on a mouse stereotactic device 
(Stoelting, Wood Dale, IL) prior to surgery. The precise location of the right lateral 
ventricle was identified as -0.9mm anterior-posterior and +0.5mm midline relative to 
bregma. A single 28GA cannula was implanted to a depth of -2.5mm from the skull and 
affixed to the skull using cyanoacrylate, dental cement and wound clips which remained 
in place for the duration of the experiment. Cannulas were capped using dummy guides 
and mice were allowed to recover for seven to ten days prior to infection with HSV-1. 
Cannula guides were cleaned daily. Only mice with intact, patent cannulas were used in 
all experiments. 
CD8(+) T Cell Depletion and Flow Cytometric Evaluation of Immune Milieu 
 Infected and uninfected animals were treated with 10µg anti-CD8a antibody 
(clone 2.43, rat IgG2b, BioXCell, West Lebanon, NH), isotype antibody or were left 
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untreated on days 15, 17 and 19 post infection (d p.i.) into the brain via the indwelling icv 
cannula. Location of the cannula was verified at sacrifice by injection of 2.5uL isotonic 
Trypan Blue (0.1% solution in phosphate buffered saline). Brains from mice in all 
treatment groups were harvested and mechanically dissociated to generate a single cell 
suspension. Brain leukocytes were isolated using a discontinuous Percoll gradient (30-
70%) and washed twice. Isolated cells were immunostained for CD45 (BD Biosciences, 
conjugated to FITC, PerCP-Cy5.5, APC, V500), CD11b (eBioscience (an Affymetrix 
Company), San Diego, CA; 1:50 dilution, conjugated to APC, APC-Cy7, eFluor 450), 
CD3e (eBioscience, 1:50, PE-Cy7), CD4 (BD Biosciences; 1:50 dilution, conjugated to 
FITC and APC-Cy7), CD8b (eBioscience; 1:50, conjugated to APC), CD62L (BD 
Biosciences; 1:50, conjugated to PE), CD103 (BD Biosciences; 1:50, conjugated to 
FITC), CD69 (BD Biosciences; 1:50, conjugated to FITC), CD25 (BD Biosciences; 1:50, 
conjugated to PE), Major Histocompatibility Class II (eBioscience; 1:50, conjugated to 
PerCP-eFluor 780), Ly6C (eBioscience; 1:50, conjugated to APC, eFluor 450, or PerCP-
eFluor 780), CD206 (BioLegend, San Diego, CA; 1:25, conjugated to APC), CD80 (BD 
Biosciences; 1:50, conjugated to PE), and CD86 (BD Biosciences; 1:50, conjugated to 
FITC).  
In vitro M2 Macrophage Polarization 
 Bone-marrow derived monocytes (BMDMs) were isolated from tibias of 
uninfected BALB/c mice by flushing serum-free macrophage culture media (Life 
Technologies, Grand Island, NY) through the marrow cavity. Bone marrow cells were 
differentiated in to macrophages by supplementing serum free macrophage media with 
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macrophage-colony stimulating factor (M-CSF, eBioscience; 10 ng/mL) and allowed to 
grow for three days. Non-adherent cells were removed by washing and adherent 
macrophages were stimulated with interleukin-4 (eBioscience; 20 ng/mL) for 4 days to 
generate alternatively activated M2 macrophages. Validation of alternative activation was 
achieved by flow cytometry for CD45, CD11b, CD206 and CD86 as well as reverse 
transcription-PCR for gene products shown to be specific for each polarization including 
interleukin-15, interleukin-6, arginase1, and CD206. 
In vivo M2 Macrophage Supplementation 
Uninfected 8 to 10-week old female BALB/c mice were anesthetized and heat-
killed or live M2 activated macrophages was administered by icv injection (-0.9mm 
anterior/posterior, +0.5mm midline, and -2.5mm dorsal/ventral relative to bregma) using 
a 27.5GA needle. Macrophages were heat-killed by incubation at 55°C for 15 minutes 
and cell death was verified by visual evaluation of the cells using a Trypan Blue (Sigma 
Aldrich) exclusion assay. 3x104 heat-killed or live macrophages were stereotactically 
injected in 3 µL saline at a rate of 1µL per minute into the right lateral ventricle.  
Flow Cytometric Analysis Endogenous NSC Proliferation 
Brains of infected and uninfected BALB/c and IFN-γR1 KO mice were isolated 
and trimmed to include the area around the lateral ventricles (+1 to -3 relative to bregma) 
using a coronal brain matrix with 1mm graduations (Braintree Scientific, Braintree, MA). 
A single cell suspension was generated using the papain-based neural tissue dissociation 
kit (Miltenyi Biotec, Auburn, CA) and myelin was removed from the suspension using 
myelin removal beads (Miltenyi) as per the manufacturer’s instructions. Cells were then 
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immunostained for CD45 (BD Biosciences, San Jose, CA; 1:50, conjugated to PerCP-
Cy5.5), a myeloid marker and nestin (BD Biosciences; 1 test, PE conjugated), a neural 
stem cell marker, or CD45 and Ki-67 (Abcam, Cambridge, MA; 1:25), a proliferation 
marker. PE conjugated high affinity donkey anti-rabbit F’(ab) fragments were used as the 
secondary antibody for Ki-67.Alternatively, cells were stained with CD45 and Sox2 
(eFluor 660, eBioscience, San Diego, CA, 1:50). To assess proliferation in the NSC 
population, brain cells were immunostained with CD45, Ki-67 and Sox2 an alternative 
NSC marker. 
Results:  
Antigen Specific CD8(+) T cells produce IFN-γ at 15 d p.i.. 
 To determine if T cells present in the brain at 15 d p.i. were HSV-1 specific, total 
brain leukocytes were isolated and stimulated with either HSV-1 antigens, SIV antigens, 
or left unstimulated. After 20 hours of ex vivo stimulation, total brain leukocytes were 
immunostained for IFN-γ and analyzed by flow cytometry. Among T cell populations 
(CD45(hi)CD3(+)), 49.4±2.76% of HSV-1 specific CD8(+) T cells produced IFN-γ (Fig. 
6.1A) whereas production of IFN-γ by non-specifically stimulated cells was negligible 
and not significantly different from unstimulated cells. In contrast, only 19.7±3.5% of 
CD4(+) T cells produced IFN-γ in response to HSV-1 antigens at 15 d p.i. (Fig. 6.1B). 
Concurrent with the robust IFN-γ production, CD8(+) T cells have been shown to 
outnumber CD4(+) T cells two to one at 15 d p.i. (Marques, Cheeran et al. 2008; 
Rotschafer, Hu et al. 2013) which demonstrates that CD8(+) T cells  
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Figure 6.1: HSV-1 specific IFN-γ production by CD8(+) T cells in the brain at 15 dpi. (A) 
CD8(+) and (B) CD4(+) subpopulations of CD45(+)CD3(+) T cells were analyzed for IFN-γ 
production subsequent to ex vivo stimulation with HSV-1 antigen for 20h. Shown in each graph is 
staining isotype (tinted gray line), non-specifically stimulated cells (dotted black line) and HSV-1 
stimulated cells (black line). Representative dot plots are shown of three independent 
experiments. 
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are the most significant contributor to IFN-γ in the brains of HSV-1 infected mice at this 
time point during infection.  
CD8(+) T cell depleted mice have increased total numbers of NSCs. 
 Previous findings in the laboratory have demonstrated that total numbers of 
endogenous NSCs significantly decreased with peak T cell infiltration and IFN-γ 
production at 15 d p.i. (Marques, Cheeran et al. 2008; Rotschafer, Hu et al. 2013). 
Depletion of CD8(+) T cells significantly increased total numbers of CD45(-)nestin(+) 
NSCs (73,884.34±12,923 total cells, p≤0.01) in the brains of infected mice compared to 
isotype antibody treated animals (14,983.98±2915.95 total cells; Fig. 6.2A). While 
addition of either antibody to uninfected mice resulted in moderate increases in total 
numbers of CD45(-)nestin(+) NSCs, this increase was not significantly different from 
untreated controls (Fig. 6.2A). Success of CD8(+) T cell depletion in the brain was 
confirmed by immunostaining with a CD8b specific antibody which revealed an absence 
of CD8(+) T cell in depleted mice while demonstrating a robust population of CD8(+) T 
cells in infected isotype antibody treated animals, . 
CD8(+) T cell depletion alters brain macrophage activation phenotypes. 
 To assess the effect of CD8(+) T cell depletion on other immune cell populations 
in the brain, activation phenotypes of infiltrating macrophage (CD45(hi)CD11b(+)) and 
microglia (CD45(int)CD11b(+)) was assessed. In the macrophage compartment, a 
significant increase in the total number of Ly6C(hi) infiltrating macrophages was 
observed following CD8(+) T cell depletion (629,062.42±45436.83 total cells; p≤0.01) 
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Figure 6.2: The NSC population increases following CD8(+) T cell depletion. (A) The total 
number of nestin(+) NSCs were significantly increased in CD8(+) depleted mice (Anti-CD8a) 
compared to untreated (Cannula) or isotype antibody treated (Isotype) controls. (B) 
Representative flow plot showing CD8b immunostaining in HSV-1 infected isotype-treated 
(middle, dotted black line) and CD8a depleted mice (bottom, solid black line) compared to 
staining isotype (top, gray line), confirming the success of CD8(+) T cell depletion. Data 
presented are averages ± SEM of 8 animals per group. ** p≤0.01. 
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compared to infected isotype antibody treated animals (170,575.08±8692.41 total cells; 
Fig. 6.3A). Further evaluation of the CD45(hi)CD11b(+) macrophage population 
revealed a shift in the abundance of CD86(+) vs CD206(+) macrophages in CD8(+) T 
cell depleted, HSV-1 infected mice compared to isotype antibody treated infected 
controls. Alteration in this ratio suggests a shift in macrophage activation. Isotype treated 
infected mice had CD86 to CD206 cells at a one to one ratio (29,749.99±3589.02 
CD86(+) macrophages to 36,306.25±6769.62 CD206(+) macrophages; Fig. 6.3B) 
whereas the CD8a depleted mice had a CD86 to CD206 ratio of one to three 
(43,975.26±4862.06 total CD86(+) macrophages to 126,191.32±24,136.54 CD206(+) 
macrophages). Untreated infected mice did not have significant alteration in the CD86 to 
CD206 ratio compared to infected isotype antibody treated mice. The change in ratio 
resulted from a significant increase in the total number of CD206(+) macrophages in 
CD8a depleted mice (126,191.32±24,136.54 total CD206(+) macrophages, p≤0.01) 
compared to isotype controls (36,306.25±6769.62 total CD206(+) macrophages). While 
administration of the CD8(+) depleting antibody resulted in an increase in the total 
number of infiltrating macrophages in uninfected mice compared to isotype treated 
animals, the total magnitude of the change was smaller. Uninfected mice had two-fold 
greater infiltrating macrophages compared to a four-fold change in population size in 
infected mice brains (Fig. 6.3A).  
To further investigate changes in microglia activation, major histocompatibility 
class II (MHCII) was evaluated subsequent to CD8(+) T cell depletion. Infected CD8a 
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Figure 6.3: Depletion of CD8(+) T cells increases Ly6C(hi) macrophage migration into the 
brain. (A) Total number of CD45(hi)CD11b(+)Ly6C(hi) infiltrating macrophages increased by 3 
fold in the infected depleted group compared to infected isotype-treated animals.  (B) 
Interestingly, among the Ly6C(hi) macrophages, there was a shift in the ratio of M1 (black bar) 
and M2 macrophages (white bar) towards a net M2 polarization phenotype. Data presented are 
averages ±SEM of 8 animals per group. ** p≤0.01.  
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depleted mice (562,412.78±8945.40 total microglia, p≤0.01) had significantly less 
expression of MHCII compared to infected isotype treated animals 
(2,079,460.47±414,555.70 total microglia; Fig. 6.4). Additionally, MHCII expression on 
microglia in infected depleted mice was reduced to levels observed in uninfected mouse 
levels (Fig. 6.4). In combination, reductions in microglial activation and changes in 
macrophage activation suggests that depletion of CD8(+) T cells resulted in an altered 
inflammatory milieu potentially leading to increases in NSC proliferation.  
CD4(+) T cell phenotypes are not altered in CD8a depleted, HSV-1 infected animals  
 To identify changes in the CD4(+) T cell compartment associated with the 
depletion of CD8(+) T cells, CD4(+) T cell phenotypes were evaluated. Surprisingly, 
total numbers of CD4(+) T cells were not altered in CD8a depleted animals, compared to 
other infected groups (Fig. 6.5A).  CD4 T cell expression of CD69 was lower in depleted 
animals (108,945.47±18451.81 cells, p=0.054; Fig. 6.5B) compared to isotype treated 
controls (200,028.29±25518.64 CD69(+) cells); however this difference was not 
statistically significant. Neither was there a significant difference in decreased expression 
of CD25 in infected depleted mice (82,977.66±12,108.54 CD25(+) cells) compared to 
infected isotype antibody treated controls (153,923.68±37514.44 CD25(+) cells). CD4(+) 
T cells also did not show a significant change in expression of the resident memory cell 
phenotype marker, CD103, between CD8a depleted infected mice (54,373.65±6915.09 
CD103(+) cells; Fig. 6.5C) and isotype infected controls (82,222.50±5745.33 CD103(+) 
cells). CD44 and CD62L were also evaluated for alteration in memory phenotypes but 
there were no significant differences observed (data not shown). 
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Figure 6.4: Microglia activation is decreased after depletion of CD8(+) T cells. Infected, 
CD8(+) T cell depleted mice expressed uninfected mouse levels of MHCII. Data presented are 
averages ±SEM of 8 animals per group. ** p≤0.01.  
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Figure 6.5: CD4(+) T cells are not affected by CD8(+) T cell depletion. (A) The total number 
of CD4(+) T cells was not significantly different between any of the infected groups. (B) Among 
the effector CD4(+) T cell subset there were no significant changes in activation markers, CD25 
(black bars) and CD69 (white bars) in the infected groups. (C) Furthermore,  no significant 
difference in the expression of memory T cell markers was observed in the CD4(+) T cell 
compartment, CD103 (black bars) and CD62L (white bars) between the infected groups. Data 
presented are averages ±SEM of 8 animals per group.  
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To assess alterations in the soluble factors expressed in the brain during chronic 
HSE, expression of T cell cytokines was evaluated. As expected, infected CD8(+) T cell 
depleted mice had significantly less IFN-γ gene expression (8.79±5.38 fold change, 
p≤0.05) compared to infected isotype controls (56.49±15.89 fold change; Fig. 6.6). No 
significant changes in interleukin-4 or interleukin-10 gene expression was observed in 
chronically infected mice (data not shown). RT-PCR analysis of HSV-1 glycoprotein D 
gene expression showed no signs of viral reactivation after CD8(+) T cells were depleted 
(data not shown). These findings suggest that removal of CD8(+) T cells alters the 
inflammatory milieu such that NSC proliferation may be promoted. 
IFN-γ inhibits NSC response to proliferative stimuli. 
Previous studies, discussed in Chapter 4, demonstrated that transplantation of ex 
vivo M2 stimulated macrophages into the lateral ventricles of uninfected mice have the 
capability to increase NSC proliferation in an uninfected brain. However, transplantation 
of the same number of ex vivo M2 polarized macrophages into the lateral ventricles of 15 
d p.i. mice had no significant impact on proliferation of Sox2(+) NSCs (Fig. 6.7A) or on 
total numbers of Sox2(+) NSCs (Fig. 6.7B). This observation is congruent with studies 
that show  ovine macrophages polarized ex vivo to an M2 polarized phenotype can 
readily acquire the M1 phenotype in the presence of M1 polarizing stimuli in vivo 
(Crespo, Bertolotti et al. 2013). The robust production of IFN-γ in the brains of HSV-1 
infected mice may repolarized transplanted M2 macrophages to an M1 phenotype. 
 
 185 
 
 
Figure 6.6: IFN-γ gene transcription decreases with CD8(+) T cell depletion. Isotype 
antibody treated mice (isotype) had a significant increase in IFN-γ gene expression compared to 
CD8(+) depleted mice (anti-CD8a). Persistent IFN- γ expression in the brains of depleted mice 
may be explained by the continued presence of CD4(+) T cells in the brain. Data presented as 
fold-change over uninfected, cannulated control animals ± SEM of five animals per treatment 
group. ** p≤0.01.  
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Figure 6.7: Transplantation of M2 macrophages does not enhance NSC proliferation in 
chronically infected mice. Brains of infected mice were injected with saline, heat-killed M2 
polarized bone-marrow derived macrophages (BMDMs), or live M2 polarized BMDMs via 
intracerebroventricular injection. (A) There was no significant difference among treatment 
groups in numbers of proliferating Sox2(+) NSCs nor was there a significant difference in (B) the 
total number of Sox2(+) NSCs in treated brains. Data presented as average ± SEM of four 
animals per treatment group.  
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An alternate approach was employed to ascertain the impact of IFN-γ on NSC 
proliferation during chronic HSE. IFN-γR1 KO mice on a BALB/c genetic background 
were used to ablate IFN-γ signaling in the brains of infected mice. Evaluation of 
proliferation in the endogenous brain cell (CD45(-)) compartment demonstrated a 
significant increase in the total numbers of Sox2(+) NSCs in infected IFN-γR1 KO mice 
compared to wild-type BALB/c controls (Fig. 6.8A). Additionally, the total numbers of 
Sox2(+) NSCs were not significantly different than uninfected, age-matched controls 
(43035.4±6828.4 total Sox2(+) cells per infected brain vs 31450.9±8335.9 total Sox2(+) 
cells per uninfected IFN-γR1 KO mouse brain; Fig. 6.8A). Surprisingly, the total 
numbers of NSCs in infected IFN-γR1 KO mice was not significantly different than 
uninfected BALB/c mice in spite of robust expression of IFN-γ at 15 d p.i. (Fig. 6.8B). 
Discussion: 
 The present study demonstrated that more than half of CD8(+) T cells persisting 
in the brains of HSV-1 infected mice, at 15 d p.i., produce IFN-γ in response to the virus. 
This phenomenon occurred concurrent with significantly decreased NSC proliferation. In 
contrast, CD8(+) T cell depleted mice had significantly increased numbers of NSCs, and 
significantly reduced IFN-γ expression compared to isotype antibody treated controls. 
This improvement is associated with a change in brain macrophage activation, 
progressing from a M1-like phenotype to an M2-like phenotype. The depletion of 
CD8(+) T cells abrogated microglial activation, as measured by MHC class II expression. 
 188 
 
 
Figure 6.8: Total numbers of NSC in 15 d p.i. infected IFN-γ receptor knockout mice 
increased. (A) Total numbers of Sox2(+) NSCs was not significantly different in uninfected or 
infected IFN-γR1 KO mice nor was it different from uninfected wild-type BALB/c mice (mean= 
solid line across graph). (B) There was no significant difference in the amount of IFN-γ produced 
at 15 d p.i. between BALB/c and IFN-γR1 KO mice. Data as presented as mean±SEM of four 
animals.   
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Figure 6.9: Macrophage polarization of experimental groups with higher NSC numbers 
skews to M2-like. CD206 (gray bars) and CD86 (black bars) from the 
CD45(hi)CD11b(+)Ly6C(hi) infiltrating macrophage population in infected mice given different 
treatments are expressed as averages (SEM can be found in the text) of between five and eight 
animals per treatment group. Numerical ratios express the total number of CD86(+) cells to 
CD206(+) macrophages. Notably, the unmanipulated wild-type (WT), cannulated (Can), and 
isotype antibody treated (Can Iso) groups had CD86 to CD206 ratios of one to one, while 
CD8(+) T cell depleted (Can Dep) and IFN-γR1 KO (IFN-γR1KO) mice had ratios closer to one 
to three. 
 
 
 
1:1 
1:1 
1:1 
1:3 
1:3 
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Surprisingly, there was no significant change in CD4(+) T cell numbers or activation 
following CD8(+) T cell depletion.  The findings in the present chapter correlate to those 
described in Chapter 4, which demonstrate that an M2 dominated immune milieus 
promotes NSCs proliferation. We further confirmed this hypothesis by evaluating NSC 
proliferation in IFN-γR1 KO mice, demonstrating that mice lacking functional IFN-γ 
signaling showed increased numbers of Sox2(+) NSCs compared to wild-type BALB/c 
mice at the same time point. Moreover, IFN-γR1 KO mice maintained an M2-like 
macrophage activation profile at 15 d p.i.. 
Collectively these findings point to an interplay between macrophage activation 
and NSC proliferation. Comparison of macrophage activation profiles of infiltrating 
macrophages at 15 d p.i. between uncannulated, cannulated untreated, or isotype antibody 
treated and CD8(+) T cell depleted or IFN-γR1 KO infected mice demonstrates that 
decreases in IFN-γ expression or loss of IFN-γ signaling results in increased numbers of 
NSC and altered macrophage polarization (Fig. 6.9). Despite variability in total numbers 
of Ly6C(hi) macrophages, only those animals lacking functional IFN-γ signaling had 
CD86 to CD206 ratios of one to three or higher whereas wild-type, cannulated, and 
isotype antibody treated mice had CD206 to CD86 ratios of one to one. 
Antigen specific CD8(+) T cells have been shown to remain in the tissue after 
resolution of infection in numerous model systems, including coronavirus-induced 
encephalitis (Phares, Stohlman et al. 2012) and allergic autoimmune encephalitis 
(Steinman 2001). In humans, memory CD8(+) T cells have been shown to circulate in the 
reproductive tract of women infected with Herpes Simplex virus-2 (Koelle, Posavad et al. 
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1998). The present study demonstrated that approximately half of CD8(+) T cells present 
in the brains of infected mice were HSV-1 specific and produced IFN-γ in response to 
viral antigen, demonstrating the possibility for development of a memory response by the 
persistent CD8(+) T cells. In other models of viral disease such as influenza, memory 
CD8(+) T cells remain in the tissue to accentuate the local immune response should the 
pathogen be reintroduced to the host (van de Sandt, Hillaire et al. 2015). Despite 
undetectable viral antigen in our model of HSE at 15 d p.i., viral DNA from latent HSV-1 
was detected, suggesting that HSV-1 specific CD8(+) T cells present after the onset of 
viral latency may be re-stimulated by viral antigen associated with reactivation events in 
the host. 
 On the other hand, CD8(+) T cells present in the brain have been linked to 
alteration of neurogenesis. In mouse models of viral encephalitis, viz. Japanese 
encephalitis (Das, Dutta et al. 2011) and West Nile encephalitis (Wang, Lobigs et al. 
2003), activated CD8(+) T are associated with decreased NSC proliferation. In this 
present study, depletion of CD8(+) T cells resulted in an increase in total numbers of 
NSCs suggesting that CD8(+) T cells can affect the processes responsible for inducing 
NSC proliferation. In vitro co-culture with activated CD8(+) T cells inhibits NSC 
proliferation in an IFN-γ dependent manner, as addition of an IFN-γ neutralizing 
antibody restores NSC proliferation (Hu, Rotschafer et al. 2014). The role of IFN-γ in the 
inhibition of NSC proliferation may be preserved in vivo as depletion of CD8(+) T cells 
was associated with a significant reduction in IFN-γ expression and increased NSC 
proliferation. Furthermore, the size of the NSC population in infected IFN-γR1 knockout 
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mice remained unaffected by infection with HSV-1, which suggests that inhibition of 
NSC proliferation during chronic HSE is likely mediated by IFN-γ.  
In Chapter 5, IFN-γ was shown to directly inhibit NSC proliferation in response to 
growth stimuli. However, indirect effects of IFN-γ, such as inducing the M1 phenotype in 
macrophages, may contribute to its ability to impair NSC proliferation. IFN-γ inhibits 
development of the M2 phenotype in macrophages, instead stimulating an M1 phenotype 
(Crespo, Bertolotti et al. 2013). M2 polarized macrophages have been shown to decrease 
infarct volume in mouse models of ischemic stroke (Hu, Li et al. 2012) and are essential 
for limb regeneration in salamanders (Godwin, Pinto et al. 2013). In Chapter 4, M2 
macrophages were demonstrated to increase total numbers of NSCs in the brains of 
BALB/c mice and were the dominant macrophage phenotype in the brain at 6 d p.i., at a 
time when the NSC population size was significantly increased. In treatment groups with 
intact IFN-γ signaling, NSC proliferation is significantly decreased at 15 d p.i. and the 
macrophage population is polarized to an M1 phenotype (shown in Chapter 4). Data 
presented in the present study suggests that IFN-γ present in the brain contributes both 
directly and indirectly, via macrophage polarization, to the inhibition of NSC 
proliferation at 15 d p.i.. However, these experiments do not identify the relative 
importance of direct or indirect mechanisms in diminishing neurogenesis and their role in 
development of neurological deficits.  
In summary, this present study shows that CD8(+) T cells negatively impact NSC 
proliferation during experimental HSE via an IFN-γ dependent mechanism. While 
previous studies have shown that IFN-γ has direct inhibitory effect on NSC proliferation, 
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we also demonstrate that removal of IFN-γ alters the polarization of macrophages 
responding to the disease and promotes a healing phenotype in those macrophages. These 
findings suggest that the removal of CD8(+) T cells or IFN-γ from the brains of infected 
mice may promote brain repair, ultimately improve neurological function in the wake of 
brain damage. Although further studies are needed to determine if alteration in 
macrophage profile in combination with improved neurogenesis is sufficient to 
ameliorate the devastating neurological deficits associated with viral encephalitis. 
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Chapter 7: Experimental Herpes Simplex encephalitis is associated with major 
differences in neural stem/progenitor cell proliferation and chronic inflammation in 
BALB/c and C57BL/6 mice. 
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Abstract: 
 Brain infection with Herpes Simplex Virus-1 (HSV-1) is a devastating disease 
that results in robust and prolonged immune cell activation. Current mouse models of 
HSE either induce an alternative immune activation during the acute phase of infection 
(BALB/c) or are ubiquitously fatal and lack a chronic phase of the disease (C57BL/6). 
The objective of this study was to develop a C57BL/6 mouse model that is more 
reflective of acute human HSE while retaining the viral spread and persistent 
inflammation observed in human patients and the BALB/c mouse model. This study 
found that the spread of virus was similar in the traditional BALB/c mouse model and 
new C57BL/6 model. Furthermore, the kinetics of immune cell infiltration were similar 
between BALB/c and C57BL/6 mice. On the other hand, acutely infiltrating macrophages 
in the C57BL/6 mouse model consistently maintain a classically activated phenotype in 
contrast to the acute alternative activation of BALB/c mice. In both models, there was 
marked duration of T cell activation in the brain similar to the human condition. 
However, persistent T cells in C57BL/6 mice were predominantly CD4(+), not CD8(+) 
as in BALB/c mice. NSC proliferation increased during acute HSE and decreased 
significantly during chronic HSE in both C57BL/6 and BALB/c mice. The robust 
inflammatory response generated by C57BL/6 mice to HSV-1 infection may provide 
additional insights into the development of disease and subsequent failure of the brain to 
repair virus-induced damage. 
 
 
 200 
 
Introduction:  
Herpes simplex virus-1 (HSV-1) is the most common cause of sporadic viral 
encephalitis in the United States (Whitley 2006; Kimberlin 2007). While the specific 
insult resulting in HSV-1 migration into the brain is unknown, the progression of the 
virus through the mouse and human brain results in severe neurological deficits that are 
thought to be the result of combined viral and immune-mediated damage (Kastrukoff, 
Lau et al. 2010). Models that specifically address individual elements of the viral and 
immune components contributing to the development of neurological deficits are required 
to identify specific therapeutic interventions.  
Despite being two strains of the same species, the immune responses of BALB/c 
and C57BL/6 mice have measurable differences which must be considered in evaluating 
data. A concise summary of the differences among immune cell types between the two 
strains may be observed in Table 7.1. BALB/c mouse T cells have a preferential shift 
towards the Th2 polarization during immune responses whereas C57BL/6 mouse T cells 
produce a more prominent Th1 polarization (Schulte, Sukhova et al. 2008). In mouse 
models of leishmaniasis, BALB/c derived T cells produced significantly more 
interleukin-4 than C57BL/6 T cells. In contrast, C57BL/6 derived T cells produced 
significantly more interferon-γ (Hsieh, Macatonia et al. 1995). However, it has also been 
shown that failure to induce a strong Th1 immune response from BALB/c T cells does 
not result in heightened Th2 responses in mouse models of pulmonary mycobacterial 
infection (Wakeham, Wang et al. 2000). BALB/c mice also have significantly larger 
numbers of regulatory T cells than their C57BL/6 counterparts, which is thought to  
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Cell Type C57BL/6 BALB/c Reference 
    
Macrophages Increased 
production of TNF-
α and IL-12 
Faster response to 
Mycobacterium 
bovis BCG 
Wakeham et al. 
2000 
Watanabe et al. 
2004 
 
T Cells Increased 
production of IFN-γ 
and IL-6 Decreased 
IL-13  
Increased IL-4 
production and B 
cell activation 
Schulte et al. 2008 
Müller et al. 1993 
Hsieh et al. 1995 
T regulatory cells Fewer natural Treg Increased natural 
Treg 
Faster production of 
inducible Treg 
Hsieh et al. 1995 
Chen et al. 2005 
Jiang et al. 2010 
 
NK cells NK1.1 positive 
High IFN-γ 
production 
NK1.1 negative 
Low IFN- γ 
production 
Stenström et al. 
2005 
Arase et al. 2001 
 
Dendritic Cells Higher expression 
of TLR-9 and TLR-
4; Increased 
production of IL-
12p40 
Higher expression 
of TLR-2, -5, and -6 
Liu et al. 2002 
“Increases” and “decreases” are direct comparisons between the mouse strains. 
Table 7.1: Differences in immune cell activities between C57BL/6 and BALB/c mouse 
strains. This table presents observed differences in immune cell types between mouse strains. 
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confer resistance to autoimmune disorders in BALB/c mice (Chen, Oppenheim et al. 
2005). 
Macrophages form BALB/c and C57BL/6 mice have different responses to the 
same activating stimuli. In mouse macrophages activated with LPS, a potent toll-like 
receptor-4 (TLR-4) agonist, C57BL/6 derived mouse macrophages produced higher 
levels of tumor necrosis factor-α and interleukin-12 than BALB/c derived macrophages. 
Furthermore, C57BL/6 derived macrophages produced measureable amounts of 
lysosomal enzymes and nitric oxide in response to experimental bacterial peritonitis, 
whereas BALB/c mice did not (Watanabe, Numata et al. 2004), which suggests that the 
two different strains of macrophages had different effector functions during disease. 
Dendritic cells also differed between the two mouse strains. Dendritic cells (DCs) derived 
from BALB/c mice expressed significantly more TLR-2, TLR-4-6 mRNA than DCs from 
C57BL/6 mice (Liu, Matsuguchi et al. 2002).These differences in the innate immune 
responses between BALB/c and C57BL/6 mice are particularly relevant to assessing NSC 
proliferation during HSE as Chapters 4, 5, and 6 of this dissertation suggest that 
macrophage activation affects the level of NSC proliferation during disease.  
The kinetics of immune cell infiltration into the brains of BALB/c mice infected 
with HSV-1 are strongly reminiscent of the human condition, with T cells persisting in 
both humans and mice long after the virus has become latent (Aurelius, Andersson et al. 
1994; Marques, Cheeran et al. 2008). While the chronic immune response to HSE is 
consistent between BALB/c mice and humans, there are substantial differences during the 
acute phase of infection. Particularly, infiltrating macrophages during acute HSE are 
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predominantly alternatively activated in the BALB/c mouse model and are only 
classically activated during chronic disease (Chapter 4). Classical macrophage activation 
through Toll-like receptor (TLR) activation has been shown to be essential to 
development of human HSE (Medzhitov and Janeway Jr 2002; Conrady, Drevets et al. 
2010). Similarly, TLR activation has been shown to be essential to development of lethal 
HSE in an intracerebral injection C57BL/6 mouse model of HSE (Kurt-Jones, Chan et al. 
2004). However, this C57BL/6 mouse model results in diffuse HSV-1 infection that is 
not consistent with the human disease.  
The overall objective of this dissertation chapter was to establish a C57BL/6 
mouse model that retained the natural, human-like progression of the virus through the 
brain and the more human-like immediate classical macrophage activation phenotype 
during acute HSE. The model was assessed in terms of NSC proliferation, immune cell 
infiltration and disease progression. 
Materials and Methods: 
Ethics Statement:  
 All studies were done in accordance with the policies of the University of 
Minnesota College of Veterinary Medicine animal care and use committee.  
HSV-1 Infection of BALB/c mice 
 Briefly, eight to ten week old female BALB/c mice were anesthetized with a 
ketamine/xylazine solution and 1.25*105 PFU of HSV-1 strain Syn17+ was instilled into 
each nostril in no more than 2µL per nostril. Animals were placed laid on their backs for 
5 minutes and then righted and returned to their home cages. Infected mice were 
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observed every day during the entire course of the disease and animals meeting moribund 
criteria were euthanized. 
HSV-1 Infection of C57BL/6 mice 
C57BL/6 mice exhibit the HSV-1 resistance NK1.1 gene loci and previous studies 
have shown that NK cells and CD8(+) T cells must be removed to induce HSE 
(Kastrukoff, Lau et al. 2010). To remove these cells, six to eight week old C57BL/6 
female mice (Charles River Laboratories, Richmond, VA) were depleted of their NK and 
CD8(+) T cells using 200 µg anti-NK1.1 and 10ug anti-CD8a (both from BioXCell, 
Lebanon, NH) by intraperitoneal injection three times at -2, 0, and +2 days post infection 
(d p.i.). On infection day the mice were anesthetized using ketamine and xylazine to 
achieve plane 3 anesthesia and a 32GA sterilized stainless steel wire was threaded up 
their nasal passages and scraped against the nasal epithelium. Mice were righted and any 
blood collecting in the nares was collected on a cotton swab. Once blood flow had 
stopped for one minute, 7.5*105 plaque forming units (PFU) of HSV-1 (Syn17+) was 
instilled into each nostril in >2µL (1.5*106 PFU total). Mice were laid on their backs for 
3 minutes and 2% lidocaine gel was applied to their nose. Mice were then returned to 
their home cages. Sham mice received the above procedure minus the virus instillation 
into the nares. Progression of clinical disease was scored using a previously established 
scale (Marques, Hu et al. 2006) from 0 (no visible signs) to 4 (ataxia and/or seizures are 
present). 1 indicates the presence of nasal lesions without neurological signs, 2 indicates 
ruffled fur, and decreased mobility, and 3 is indicative of spinning behaviors and/or lack 
of coordinated movement. Mice meeting euthanasia criteria at a clinical score of 4. 
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HSV-1 localization in the brain 
 Infected mice were collected each day on days 4-11 post infection (n=3 per day) 
and perfused using 4% paraformaldehye. Sham animals (n=3) were collected at 11 d p.i. 
and perfused as with the infected animals. Brains were isolated from the perfused animals 
and cryopreserved by passaging through a 30% sucrose solution and frozen in optimal 
cutting temperature (OCT) medium (Sakura, Torrance, CA). Brains were sectioned into 
10µm longitudinal sections and sections were collected every 200µm throughout the 
brain. 10 sections were collected per slide with 15 slides collected per brain. 
 For immunohistochemistry for HSV-1, sections were quenched of endogenous 
peroxidases using 0.3% hydrogen peroxide in phosphate buffered saline (PBS) for 10 
minutes at room temperature. Slides were then washed three times for five minutes in 
PBS before permeabilizing using 0.5% Triton-X 100 (Sigma Aldrich, St. Louis, MO) in 
PBS for 10 minutes at room temperature. Slides were washed as before. Non-specific 
antibody binding was blocked using 10% bovine serum albumin and 5% goat serum for 
one hour at room temperature, followed by application of anti-HSV-1 early/immediate 
early proteins (polyclonal rabbit IgG; 1:100 DAKO Technologies, Carpinteria, CA) in 
blocking solution. The antibody was incubated overnight at 4°C and washed three times 
as before. Following washing, anti-rabbit IgG conjugated to AlexaFluor 488 (1:500, Life 
Technologies, Carlsbad, CA) was applied for 30 minutes. Finally cells were washed and 
counterstained with DAPI immediately prior to imaging on a Nikon fluorescent 
microscope. 
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Immune Cell Phenotyping 
 Infected and sham infected mice were collected at 3, 5, 8, 15 and 30 d p.i. for flow 
cytometry. Brains and cervical lymph nodes were isolated and mechanically dissociated 
to generate a single cell suspension. 100µL of tissue was collected and preserved in 
RNAlater for further gene analysis at each time point. The single cell suspension was 
then depleted of myelin using Myelin Removal Beads II (Miltenyi Biotec, Auburn, CA) 
as per the manufacturer’s instructions. Following myelin removal, brain and lymph node 
cells were immunostained for CD45, CD11b, CD86, CD4, CD8,CD3, MHC II, CD25, 
FoxP3 (eBioscience, San Diego, CA) and CD206 (BioLegend, San Diego, CA) for 15 
minutes at 4°C. Following two wash steps, the cells were fixed in a 1% 
paraformaldehyde solution for 15 minutes at room temperature. Cells were then 
resuspended in phosphate buffered saline for flow cytometry. AccuCount blank particles 
(Spherotech, Lake Forest, IL) were added for absolute quantification and samples were 
read on a BD FACSCanto within 24 hours of collection.  
Quantification of NSC proliferation 
 Infected and sham-infected brains for quantification of the NSC population were 
prepared as for immune cell phenotyping described above. Following myelin depletion 
brains were immunostained for CD45 for 15 minutes at 4°C. Samples were then fixed 
and permeabilized using the BD CytoFix/CytoPerm kit (BD Biosciences) as per the 
manufacturer’s instructions for 20 minutes at 4°C. Cells were washed two times in 
CytoFix/CytoPerm wash buffer and stained with anti-nestin PE (BD Biosciences), an 
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NSC marker, and anti-Ki-67 (Abcam, Cambridge, MA), a proliferation marker, or anti-
Sox2 eFluor 670, an NSC marker, and anti-Ki-67 (Abcam) for 20 minutes at 4°C. Use of 
nestin or Sox2 to identify the NSC population was dependent on antibody availability at 
time of experimentation. Samples were washed twice in the CytoFix/CytoPerm wash 
solution and anti-rabbit IgG PE (Ki-67 secondary antibody; Life Technologies) was 
applied for 20 minutes at 4°C. Finally cells were washed twice more as above and 
resuspended in PBS. Blank AccuCount particles (Spherotech) were added and the 
samples were read on a BD FACSCanto within 24 hours.  
Morris T-modified Water Maze 
 Changes in short term memory were measured as described previously (Ganguly 
and Poo 2013). Briefly, mice entered the T maze in one set arm. Relative position of that 
arm to visual cues in the pool was unaltered. During the initial training run one arm of the 
T-maze was blocked using transparent Plexiglas and an accessible platform was found on 
the opposite arm relative to the one that was blocked off. Test rums immediately 
followed the training and were conducted identically except the platform was then 
removed from the previously unblocked arm, such that the animal had to correctly make 
the opposite turn from the training run in the test run to find the platform. Animals were 
given 60 seconds to find the platform and then were shown the location. In our paradigm, 
30 d p.i. infected and 30 d p.i. sham infected animals were tested and deficits were 
identified as failure to improve the frequency of correct answers.  
Statistics: 
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 All experiments were analyzed for statistical significance using the Student’s T 
test. Significance is reported at the p<0.05 and p<0.01 levels. 
Results: 
HSV-1 Progression through the Brain 
 Extensive work looking at the progression of virus in the brains of infected 
BALB/c mice was done by Armien et al. which demonstrated that the virus has two 
routes of entry into the brain. The virus first moves through the cribriform plate and into 
the olfactory bulb as early as 2 days post infection (d p.i.). From the olfactory bulb, the 
virus progresses through the entorhinal cortex at 5 d p.i. and into the temporal cortex by 7 
d p.i.. Secondly, HSV-1 antigen can be seen in the trigeminal ganglion at 5 d p.i. and 
progresses into the brainstem by 7 d p.i. (Armien, Hu et al. 2010). Both routes of 
infection result in lesions in the temporal lobe cortex and hippocampus by 7 d p.i.. In the 
C57BL/6 mouse model, multiple foci were observed as the infection progressed and can 
be observed schematically in Fig. 1A. Robust labeling of HSV-1 in the mouse brain was 
observed as early as four days post infection in the olfactory bulb (Fig.1B). From the 
olfactory bulb the virus progressed into the cerebral cortex via the anterior olfactory 
nucleus by 6 d p.i. (Fig. 1C). Infection in the hypothalamus was observed between 7 and 
9 days post infection (Fig. 1D) with cortical involvement evident by 9 d p.i. (Fig. 1E). 
Gene expression data of the HSV-1 gD glycoprotein was elevated more than 3 fold 
higher than uninfected mice from 3 d p.i. through day 12 (data not shown). Importantly, 
as in the BALB/c mouse model of HSE, viral antigen in the brains of infected C57BL/6  
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Figure 7.1: Localization of HSV-1 in C57BL/6 mouse brains. Conserved regions of HSV-1 
intermediate-early protein staining are schematically diagramed on (A) a representative 
longitudinal brain section. White letters indicate sites of HSV-1 staining shown in (B-E). (B) 
HSV-1 was first observed in the olfactory bulb prior to progressing into the (C) ventral striatum 
by 6 d p.i.. Significant ingression was observed by 8 d p.i. when HSV-1 could be found in the (D) 
hypothalamus and (E) cerebral cortex. Representative images are shown of 5 sections per animal 
with three animals collected at each time point.   
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mice became undetectable by 15 d p.i. which demonstrates that immune cell activity 
continues well after the disease is resolved. Previous reports in the BALB/c mouse model 
have established that the mortality rate expected is approximately 50% (Marques, Hu et 
al. 2006; Marques, Cheeran et al. 2008; Armien, Hu et al. 2010; Rotschafer, Hu et al. 
2013), which is consistent with the mortality observed in this study (Fig 2A). Peak 
morbidity was observed in both mouse strains between 5 and 11 d p.i.. Consistent with 
peak lethality at those time points, clinical disease scores also peaked between 4 and 10 d 
p.i. in both mouse model systems (Fig. 2B). Importantly the progression of the virus 
through the brain was localized to discrete regions in both model systems and followed 
the same morbidity and mortality kinetics as BALB/c mice infected with HSV-1 by 
intranasal inoculation as presentation of virus lesions as discrete viral lesions are 
characteristic of the human disease (Margaret 1982). 
HSE is associated with alterations in NSC proliferation and learning. 
NSC proliferation in the C57BL/6 mouse model responded dynamically to the 
infection. Peak NSC numbers (CD45(-)nestin(+)) occurred at 6 d p.i. (74733.6±7730.8, 
p<0.01) in infected BALB/c mice and total NSC numbers were significantly decreased at 
10 d p.i. (26680.6±6604.0, p<0.05; Fig. 3A). Similarly, the C57BL/6 mouse model had 
peak NSC numbers at 6 d p.i. (32548.3±5332.9 cells per brain; Fig. 3B) and the NSC 
population was significantly decreased by 10 d p.i. (8987.9±2451.7 cells per brain, 
p<0.01). In contrast to the BALB/c mouse model, the increase observed at 6 d p.i. in 
C57BL/6 mice was not significantly increased compared to sham infected controls. 
However, significant (p<0.01) depression of the NSC population persists in infected mice  
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Figure 7.2: Survival and clinical scores of HSV-1 infected BALB/c and C57BL/6 mice. 
Infected and sham infected mouse survival was charted. (A) In both model systems peak 
mortality occurred between 5 d p.i. and 11 d p.i.. (B) Clinical disease scores were consistent 
between the mouse models. Data presented for three experiments with ten animals per 
background.  
A 
B 
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Figure 7.3: Kinetics of NSC proliferation in response to HSE in BALB/c and C57BL/6 mice. 
(A) Total numbers of NSCs in BALB/c mice. (B) In C57BL/6 mice, there is no significant 
increase in cell numbers. Total numbers of NSCs become significantly decreased at 10 d p.i. and 
remain decreased through the last time-point measured, 30 d p.i.. Data presented are the 
average±SEM of between five and eight animals per group, * p<0.01. 
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out to 30 d p.i. in both mouse models which suggests that viral infection has significant 
impacts on adult neurogenesis consequent to HSE.  
Infection of BALB/c mice has been previously demonstrated to result in 
substantial spatial memory deficits following infection (Armien, Hu et al. 2010). To 
assess neurological deficits in HSV-1 infected C57BL/6 mice, learning abnormalities 
were assessed in this model. The level of neurological impairment in infected C57BL/6 
mice was assessed using a modified T-Morris water maze task which tests the short term 
spatial memory in infected animals. Infected mice had a trend of worsened spatial 
memory as these animals performed poorly in the behavior test compared to their sham-
infected C57BL/6 controls. Specifically, infected mice failed to increase their incidence 
of correct turning in the testing trials whereas sham-infected mice showed a trend of 
increased frequency of correct turning (Fig. 4), which suggests that the C57BL/6 model is 
producing neurological deficits consistent both with the BALB/c model as well as the 
human condition of HSE. 
Immune Cell Infiltration in the Infected Brain 
Macrophage infiltration had similar trends in both BALB/c and C57BL/6 mice. 
Total numbers of Ly6C(hi) macrophages peaked at 6 d p.i (86835.1±7100.8 cells per 
C57BL/6 brain and 282,000 ± 13,880 cells per BALB/c brain, p<0.01; Fig. 5A&C). 
However, there was a significant (p<0.1) difference in the magnitude of macrophage 
infiltration between the mouse models. Despite the difference in population size, both 
populations were reduced by five-fold at 15 d p.i. which suggests that cellular  
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Figure 7.4: Infected C57BL/6 mice have decreased short-term memory. Infected and 
uninfected animals at 30 d p.i. had their short-term memory tested in a T modified Morris water 
maze task. Sham (open circles) and infected (black circles) were tested and the frequency of 
correct turns was measured. Data presented are the average±SEM of three animals per group.   
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Figure 7.5: Kinetics of macrophage infiltration and polarization into HSV-1 infected 
BALB/c and C57BL/6 mouse brains. Total number of CD45(hi)CD11b(+)Ly6C(hi) infiltrating 
macrophages peaked at 6 d p.i. in both (A) BALB/c and (C) C57BL/6 mice. M1 polarized 
macrophages (black bar) was quantified and compared to M2 polarized macrophages (gray bar) 
in (B) BALB/c mice and (D) C57BL/6 mice. Data presented are averages ±SEM of 5 animals per 
time-point. ** p≤0.01.  
A B 
D C 
** 
** 
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mechanisms controlling macrophage infiltration may be preserved in both model 
systems. Specific evaluation of the polarization of the infiltrating macrophages revealed 
notable differences in the population of CD86(+) classically activated macrophages 
between the two mouse models. BALB/c mice at 6 d p.i. had a ratio of CD86(+) M1 
macrophages to CD206(+) M2 macrophages of one to five (Fig 5B) whereas C57BL/6 
mice had a ratio of five to one at 6 d p.i. (Fig 5D). The difference in macrophage 
polarization between mouse models at 5 and 15 d p.i. was statistically significant at the 
p<0.01 level. 
Previous studies in the BALB/c mouse model have demonstrated that microglial 
cells are robustly activated after mice are infected with HSV-1 (Marques, Cheeran et al. 
2008). Activation manifests as significant increases in chemokine production and 
significant up regulation of major histocompatibility class II (MHCII). As early as 8 d p.i. 
approximately 80% of microglia (CD45(int)CD11b(+)) in the brain are expressing 
MHCII whereas uninfected mice had no measureable expression of MHCII. Furthermore, 
microglia continued to express MHCII past 30 d p.i. (Marques, Cheeran et al. 2008). In 
the C57BL/6 mouse model system, microglial activation began at 3 d p.i. with a modest 
increase in the total numbers of MHCII(+) microglia (62031.2±17556.1 cells per brain, 
ns; Fig. 6). Significant increases in numbers of activated microglia activation began at 6 d 
p.i. (201662.7±14161.7 cells per brain, p<0.01) and remained significantly elevated at 15 
and 30 d p.i. (142993.9±31846.7 cells per brain at 15 d p.i., p<0.01; 103930.0±18081.6 
cells per brain at 30 d p.i., p<0.01) which is consistent with what is observed in the 
BALB/c model system. 
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Figure 7.6: Microglial activation is dynamic during HSE. Total brain microglia were analyzed 
for MHCII expression. Notably in (A) C57BL/6 and (B) BALB/c microglial activation stayed 
elevated at 15 d p.i.. Data presented are averages ±SEM of 5 animals per time point, p<0.01 
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Kinetics of T cell infiltration were similar between the BALB/c and C57BL/6  
mouse model systems. In BALB/c mice notable numbers of T cells (CD45(hi)CD3(+)) 
infiltrate the infected brain by 8 d p.i. with peak T cell infiltration occurring at 15 d p.i. 
(Marques, Cheeran et al. 2008). Notably, as the T cell infiltration progressed, the 
phenotype shifted from one to one CD4(+) to CD8(+) at 8 d p.i. to one to two at 15 d p.i. 
(Marques, Cheeran et al. 2008). A marked difference between BALB/c and C57BL/6 
mice infected with HSV-1 was the timing of peak T cell infiltration. Total numbers of T 
cells peaked at 8 d p.i. (1007353.6±222926.5 cells per brain, p<0.01) and although T cells 
remained elevated through 30 d p.i., total numbers decreased dramatically at 15 d p.i. 
(Fig. 7A). Furthermore, CD4(+) T cells outnumbered CD8(+) T cells persistently 
throughout the infection.  At 8 d p.i., CD4(+) T cells outnumbered CD8(+) T cells in a 
three to two ratio (601998.8±84059.0 CD4(+) T cells per brain vs 405354.8±138867.4 
CD8(+) T cells per brain) and by 15 d p.i. CD4(+) T cells outnumbered CD8(+) T cells 
almost six to one (282777.2±88385.5 CD4(+) T cells per brain vs 50028.9±15916.1 
CD8(+) T cells per brain). On the other hand, interferon-γ (IFN- γ) expression was 
significantly elevated during T cell infiltration and peaked at 15 d p.i. in the C57BL/6 
model. IFN-γ remained significantly elevated at 30 d p.i. (Fig. 8). IFN- γ has been well 
documented to persist after 15 d p.i. in BALB/c mice and has been shown to inhibit NSC 
proliferation in Chapters 5 and 7 of this dissertation (Marques, Cheeran et al. 2008). 
While the kinetics of T cell infiltration was significantly (p<0.01) different in C57BL/6 
mice compared to BALB/c mice, the timing and duration of IFN- γ expression was not 
significantly altered between the strains. 
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Figure 7.7: CD4(+) T cells dominate the immune response at 15 d p.i.. Total brain T cells 
were evaluated in uninfected and HSV-1 infected C57BL/6 mice. (A) The total number of T cells 
increased at 8 d p.i. (B) Among the NK cell subset there were no significant changes in total 
numbers. Data presented are averages ±SEM of 5 animals per time-point.  
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Figure 7.8: IFN-γ gene transcription peaks at 15 d p.i.  IFN-γ gene expression was 
undetectable at 6 d p.i. and peaked at 15 d p.i.. Furthermore, IFN- γ expression was elevated past 
30 d p.i. Data presented as fold-change over uninfected control animals ± SEM of five animals 
per time-point. 
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NK cells do not affect the course of HSE in C57BL/6 mice 
Given the importance of the NK1.1 gene loci in resistance of C57BL/6 mice to 
infection with HSV-1 (Kastrukoff, Lau et al. 2010), changes in the NK and NK T cell 
populations was measured. Surprisingly, numbers of NK and NK T cells did not change 
significantly at any time post infection including the 3 d p.i. time point which occurred 1 
day after the final injection with anti-NK1.1 and anti-CD8a antibodies (Fig. 7B) which 
suggests that NK cells are consistent throughout the course of infection and do not 
significantly contribute to the immune response in the brain. 
Discussion:  
 The objective of this dissertation chapter was to develop a new C57BL/6 mouse 
model of HSE that maintained the viral spread observed in the BALB/c model while 
altering the acute macrophage phenotype to more closely mirror the human condition. 
The C57BL/6 mouse infection with HSV-1 resulted in a robust inflammatory response 
and dynamic alteration in NSC proliferation. HSV-1 viral proteins were observed in the 
same brain regions of infected C57BL/6 mice as in the BALB/c mouse model at similar 
time points (Table 7.2). No significant differences in mortality (p=0.9378) or clinical 
disease scores (p=0.8734) were observed between infected BALB/c and C57BL/6 mice. 
Similar to the BALB/c mouse model, total numbers of NSCs were increased at 6 d p.i. 
and decreased by 10 d p.i. in C57BL/6 mice. Macrophage infiltration kinetics were 
similar between the strains (p=0.2645); however, macrophage phenotype was 
consistently polarized to classical  
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 Criteria BALB/c Model C57BL/6 Model P-value 
 Gross Findings    
 HSV-1 Antigen 
Present 
Olfactory bulb at 2 d p.i., 
Entorhinal cortex at 5 d p.i. 
Temporal cortex at 7 d p.i.  
Olfactory bulb at 4 d p.i. 
Entorhinal cortex at 6 d p.i. 
Cerebral cortex at 8 d p.i. 
0.0837 
0.2843 
0.5786 
 Viral antigen  not 
detectable 
ND at 15 d p.i.  ND at 15 d p.i. 0.8258 
 Clinical Scores 8 days at 4;  
mortality at 50%, 
7 days at 4; 
mortality at 50% 
0.8734 
0.9378 
 Inflammatory 
Milieu Findings 
   
 Kinetics of NSC 
proliferation 
Peak at 6 d p.i.  
Depressed at 10 d p.i. 
 
Peak at 6 d p.i.  
Depressed at 10 d p.i. 
 
0.2374 
0.9534 
 Macrophage 
Infiltration and 
Activation 
Infiltration peak at 6 d p.i. 
M1: M2 ratio of 5:1 
Persistently M1 dominant 
 
Infiltration peak at 6 d p.i. 
M1: M2 ratio of 1:5  
M2 dominant at 6 d p.i. 
M1 dominant at 15 d p.i. 
 
0.2645 
0.0023 
0.0042 
 T cell Infiltration and 
Activation 
Peak infiltration at 15  
d p.i. 
CD8(+) dominant at 15  
d p.i. 
Robust IFN-γ expression at  
15 d p.i. 
Peak infiltration at 8  
d p.i. 
CD4(+) dominant at 15 
d p.i. 
Robust IFN-γ expression at 
15 d p.i. 
0.0062 
 
0.0034 
0.5963 
Bold indicates significant differences between mouse model systems. P-values measure between 
the two strains. 
Table 7.2: Summary of HSE Model Systems. Brief description of HSE progression in BALB/c 
and C57BL/6 mouse model systems. While there were many similarities between the model 
systems, significant differences emerged. 
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(M1) activation (p=0.0042). T cell infiltration was composed primarily of CD4(+) T 
cells, with peak T cell infiltration occurring at 10 d p.i. (p=0.0062). On the other hand, 
there was robust production of IFN-γ at 15 and 30 d p.i. (p=0.5963), which suggests that 
the immune response induced in C57BL/6 was primarily a Th1 polarized response. 
Adult neurogenesis in C57BL/6 mice had marked similarities to the BALB/c 
mouse model of HSE. NSCs have been shown to proliferate robustly in a C57BL/6 
mouse model of Japanese encephalitis; however proliferation in this model lasts less than 
three days before total numbers of NSCs are significantly depressed. This depression 
lasts through the last time point measured at 9 d p.i. (Das and Basu 2008). This study 
demonstrated that NSCs in infected C57BL/6 mouse brains respond to infection with 
HSV-1 with a slight increase in total numbers of cells prior to an abrupt decrease that 
remains significantly lower than uninfected mice through 30 d p.i.. In contrast, BALB/c 
experience a more robust increase in proliferation at 6 d p.i. that is significant (p<0.01) 
prior to a notable drop in the total number of NSCs at 10 d p.i. which suggests that, while 
C57BL/6 NSCs have a dynamic response to HSE, the response is different than the 
BALB/c mice.  
 Differences in the NSC response to HSE between the models may be explained 
by persistent M1 activation of brain infiltrating macrophages during normal NSC 
proliferation. While the M1 phenotype of macrophages is observed in humans during 
acute HSE (Conrady, Drevets et al. 2010), previous studies in this dissertation have 
shown that M1 macrophages are only present during chronic HSE when NSC 
proliferation is impaired and there is robust IFN-γ present (Chapters 5&6). During acute 
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HSE in BALB/c mice, M2 macrophages are present and NSC proliferation is increased 
(see chapter 4). In a similar manner, NSC proliferation was reversibly associated with 
macrophage activation in a C57BL/6 mouse model of Japanese Encephalitis, as treatment 
with minocycline, an alternative phenotype inducing stimulus, induced a significant 
increase in NSC proliferation and concurrent decrease in M1 macrophage activation and 
IFN-γ production (Dutta, Mishra et al. 2010). This study found that NSC proliferation 
was impaired under M1 macrophage dominant conditions in the presence of IFN-γ 
similar to the Japanese Encephalitis, which suggests that the C57BL/6 mouse model of 
HSE may provide more relevant information on the interactions of macrophages and 
NSCs during acute viral encephalitis in humans than the BALB/c mouse model.  
 T cell kinetics during HSE are similar between the two strains despite difference 
in T cell phenotype. Previous studies in the BALB/c mouse model have demonstrated 
that T cells begin to infiltrate the infected brain around 6 d p.i. with peak infiltration 
occurring around 15 d p.i. (Marques, Cheeran et al. 2008). Infiltration in the C57BL/6 
mouse model of HSE presented here also was measureable at 8 d p.i., however, peak T 
cell infiltration also occurred at 8 d p.i.. Moreover, the phenotype of infiltrating T cells 
was CD4(+) dominant at 8, 15, and 30 d p.i. in C57BL/6 mice. In contrast, the BALB/c 
mice have equal numbers of infiltrating CD4(+) and CD8(+) T cells at 8 d p.i. and 
gradual increase in the CD8(+) T cell compartment such that at 15 d p.i. CD8(+) T cells 
outnumber CD4(+) T cells two to one (Marques, Cheeran et al. 2008). While C57BL/6 
mice infected in this study were CD8(+) T cell depleted, pilot studies using the CD8(+) T 
cell depleting antibody demonstrated that the splenic CD8(+) T cell compartment is 
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normally restored within 5 days of the last depletion treatment (data not shown), 
indicating that the CD4(+) dominance is due to the lack of available CD8(+) T cells. 
Furthermore, despite the preponderance of CD4(+) T cells, there was still robust 
production of IFN-γ in the brains of infected C57BL/6 mice at 15 and 30 d p.i. suggesting 
that the T cell polarization was Th1 as in the BALB/c mouse model. 
 Progression of the virus through the brain in infected mice was consistent between 
BALB/c and C57BL/6 mouse strains. Previous studies using the BALB/c mouse model 
of disease demonstrated that the primary movement of the virus occurs in a retrograde 
manner with viral infection limited to specific tracts in the brain even while inflammation 
occurs at sites distant from actual viral lesions (Webb SJ 1989; Armien, Hu et al. 2010). 
The present study suggests that intranasal instillation of virus with nasal scarification 
results in the same progression of the virus in C57BL/6 mice. Gross measures of disease, 
such as clinical scores were consistent between the mouse strains and suggested that this 
route of infection resulted in similar kinetics of disease. Furthermore, evaluation of 
neurological deficits reveal measureable losses in spatial memory in BALB/c mice 
(Armien, Hu et al. 2010). Similarly, HSV-1 infection in C57BL/6 mice results deficits in 
spatial memory albeit less severe deficits than those observed in BALB/c mice. 
This dissertation chapter describes the use of a C57BL/6 mouse model of HSE 
which provides a tool for assessing NSC-macrophage interactions during acute HSE. 
Furthermore, the trends observed in NSC proliferation in the C57BL/6 mouse model 
affirm the findings of the BALB/c mouse model (Chapters 4&6) which suggest that an 
M1 dominant macrophage milieu in the presence of IFN-γ is connected to impaired NSC 
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proliferation. Both BALB/c and C57BL/6 mouse models of HSE suggest that the IFN-γ is 
the key mediator of the observed reduction of NSC proliferation. This effect of IFN-γ on 
NSC proliferation may be preserved in human HSE patients, as IFN-γ has been found in 
the cerebrospinal fluid of HSE patients after disease resolution and during peak brain 
remodeling (Lellouch-Tubiana, Fohlen et al. 2000; James, Kimberlin et al. 2009). 
Identifying mechanisms to control the production of IFN-γ in the brains of human 
patients may provide an avenue for future studies to improve adult neurogenesis 
following HSE. 
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Conclusions and Limitations: 
 Several significant findings related to reparative processes in the HSV-1 infected 
mouse brain have been described in this dissertation. These studies provide the first 
documentation that neural stem/progenitor cells (NSCs) proliferate in response to HSV-1 
brain infection. Increased NSC proliferation is associated with changes in the 
macrophage activation phenotype because M2 polarized macrophages were shown to 
increase NSC proliferation both in vivo and in vitro, whereas M1 macrophages were 
associated with decreased NSC proliferation. CD8(+) T cells were found to impair NSC 
proliferation both in vivo and in vitro via production of interferon-γ (IFN-γ). IFN-γ is a 
potent stimulator of the M1 macrophage phenotype, which is the dominant phenotype 
observed at 15 d p.i., when NSC proliferation declines below control levels. Expanding 
beyond the original BALB/c mouse system, a C57BL/6 mouse model of Herpes Simplex 
encephalitis (HSE) was developed to aid in further assessing the impact of inflammation 
in altering adult neurogenesis, specifically by exploiting pre-existing knockout mice that 
have been constructed on the C57/BL/6 genetic background. 
Kinetics of NSC proliferation 
The kinetic response of NSCs to HSE was dynamic over the course of infection. 
Total NSC proliferation in this dissertation was defined as the change in numbers of any 
one of the three cell populations in the brain that are capable of proliferation. The 
proliferating NSC cell types include: B cells, primordial astroglia-like cells, C cells, 
transit amplifying cells, and A cells, migratory neuroblasts. The different possible 
phenotypes of proliferating cells in response to brain damage highlights the complexity of 
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adult neurogenesis. Reactive neurogenesis, in response to damage, begins when B cells 
differentiate into transit amplifying cells to generate more C cells and migratory 
neuroblasts (Doetsch, Garcı́a-Verdugo et al. 1997; Doetsch, Caillé et al. 1999). All three 
populations proliferate in close proximity to the neurogenic niche. However, this study 
did not address each proliferating cell population individually. It is possible that each of 
these populations responds to different immune cues and contribute disproportionately to 
brain repair. Additionally, the functional outcomes of NSCs proliferating during acute 
HSE were not investigated in these studies. NSCs have the capacity to differentiate into 
neurons, astrocytes and oligodendrocytes under physiological and inflammatory 
conditions (Arvidsson, Collin et al. 2002). As terminally differentiated neurons and 
astrocytes cannot innately be reprogrammed into other brain cell types (Brami-Cherrier, 
Anzalone et al. 2014; Paşca, Panagiotakos et al. 2014), the functional recovery of 
neuronal circuitry following viral encephalitis requires that adult neurogenesis not only 
produces neurons, but also successfully replaces damaged neurons by integration into the 
existing neuronal circuitry. 
Alterations in NSC proliferation were associated with concurrent change in 
fibroblast growth factor-2 (FGF-2) gene expression. NSCs have been shown to proliferate 
in response to FGF-2 in models of experimental autoimmune encephalitis (EAE) (Brown, 
Couillard-Després et al. 2003). Similarly, NSCs were found to be responsive to FGF-2 
during HSE in Chapter 3 of this dissertation. Similar studies utilizing mouse models of 
Alzheimer’s disease have demonstrated that supplementation of FGF-2 to the damaged 
brain increases NSC proliferation, concurrent with improved memory development 
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(Kiyota, Ingraham et al. 2011). In addition, the studies presented in this dissertation also 
demonstrated that expression of neurotrophin-3 (NT-3) was differentially regulated 
during acute and chronic HSE, suggesting that NT-3 may also have a role in temporal 
regulation of NSC proliferation during HSE. While the role of NT-3 was not elucidated 
in this study, FGF-2 supplementation into the brain increased proliferation of NSCs 
within 3 days after treatment. Further supporting a role of FGF-2 in neurogenesis initiated 
during HSE, NSC proliferation was suppressed at time points where FGF-2 was down 
regulated.  
Macrophage interactions increase NSC proliferation during acute HSE 
Alternatively activated, M2 macrophages, comprised the largest fraction of 
infiltrating immune cells at 5 d p.i.. Furthermore, M2 macrophages increased NSC 
proliferation both in vivo and in vitro. Increased NSC proliferation in response to M2 
macrophages in vivo and in vitro is consistent with previously established restorative 
functions of alternatively activated macrophages because M2 polarized macrophages 
have been shown to promote tissue regeneration in mouse models of stroke (Ekdahl, 
Kokaia et al. 2009; Zhou, Cheng et al. 2011; Hu, Li et al. 2012), West Nile encephalitis 
(Getts, Terry et al. 2012), skeletal muscle damage (Arnold, Henry et al. 2007), and 
allergic asthma (Hong, Chung et al. 2014). However, macrophage polarization is not 
rigidly fixed but, instead, reflects a spectrum of continuous activation phenotypes making 
the definitions of “classical” and “alternative” activation intrinsically artificial (Crespo, 
Bertolotti et al. 2013). Therefore in vitro M2-polarized CD206(+) macrophages may not 
perfectly mimic cells designated as M2 polarized by in vivo polarization based solely on 
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their CD206(+) expression. In a study of Alzheimer’s patients classification of 
macrophage phenotypes in the cerebrospinal fluid into M1 or M2 phenotypes, based on 
gene expression, concluded that identifying macrophage polarization states in the human 
was impossible using current known markers (Wilcock 2014). However, regardless of the 
categories of discernable macrophage phenotypes in the brain, their effects on NSC 
proliferation based on CD206 expression is similar in vivo and in vitro, suggesting that 
the signals associated with macrophage activation play a critical role in modulating 
neurogenesis.  
M2 macrophage induced NSC proliferation was found to be dependent on Wnt5a. 
The identification of Wnt5a as a possible soluble mediator produced by the immune 
system that drives NSC proliferation, both in vivo and in vitro, represents a major new 
finding. Involvement of the Wnt pathway suggests that embryonic mechanisms used 
during brain development, including Wnt signaling, may be preserved in adult brains 
(Masckauchán, Agalliu et al. 2006; Halleskog, Dijksterhuis et al. 2012; Cunningham, 
Martínez-Cerdeño et al. 2013; Halleskog and Schulte 2013) and that Wnt signaling may 
potentially be harnessed for therapeutic purposes. Wnt3a has been shown to increase 
numbers of immature neurons and decrease brain lesion volume in mouse stroke models 
(Shruster, Ben-Zur et al. 2012). Wnt3a was not found to have a significant impact on 
neurogenesis in HSE, however, this may explained by the reciprocal inhibition of Wnt3a 
and Wnt5a expression in the brain (Sato, Yamamoto et al. 2010). While Wnt5a is a 
prototypical activator of the non-canonical Wnt/β-catenin pathway (Pourreyron, Reilly et 
al. 2012), Wnt5a has also been shown to interact with different proteins in the canonical 
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pathway to promote midbrain dopaminergic neuron development (Andersson, Saltó et al. 
2013). These findings suggest that the mechanism of NSC proliferation mediated by 
Wnt5a is more complex than elucidated in the current work and further studies are 
required to understand the intricacies of the pathway responsible for inducing 
neurogenesis. 
CD8(+) T cells impair NSC proliferation during chronic HSE 
In this dissertation, CD8(+) T cells were shown to impair NSC proliferation, both 
in vivo and in vitro, through production of IFN-γ. The increase in total number of NSCs 
observed in the absence of CD8(+) T cells in the HSV-1 infected mouse brain suggests 
that these cells contribute to inhibiting NSC proliferation during chronic HSE. 
Concurrent reduction of IFN-γ expression in CD8(+) T cell depleted mice and loss of the 
inhibitory effect in IFN-γ receptor 1 knockout mice (despite the presence of IFN-γ 
producing CD8(+) T cells), suggests that the effect on NSC proliferation is mediated by 
IFN-γ. In the present studies, depletion of CD8(+) T cells required the installation of 
intracerebroventricular cannulas into the lateral ventricles as the blood-brain barrier is 
intact at 15 d p.i. (data not shown). CD8(+) T cells are required to clear the active HSV-1 
infection (Mackay, Wakim et al. 2012), however cannula placement resulted in the 
transection of the right hippocampus which complicates interpretation of behavioral 
testing data in treated mice. Even though behavioral assessments were not fully 
interpretable in these studies, an increase in NSC proliferation was observed in CD8(+) T 
cell depleted mice, suggesting that an improvement in neurological deficits may be 
associated with depleting CD8(+) cells during the chronic phase of HSE. An important 
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future direction of these studies is to assess learning and memory in mice lacking CD8(+) 
T cells using a less intrusive method to remove these cells from the brain. 
Perhaps the most important finding of these studies is the role of IFN-γ in 
impairing NSC proliferation in vivo and in vitro, as IFN-γ’s effects may be seen in many 
types of brain damage. In these studies, the NSC population in infected IFN-γR1 
knockout mice was unaffected by infection with HSV-1, which suggests that inhibition of 
NSC proliferation is mediated by IFN-γ. On the other hand, these findings also raise 
questions of whether IFN-γ’s effects on NSC proliferation are mediated by direct 
interaction with NSCs or indirectly through macrophage activation during HSE. 
Additional research may be needed to tease out the contribution of direct and indirect 
mechanisms by which IFN-γ inhibits NSC proliferation. Understanding the mechanisms 
of neurological damage following HSE may be dependent on identifying the specific 
contributions of IFN-γ to inhibition of neurogenesis and development of brain damage at 
sites distal to the neurogenic niches. However, these studies only utilize the BALB/c 
mouse genetic background. In-bred mouse strains are known to have significant 
differences in generating immune responses to similar stimulation (Fiorentino, Bond et 
al. 1989) that decreases the applicability of these findings to out-bred populations, such 
as humans.  
Alterations in NSC proliferation dependent on mouse genetic background 
 To begin to address the impact of genetic background on neurogenesis discussed 
in this chapter, a C57BL/6 mouse model for HSE was developed. Despite notable 
differences in the peak of T cell infiltration and the phenotype of infiltrating T cells, 
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many other similarities in the immune response was observed between the two strains. 
Particularly, the prominent presence of M1 macrophages during the chronic phase of 
infection, the robust decrease in NSC proliferation, and the prominent production of IFN-
γ in the chronic phase of HSE are similar in both models.  This finding suggests that the 
C57BL/6 model may be useful for further assessment of the role of IFN-γ in the brains of 
mice surviving HSE.  
Summary 
Collectively, the findings in this dissertation demonstrate that the inflammatory 
milieu has a profound influence on the brain’s reparative processes, both by direct and 
indirect mechanisms. A summary of the conclusions and future directions of these studies 
is represented diagrammatically in Figure 8.1. These studies demonstrated that 
inflammation resulting from HSV-1 brain infection decreases NSC proliferation under 
conditions that promote classical macrophage activation phenotype.  In this context, the 
ongoing inflammatory processes may contribute directly to the development of 
neurological sequelae. Future directions for this research should primarily focus on the 
steps in adult neurogenesis that follow NSC proliferation. In addition, further 
manipulation of the brain milieu to direct inflammatory processes that drive neurogenesis 
will be critical to understand the contribution of the interaction between the two systems, 
viz. immune system, and neurogenesis. Specific points of interventions identified in this 
dissertation as having therapeutic potential are mechanisms that reduce IFN-γ levels in 
the post-encephalitic brain and mechanisms to increase the concentration of Wnt5a in the  
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Figure 8.1: Summary of thesis limitations and future directions. Previous studies have 
established that existing immune cell activation contributes to the development of neurological 
sequelae. The major findings of this dissertation are found to the left of the boxes and items to the 
right of the boxes detail the limitations of the current studies as well as important future directions 
suggested by the findings of this dissertation (Wnt5a and IFN-γ).  
Inflammation 
Decreased NSC 
proliferation IFN-γ Neurological 
Sequelae 
Classical 
Macrophage 
Activation 
Other Steps 
Excessive Immune Cell Activation 
Wnt5a 
Manipulation of the 
Brain Milieu 
 240 
 
brain to increase adult neurogenesis. These interventions, while promising, require 
further evaluation to assess safety and efficacy. The studies presented in this dissertation 
clearly establish that controlling neuroinflammation is a prerequisite for any successful 
attempt to induce NSC proliferation or brain repair. Ultimately, these insights may 
facilitate the development of therapeutic interventions to achieve life altering 
improvements for viral encephalitis survivors. 
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